UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Amendment No. 24)*
URS CORPORATION
--------------------------
(Name of Issuer)
Common Stock, Par Value $0.01 Per Share
Series A Preferred Stock, Par Value $1.00 Per Share
Series B Exchangeable Convertible Preferred Stock, Par Value $1.00 Per Share
Series C Preferred Stock, Par Value $1.00 Per Share
---------------------------------------------------------------
(Title of Class of Securities)
903236107
--------------------------
(CUSIP Number)
Murray A. Indick
Richard C. Blum & Associates, L.P.
909 Montgomery Street, Suite 400
San Francisco, CA 94133
(415) 434-1111
--------------
(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)
June 9, 1999
------------
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to
report the acquisition which is the subject of this Schedule 13D, and is
filing this schedule because of Rule 13d-1(b)(3) or (4), check the following
box [ ].
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities,
and for any subsequent amendment containing information which would alter
disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be
deemed to be "filed" for the purpose of Section 18 of the Securities Exchange
Act of 1934 ("Act") or otherwise subject to the liabilities of that section of
the Act but shall be subject to all other provisions of the Act (however, see
the Notes).
Page 1 of 107
CUSIP NO. 903236107 SCHEDULE 13D Page 2 of 107
- ------------------------------------------------------------------------------
1. NAME OF REPORTING PERSON RICHARD C. BLUM & ASSOCIATES, L.P.
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON 94-3205364
- ------------------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [x]
(b) [x]
- ------------------------------------------------------------------------------
3. SEC USE ONLY
- ------------------------------------------------------------------------------
4. SOURCE OF FUNDS* See Item 3
- ------------------------------------------------------------------------------
5. CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEMS 2(d) or 2(e) [ ]
- ------------------------------------------------------------------------------
6. CITIZENSHIP OR PLACE OF ORGANIZATION California
- ------------------------------------------------------------------------------
7. SOLE VOTING POWER -0-
NUMBER OF -----------------------------------------------------------
SHARES 8. SHARED VOTING POWER Common Stock 2,919,888**
BENEFICIALLY
OWNED BY EACH -----------------------------------------------------------
PERSON WITH 9. SOLE DISPOSITIVE POWER -0-
-----------------------------------------------------------
10. SHARED DISPOSITIVE POWER Common Stock 2,919,888**
- ------------------------------------------------------------------------------
11. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
Common Stock 2,919,888**
- ------------------------------------------------------------------------------
12. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES [ ]
- ------------------------------------------------------------------------------
13. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
Common Stock 19.1%**
- ------------------------------------------------------------------------------
14. TYPE OF REPORTING PERSON PN, IA
- ------------------------------------------------------------------------------
** See Item 5 below
*SEE INSTRUCTIONS BEFORE FILLING OUT!
CUSIP NO. 903236107 SCHEDULE 13D Page 3 of 107
- ------------------------------------------------------------------------------
1. NAME OF REPORTING PERSON RICHARD C. BLUM & ASSOCIATES, INC.
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON 94-2967812
- ------------------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [x]
(b) [x]
- ------------------------------------------------------------------------------
3. SEC USE ONLY
- ------------------------------------------------------------------------------
4. SOURCE OF FUNDS* See Item 3 below
- ------------------------------------------------------------------------------
5. CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEMS 2(d) or 2(e) [ ]
- ------------------------------------------------------------------------------
6. CITIZENSHIP OR PLACE OF ORGANIZATION California
- ------------------------------------------------------------------------------
7. SOLE VOTING POWER -0-
NUMBER OF -----------------------------------------------------------
SHARES 8. SHARED VOTING POWER Common Stock 2,919,888**
BENEFICIALLY
OWNED BY EACH -----------------------------------------------------------
PERSON WITH 9. SOLE DISPOSITIVE POWER -0-
-----------------------------------------------------------
10. SHARED DISPOSITIVE POWER Common Stock 2,919,888**
- ------------------------------------------------------------------------------
11. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
Common Stock 2,919,888**
- ------------------------------------------------------------------------------
12. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES [ ]
- ------------------------------------------------------------------------------
13. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
Common Stock 19.1%**
- ------------------------------------------------------------------------------
14. TYPE OF REPORTING PERSON CO
- ------------------------------------------------------------------------------
** See Item 5 below
*SEE INSTRUCTIONS BEFORE FILLING OUT!
CUSIP NO. 903236107 SCHEDULE 13D Page 4 of 107
- ------------------------------------------------------------------------------
1. NAME OF REPORTING PERSON RICHARD C. BLUM
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
- ------------------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [x]
(b) [x]
- ------------------------------------------------------------------------------
3. SEC USE ONLY
- ------------------------------------------------------------------------------
4. SOURCE OF FUNDS* See Item 3
- ------------------------------------------------------------------------------
5. CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEMS 2(d) or 2(e) [ ]
- ------------------------------------------------------------------------------
6. CITIZENSHIP OR PLACE OF ORGANIZATION U.S.A.
- ------------------------------------------------------------------------------
7. SOLE VOTING POWER Common Stock 24,475**
NUMBER OF -----------------------------------------------------------
SHARES 8. SHARED VOTING POWER
BENEFICIALLY Common Stock 2,919,888**
OWNED BY EACH Series A Preferred Stock 46,082.95**
PERSON WITH Series C Preferred Stock 450,000**
-----------------------------------------------------------
9. SOLE DISPOSITIVE POWER
Common Stock 24,475**
-----------------------------------------------------------
10. SHARED DISPOSITIVE POWER
Common Stock 2,919,888**
Series A Preferred Stock 46,082.95**
Series C Preferred Stock 450,000**
- ------------------------------------------------------------------------------
11. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
Common Stock 2,944,363**
Series A Preferred Stock 46,082.95**
Series C Preferred Stock 450,000**
- ------------------------------------------------------------------------------
12. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES [ ]
- ------------------------------------------------------------------------------
13. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
Common Stock 19.3%**
Series A Preferred Stock 100.0%**
Series C Preferred Stock 100.0%**
- ------------------------------------------------------------------------------
14. TYPE OF REPORTING PERSON IN
- ------------------------------------------------------------------------------
** See Item 5 below
*SEE INSTRUCTIONS BEFORE FILLING OUT!
CUSIP NO. 903236107 SCHEDULE 13D Page 5 of 107
- ------------------------------------------------------------------------------
1. NAME OF REPORTING PERSON THE COMMON FUND
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON 23-7037968
- ------------------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [ ]
(b) [x]
- ------------------------------------------------------------------------------
3. SEC USE ONLY
- ------------------------------------------------------------------------------
4. SOURCE OF FUNDS* See Item 3
- ------------------------------------------------------------------------------
5. CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEMS 2(d) or 2(e) [ ]
- ------------------------------------------------------------------------------
6. CITIZENSHIP OR PLACE OF ORGANIZATION New York
- ------------------------------------------------------------------------------
7. SOLE VOTING POWER -0-
NUMBER OF -----------------------------------------------------------
SHARES 8. SHARED VOTING POWER Common Stock 1,077,980**
BENEFICIALLY
OWNED BY EACH -----------------------------------------------------------
PERSON WITH 9. SOLE DISPOSITIVE POWER -0-
-----------------------------------------------------------
10. SHARED DISPOSITIVE POWER Common Stock 1,077,980**
- ------------------------------------------------------------------------------
11. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
Common Stock 1,077,980**
- ------------------------------------------------------------------------------
12. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES [ ]
- ------------------------------------------------------------------------------
13. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
Common Stock 7.0%**
- ------------------------------------------------------------------------------
14. TYPE OF REPORTING PERSON CO
- ------------------------------------------------------------------------------
** See Item 5 below
*SEE INSTRUCTIONS BEFORE FILLING OUT!
CUSIP NO. 903236107 SCHEDULE 13D Page 6 of 107
- ------------------------------------------------------------------------------
1. NAME OF REPORTING PERSON RCBA STRATEGIC PARTNERS, L.P.
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON 94-3303833
- ------------------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [x]
(b) [x]
- ------------------------------------------------------------------------------
3. SEC USE ONLY
- ------------------------------------------------------------------------------
4. SOURCE OF FUNDS* See Item 3
- ------------------------------------------------------------------------------
5. CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEMS 2(d) or 2(e) [ ]
- ------------------------------------------------------------------------------
6. CITIZENSHIP OR PLACE OF ORGANIZATION Delaware
- ------------------------------------------------------------------------------
7. SOLE VOTING POWER -0-
NUMBER OF -----------------------------------------------------------
SHARES 8. SHARED VOTING POWER
BENEFICIALLY Series A Preferred Stock 46,082.95**
OWNED BY EACH Series C Preferred Stock 450,000**
PERSON WITH -----------------------------------------------------------
9. SOLE DISPOSITIVE POWER -0-
-----------------------------------------------------------
10. SHARED DISPOSITIVE POWER
Series A Preferred Stock 46,082.95**
Series C Preferred Stock 450,000**
- ------------------------------------------------------------------------------
11. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
Series A Preferred Stock 46,082.95**
Series C Preferred Stock 450,000**
- ------------------------------------------------------------------------------
12. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES [ ]
- ------------------------------------------------------------------------------
13. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
Series A Preferred Stock 100.0%**
Series C Preferred Stock 100.0%**
- ------------------------------------------------------------------------------
14. TYPE OF REPORTING PERSON PN
- ------------------------------------------------------------------------------
** See Item 5 below
*SEE INSTRUCTIONS BEFORE FILLING OUT!
CUSIP NO. 903236107 SCHEDULE 13D Page 7 of 107
- ------------------------------------------------------------------------------
1. NAME OF REPORTING PERSON RCBA GP, L.L.C.
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON 94-3303831
- ------------------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [x]
(b) [x]
- ------------------------------------------------------------------------------
3. SEC USE ONLY
- ------------------------------------------------------------------------------
4. SOURCE OF FUNDS* See Item 3
- ------------------------------------------------------------------------------
5. CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEMS 2(d) or 2(e) [ ]
- ------------------------------------------------------------------------------
6. CITIZENSHIP OR PLACE OF ORGANIZATION Delaware
- ------------------------------------------------------------------------------
7. SOLE VOTING POWER -0-
NUMBER OF -----------------------------------------------------------
SHARES 8. SHARED VOTING POWER
BENEFICIALLY Series A Preferred Stock 46,082.95**
OWNED BY EACH Series C Preferred Stock 450,000**
PERSON WITH -----------------------------------------------------------
9. SOLE DISPOSITIVE POWER -0-
-----------------------------------------------------------
10. SHARED DISPOSITIVE POWER
Series A Preferred Stock 46,082.95**
Series C Preferred Stock 450,000**
- ------------------------------------------------------------------------------
11. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
Series A Preferred Stock 46,082.95**
Series C Preferred Stock 450,000**
- ------------------------------------------------------------------------------
12. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES [ ]
- ------------------------------------------------------------------------------
13. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
Series A Preferred Stock 100.0%**
Series C Preferred Stock 100.0%**
- ------------------------------------------------------------------------------
14. TYPE OF REPORTING PERSON OO (Limited Liability Company)
- ------------------------------------------------------------------------------
** See Item 5 below
*SEE INSTRUCTIONS BEFORE FILLING OUT!
CUSIP NO. 903236107 SCHEDULE 13D Page 8 of 107
This Amendment No. 24 amends the Statement on Schedule 13D (the "Schedule
13D") filed with the Securities and Exchange Commission (the "Commission") on
May 7, 1999 by Richard C. Blum & Associates, L.P., a California limited
partnership ("RCBA L.P."); Richard C. Blum & Associates, Inc., a California
corporation ("RCBA Inc."); The Common Fund, a New York non-profit corporation,
RCBA Strategic Partners, L.P. ("Strategic), a Delaware limited partnership,
RCBA GP, L.L.C. ("RCBA GP"), a Delaware limited liability company; and Richard
C. Blum, the Chairman and a substantial shareholder of RCBA Inc. and a
Managing Member of RCBA GP (collectively, the "Reporting Persons"). The
principal executive office and mailing address of the Issuer is 100 California
Street, Suite 500, San Francisco, CA 94111-4529. This amendment to the
Schedule 13D relates to shares of Series A Preferred Stock, par value $1.00
(the "Series A Preferred Stock"), Series B Exchangeable Convertible Preferred
Stock, par value $1.00 (the "Series B Preferred Stock"), and Series C
Preferred Stock, par value $1.00 (the "Series C Preferred Stock"). The
following amendments to the Schedule 13D are hereby made. Unless otherwise
defined herein, all capitalized terms shall have the meanings ascribed to them
in the Schedule 13D.
Item 4. Purpose of Transaction
- -------------------------------
Item 4 of the Schedule 13D is hereby amended to add the following additional
information:
The transaction previously described in the Schedule 13D Amendment No. 23 was
consummated on June 9, 1999. See also Issuer's Form 8-K, dated June 11, 1999.
A copy of a corrected and conformed Securities Purchase Agreement dated as of
May 5, 1999, and executed copies dated June 9, 1999 of a Registration Rights
Agreement and Certificates of Designation for the Series A Preferred Stock, the
Series C Preferred Stock, and the Series B Exchangeable Convertible Preferred
Stock of Issuer are attached hereto as Exhibits B, C, D, E and F, respectively,
and incorporated by reference herein.
Item 5. Interest in Securities of the Issuer
- ---------------------------------------------
Item 5 of the Schedule 13D is hereby amended as follows:
(a),(b) According to information furnished to the Reporting Persons by the
Issuer, there were 46,082.95 shares of the Series A Preferred Stock, no shares
of the Series B Preferred Stock, and 450,000 shares of the Series C Preferred
Stock issued and outstanding as of June 9, 1999, and 15,291,235 shares of
Common Stock issued and outstanding as of March 1, 1999, per Issuer's most
recent Form 10Q. Based on such information, after taking into account the
transactions described in 5(c) below, the Reporting Persons report the
following direct holdings of the Common Stock and the corresponding percentage
interests: 1,077,980 shares owned by The Common Fund (7.0%); 996 shares owned
by RCBA L.P. (less than 1%); and 1,840,912 shares owned by the limited
partnerships for which RCBA, L.P. serves as sole general partner and its other
investment advisory client accounts (12.0%). These percentages assume no
issuance of the Series B Preferred Stock and that the Issuer will repurchase
the Series C Preferred Stock, when required to do so, with cash.
CUSIP NO. 903236107 SCHEDULE 13D Page 9 of 107
RCBA Strategic reports direct holdings of 46,082.95 shares of the Series A
Preferred Stock (100% of total shares outstanding), no holdings of the Series
B Preferred Stock, and 450,000 shares of the Series C Preferred Stock (100% of
total shares outstanding). Voting and investment power concerning the shares
of the Series A Preferred Stock, the Series B Preferred Stock and the Series C
Preferred Stock are held solely by RCBA GP, which would be deemed to have
beneficial ownership of these shares.
Voting and investment power concerning the shares of Common Stock are held
solely by RCBA L.P., which would be deemed to have beneficial ownership of an
aggregate of 2,919,888 shares of the Common Stock which is 19.1% of the
outstanding Common Stock (assuming no issuance of the Series B Preferred Stock
and that the Issuer will repurchase the Series C Preferred Stock, when
required to do so, with cash). Based on the relationship of the Reporting
Persons described below, the Reporting Persons may be deemed to be members in
a group. The Common Fund disclaims membership in a group with any of the
Reporting Persons, and disclaims beneficial ownership of any shares held by
the Reporting Persons.
As the sole general partner of RCBA L.P., RCBA Inc. is deemed the beneficial
owner of the securities over which RCBA L.P. has voting and investment power.
As Chairman, director and a substantial shareholder of RCBA Inc., Richard C.
Blum might be deemed to be the beneficial owner of the securities beneficially
owned by RCBA Inc. In addition, Mr. Blum has sole beneficial ownership of
24,475 shares of the Common Stock (consisting of shares held directly, shares
as beneficiary of a trust and options currently exercisable). Accordingly, Mr.
Blum reports beneficial ownership of 2,944,363 shares of the Common Stock,
which is 19.3% of the total Common Stock shares outstanding. Additionally, as
a Managing Member of RCBA GP, Mr. Blum may be deemed to be the beneficial owner
of the securities over which RCBA GP has voting and investment power, and he
reports 46,082.95 shares of the Series A Preferred Stock (100% of total shares
outstanding) and 450,000 shares of the Series C Preferred Stock (100% of total
shares outstanding). Although Mr. Blum is joining in this Schedule as a
Reporting Person, the filing of this Schedule shall not be construed as an
admission that he, or any of the other shareholders, directors or executive
officers of RCBA Inc., or managing members and members of RCBA GP, is, for any
purpose, the beneficial owner of any of the securities that are beneficially
owned by RCBA Inc or RCBA GP, except to the extent of any pecuniary interest
therein.
(c) In addition to the transaction described in Item 4, on June 2, 1999, the
Reporting Persons distributed 14,000 shares of the Common Stock to a limited
partner of one of the limited partnerships for which RCBA L.P. serves as the
general partner. No other transactions in Issuer's securities were effected
by the Reporting Persons during the last 60 days.
(d), (e) Not applicable.
CUSIP NO. 903236107 SCHEDULE 13D Page 10 of 107
Item 6. Contracts, Arrangements, Understandings or Relationships with Respect
to Securities of the Issuer
- ------------------------------------------------------------------------------
Item 6 of the Schedule 13D is hereby amended as follows:
None of the Reporting Persons or, to the best knowledge of the Reporting
Persons, the other persons named in Item 2, is a party to any contract,
arrangement, understanding or relationship with respect to any securities of
the Issuer, including but not limited to the transfer or voting of any
securities of the Issuer, finder's fees, joint ventures, loan or option
arrangements, puts or calls, guarantees of profits, division of profits or
loss, or the giving or withholding of proxies, except (i) as previously
disclosed, (ii) as noted above, RCBA L.P. has voting and investment power of
the shares held by it for the benefit of the Common Fund, and (iii) agreements
and related documents attached hereto as Exhibits B, C, D, E and F.
Item 7. Material to be Filed as Exhibits
- -----------------------------------------
Exhibit A Joint Filing Undertaking.
Exhibit B Securities Purchase Agreement.
Exhibit C Registration Rights Agreement.
Exhibit D Certificate of Designation of Series A Preferred Stock
of URS Corporation.
Exhibit E Certificate of Designation of Series C Preferred Stock
of URS Corporation.
Exhibit F Certificate of Series B Exchangeable Convertible Preferred
Stock of URS Corporation.
CUSIP NO. 903236107 SCHEDULE 13D Page 11 of 107
SIGNATURES
After reasonable inquiry and to the best of our knowledge and belief, the
undersigned certify that the information set forth in this statement is true,
complete and correct.
Dated: June 11, 1999
RICHARD C. BLUM & ASSOCIATES, INC. RICHARD C. BLUM & ASSOCIATES, L.P.
By Richard C. Blum & Associates, Inc.
its general partner
By /s/ Murray A. Indick By /s/ Murray A. Indick
------------------------------- -----------------------------------
Murray A. Indick Murray A. Indick
Managing Director, General Managing Director, General Counsel,
Counsel, Chief Administrative Chief Administrative Officer and
Officer and Secretary Secretary
THE COMMON FUND
By: Richard C. Blum & /s/ Murray A. Indick
Associates, L.P., its --------------------------------
investment advisor RICHARD C. BLUM
By: Richard C. Blum &
Associates, Inc., its By: Murray A. Indick
general partner Attorney-in-Fact
By: /s/ Murray A. Indick
-----------------------
Murray A. Indick,
Managing Director, General
Counsel, Chief Administrative
Officer and Secretary
RCBA GP, L.L.C. RCBA STRATEGIC PARTNERS, L.P.
By RCBA GP, L.L.C., its general partner
By /s/ Murray A. Indick By /s/ Murray A. Indick
------------------------------- -----------------------------------
Murray A. Indick, Member Murray A. Indick, Member
CUSIP NO. 903236107 SCHEDULE 13D Page 12 of 107
Exhibit A
JOINT FILING UNDERTAKING
The undersigned, being duly authorized thereunto, hereby execute this
agreement as an exhibit to this Schedule 13D to evidence the agreement of the
below-named parties, in accordance with the rules promulgated pursuant to the
Securities Exchange Act of 1934, to file this Schedule jointly on behalf of
each such party.
Dated: June 11, 1999
RICHARD C. BLUM & ASSOCIATES, INC. RICHARD C. BLUM & ASSOCIATES, L.P.
By Richard C. Blum & Associates, Inc.
its general partner
By /s/ Murray A. Indick By /s/ Murray A. Indick
------------------------------- -----------------------------------
Murray A. Indick Murray A. Indick
Managing Director, General Managing Director, General Counsel,
Counsel, Chief Administrative Chief Administrative Officer and
Officer and Secretary Secretary
THE COMMON FUND
By: Richard C. Blum & /s/ Murray A. Indick
Associates, L.P., its --------------------------------
investment advisor RICHARD C. BLUM
By: Richard C. Blum &
Associates, Inc., its By: Murray A. Indick
general partner Attorney-in-Fact
By: /s/ Murray A. Indick
-----------------------
Murray A. Indick,
Managing Director, General
Counsel, Chief Administrative
Officer and Secretary
RCBA GP, L.L.C. RCBA STRATEGIC PARTNERS, L.P.
By RCBA GP, L.L.C., its general partner
By /s/ Murray A. Indick By /s/ Murray A. Indick
------------------------------- -----------------------------------
Murray A. Indick, Member Murray A. Indick, Member
CUSIP NO. 903236107 SCHEDULE 13D Page 13 of 107
Exhibit B
SECURITIES PURCHASE AGREEMENT
Dated as of May 5, 1999
By and Between
RCBA Strategic Partners, L.P.,
and
URS Corporation
Corrected and Conformed Copy
CUSIP NO. 903236107 SCHEDULE 13D Page 14 of 107
Table of Contents
ARTICLE I
DEFINITIONS; CERTAIN REFERENCES ........................................... 2
ARTICLE II
CLOSING ................................................................... 6
2.1 Time and Place of Closing ........................................ 6
2.2 Transactions at the Closing ...................................... 6
2.3 Use of Proceeds .................................................. 6
ARTICLE III
CONDITIONS PRECEDENT TO OBLIGATIONS OF PURCHASER .......................... 6
3.1 Material Adverse Effect .......................................... 6
3.2 Minimum D&M EBITDA ............................................... 7
3.3 Certificate of Designation ....................................... 7
3.4 Closing Deliveries ............................................... 7
3.5 HSR .............................................................. 8
3.6 Section 203 ...................................................... 8
3.7 Merger Agreement ................................................. 8
3.8 Credit Facility .................................................. 8
3.9 Subordinated Notes Offering ...................................... 8
3.10 Simultaneous Closing ............................................. 8
3.11 Accuracy of Seller's Representations and Warranties .............. 8
3.12 Compliance by Seller ............................................. 8
3.13 No Legal Action .................................................. 9
ARTICLE IV
CONDITIONS PRECEDENT TO OBLIGATIONS OF SELLER ............................. 9
4.1 Closing Deliveries ............................................... 9
4.2 HSR .............................................................. 9
4.3 Simultaneous Closing ............................................. 9
4.4 Accuracy of Purchaser's Representations and Warranties ........... 9
4.5 Compliance by Purchaser.......................................... 10
4.6 No Legal Action ................................................. 10
ARTICLE V
REPRESETNATIONS AND WARRANTIES OF SELLER ................................. 10
5.1 Organization, Good Standing, Power, Authority, Etc............... 10
5.2 Capitalization of Seller ........................................ 10
5.3 SEC Documents; Financial Statements ............................. 11
5.4 Authority and Qualifications of Seller .......................... 12
5.5 No Contravention, Conflict, Breach, Etc. ........................ 13
5.6 Consents ........................................................ 13
5.7 Vote Required ................................................... 13
5.8 Certain Approvals ............................................... 13
5.9 Brokers ......................................................... 14
5.10 Certain Agreements .............................................. 14
5.11 No Material Adverse Change ...................................... 14
5.12 Exemption from Registration ..................................... 14
5.13 Opinion of Independent Investment Banking Firm .................. 14
5.14 Other Matters ................................................... 14
CUSIP NO. 903236107 SCHEDULE 13D Page 15 of 107
ARTICLE VI
REPRESETNATIONS AND WARRANTIES OF PURCHASER ............................. 15
6.1 Organization, Good Standing, Power, Authority, Etc............... 15
6.2 Authority and Qualifications of Purchaser ....................... 15
6.3 No Contravention, Conflict, Breach, Etc. ........................ 15
6.4 Consents ........................................................ 16
6.5 Brokers ......................................................... 16
6.6 Investment Intent ............................................... 16
ARTICLE VII
CORPORATE GOVERNANCE ..................................................... 16
7.1 Board of Directors .............................................. 16
7.2 Observer Rights for Purchaser Designee .......................... 16
ARTICLE VIII
COVENANTS OF THE PARTIES ................................................. 17
8.1 Restrictions .................................................... 17
8.2 Pre-Closing Activities .......................................... 17
8.3 Filing with SEC ................................................. 17
8.4 Stockholder Meeting.............................................. 17
8.5 Proxy Statement.................................................. 18
8.6 Stock Exchange Listing .......................................... 18
8.7 HSR ............................................................. 18
8.8 Equity Proposals ................................................ 18
8.9 Publicity ....................................................... 19
8.10 Securities ...................................................... 19
8.11 Access, Information and Confidentiality ......................... 21
8.12 Maintenance of Business ......................................... 22
8.13 Exchange ........................................................ 22
8.14 Tax Matters ..................................................... 23
8.15 Authorized Shares ............................................... 24
ARTICLE IX
TERMINATION .............................................................. 24
9.1 General ......................................................... 24
9.2 Breach by Seller ................................................ 24
9.3 Breach by Purchaser ............................................. 24
9.4 Specific Remedies ............................................... 25
ARTICLE X
SURVIVAL; INDEMNIFICATION ................................................ 25
10.1 Survival of Representations and Warranties and Covenants ....... 25
10.2 Indemnification of Seller ...................................... 25
10.3 Indemnification of Purchaser ................................... 25
ARTICLE XI
MISCELLANEOUS ............................................................ 25
11.1 Successors and Assigns ......................................... 25
11.2 Performance; Waiver ............................................ 26
11.3 Notices ........................................................ 26
11.4 Expenses ....................................................... 27
CUSIP NO. 903236107 SCHEDULE 13D Page 16 of 107
11.5 Governing Law .................................................. 27
11.6 Severablity; Interpretation .................................... 27
11.7 Headings ....................................................... 27
11.8 Entire Agreement ............................................... 27
11.9 Counterparts ................................................... 28
11.10 Absence of Third Party Beneficiary Rights ...................... 28
11.11 Mutual Drafting ................................................ 28
11.12 Further Representations ........................................ 28
11.13 Specific Performance; Remedies ................................. 28
CUSIP NO. 903236107 SCHEDULE 13D Page 17 of 107
SECURITIES PURCHASE AGREEMENT
This SECURITIES PURCHASE AGREEMENT (the "Agreement") is made and entered
into as of May 5, 1999, by and between RCBA Strategic Partners, L.P., a
Delaware limited partnership ("Purchaser"), and URS Corporation, a Delaware
corporation ("Seller").
WHEREAS, Seller wishes to sell, and Purchaser wishes to purchase, an
aggregate of 46,082.95 newly issued shares of Series A Preferred Stock of
Seller, par value $1.00 ("Series A Preferred Stock") and 450,000 newly issued
shares of Series C Preferred Stock of Seller, par value $1.00 ("Series C
Preferred Stock") (collectively, as to the Series A Preferred Stock and Series
C Preferred Stock issued on the date hereof, the "Bridge Securities") for the
consideration and upon the terms and subject to the conditions set forth in
this Agreement; and
WHEREAS, the Series A Preferred Stock and Series C Preferred Stock will
not be convertible into common stock of Seller and will not have voting rights
because such conversion and voting rights would require (i) prior stockholder
approval by the stockholders of Seller pursuant to New York Stock Exchange
("NYSE") Rules and (ii) an amendment to Seller's Articles of Incorporation to
increase the number of authorized common shares; and
WHEREAS, Seller is using the funds raised by this Agreement to purchase
all of the outstanding equity of the Dames & Moore Group, a Delaware
corporation ("D&M"), and such purchase is due to close before the approval of
the stockholders of Seller referred to above could be sought or obtained; and
WHEREAS, Seller has agreed to use its best efforts to obtain such
stockholder approval and Purchaser has agreed to vote, and to cause all
affiliated entities to vote, all voting securities they hold in the Seller in
favor of such approval; and
WHEREAS, Seller and Purchaser have agreed that upon receiving stockholder
approval for the transactions contemplated hereby the Bridge Securities so
purchased (and any additional shares of Series A Preferred Stock paid as
dividends thereon) will automatically, and without any further action of
either party, convert into shares of Series B Exchangeable Convertible
Preferred Stock of Seller, par value $1.00 (the "Series B Preferred Stock").
NOW, THEREFORE, in consideration of the premises and of the respective
representations, warranties, covenants, agreements and conditions contained
herein, each of Purchaser and Seller (together "Parties") agree as follows:
ARTICLE I
DEFINITIONS; CERTAIN REFERENCES
The terms defined in this Article I, whenever used in this Agreement,
shall have the following meanings for all purposes of this Agreement:
1.1 "Act" means the Securities Act of 1933, as amended.
CUSIP NO. 903236107 SCHEDULE 13D Page 18 of 107
1.2 "Affiliate" has the meaning set forth in Rule 12b-2 under the
Exchange Act.
1.3 "Board" means the Board of Directors of Seller.
1.4A "Bridge Notes" has the meaning set forth in Section 3.9 of this
Agreement.
1.4 "Bridge Securities" has the meaning given it in the first recital
of this Agreement.
1.5 "Business Day" shall have the meaning specified in Rule 14d-1(e)(6)
of the Exchange Act.
1.6 "Capital Stock" has the meaning given it in Section 5.2 of this
Agreement.
1.7 "Certificates of Designation" means the Certificate of Designation
of Seller classifying 300,000 shares as Series A Preferred Stock, the
Certificate of Designation of Seller classifying 150,000 shares as Series B
Exchangeable Convertible Preferred Stock, and the Certificate of Designation
of Seller classifying 450,000 shares as Series C Preferred Stock, each to be
filed by Seller with the Office of the Secretary of State for the State of
Delaware on or prior to the date and time of the Closing, a true and correct
copy of the text of each of which is attached as Exhibit 1.7 hereto.
1.8 "Certificate of Incorporation" means the Certificate of
Incorporation of Seller as filed with the Office of the Secretary of State for
the State of Delaware, as amended from time to time.
1.9 "Closing" has the meaning set forth in Section 2.1 of this
Agreement.
1.10 "Closing Date" has the meaning set forth in Section 2.1 of this
Agreement.
1.11 "Common Stock" means the common stock, par value $.01 per share, of
Seller.
1.12 "Conversion Shares" means the shares of Common Stock issuable or
issued upon conversion of the Series B Preferred Stock pursuant to the terms
of this Agreement and the Certificate of Designation for the Series B
Preferred Stock.
1.12A "Credit Facility" has the meaning given it in Section 3.8 of this
Agreement.
1.13 "DGCL" means the Delaware General Corporation Law, as amended.
1.13A "D&M" has the meaning given it in the third recital of this
Agreement.
CUSIP NO. 903236107 SCHEDULE 13D Page 19 of 107
1.14 "Equity Proposal" has the meaning set forth in Section 8.8 of this
Agreement.
1.14A "Exchange" has the meaning given it in Section 8.13 of this
Agreement.
1.15 "Exchange Act" means the Securities Exchange Act of 1934, as
amended.
1.15A "Exchange Approval" has the meaning given it in Section 8.4 of this
Agreement.
1.16 "Exchange Debentures" means the subordinated debentures into which
the Series B Preferred Stock is exchangeable (at the option of Seller) and
which will have substantially the same terms as the Series B Preferred Stock,
the form of which will be agreed by the parties hereto prior to Closing if
either party so requests.
1.17 "Filed SEC Documents" has the meaning given it in Section 5.3 of
this Agreement.
1.18 "GAAP" has the meaning given it in Section 5.3 of this Agreement.
1.19 "Government Entity" means any foreign, federal, state, or local
court or tribunal or administrative, governmental or regulatory body, agency,
commission, division, department, public body or other authority.
1.20 "HSR" has the meaning given it in Section 3.5 of this Agreement.
1.21 "Indemnifiable Losses" shall mean any and all direct or indirect
demands, claims, payments, obligations, actions, or causes of action,
assessments, losses, liabilities, costs, or expenses paid or incurred, any
kind or character (whether or not known or asserted before the date of this
Agreement, fixed or unfixed, conditional or unconditional, choate or inchoate,
liquidated or unliquidated, secured or unsecured, accrued, absolute,
contingent, or otherwise). Indemnifiable Losses shall include penalties,
interest, or any amount payable to a third party as a result of such
Indemnifiable Losses. Indemnifiable Losses shall include legal or other
expenses reasonably incurred in connection with investigating or defending any
claims or actions, whether or not resulting in any liability, and all amounts
paid in settlement of claims or actions in accordance with Article X.
1.22 "Issuable Securities" means the Series A Preferred Stock, the
Series B Preferred Stock, the Conversion Shares, the Series C Preferred Stock,
the Series C Redemption Shares and the Exchange Debentures.
1.23 "Knowledge of Seller" means to the actual or constructive knowledge
of any executive officer or director of Seller.
1.24 "Liens" has the meaning given it in Section 5.2 of this Agreement.
CUSIP NO. 903236107 SCHEDULE 13D Page 20 of 107
1.25 "Material Adverse Effect" means any condition, event or development
having, or likely to have a material adverse effect on the business,
operations, properties, assets, liabilities, financial condition, or prospects
of Seller and the Subsidiaries, taken as a whole, or of Purchaser, taken as a
whole (as applicable).
1.25A "Merger Agreement" has the meaning given it in Section 2.3 of this
Agreement.
1.26 "NYSE" has the meaning given it in the second recital of this
Agreement.
1.26A "Offer" has the meaning given it in the Merger Agreement.
1.27 "Person" means and includes an individual, a partnership, a joint
venture, a corporation, a trust, limited liability company, an unincorporated
organization and a Government Entity.
1.28 [Intentionally omitted]
1.29 "Proxy Statement" means the proxy statement to be sent to the
shareholders of Seller in connection with the Stockholder Meeting of Seller
with respect to, among other matters, the Stockholder Meeting Matters.
1.30 "Purchase Price" means, for the Bridge Securities to be purchased
by Purchaser, $100,000,000 in the aggregate.
1.31 "Purchaser" has the meaning set forth in the first paragraph of
this Agreement.
1.32 "Registration Rights Agreement" means the Registration Rights
Agreement to be dated as of the date of the Closing among Seller and
Purchaser, in substantially the form attached as Exhibit 1.32 hereto, as
amended, supplemented and modified from time to time in accordance with the
terms thereof.
1.33 "Schedule 14D-9" has the meaning set forth in Section 5.6 of this
Agreement.
1.33A "SEC" means the Securities and Exchange Commission.
1.33B "Seller" has the meaning given it in the first paragraph of this
Agreement.
1.34 "Series C Redemption Shares" means the shares of Common Stock
issuable or that may be issued upon redemption of the Series C Preferred Stock
pursuant to the terms of this Agreement and the Certificate of Designation for
the Series C Preferred Stock.
1.35 [Intentionally omitted]
CUSIP NO. 903236107 SCHEDULE 13D Page 21 of 107
1.36 "Significant Holder" means Purchaser and any transferee of
Purchaser for so long any such person owns Issuable Securities in the
aggregate equal to at least ten (10) percent of (a) prior to Stockholder
Approval, the Issuable Securities purchased by Purchaser and issued on the
Closing Date, or (b) at any other time, the Issuable Securities issued to
Purchaser in exchange for the Series A Preferred Stock and the Series C
Preferred Stock on the effective date of that Exchange. In determining the
number of Issuable Securities held by any person or outstanding at any time,
(i) each share of Series A Preferred Stock shall be deemed to be convertible
into Common Stock (on the same terms and conditions as the Series B Preferred
Stock) and to have been converted (to the fullest extent then determinable)
and such calculation shall include the hypothetical number of shares of Common
Stock that then would be deliverable upon the conversion of such stock (as if
such stock were converted), and (ii) each share of Series C Preferred Stock
shall be deemed to have been redeemed in exchange for Common Stock, and each
share of Series B Preferred Stock shall be deemed to have been converted (in
either case, to the fullest extent then determinable) and such calculation
shall include the number of Series C Redemption Shares or Conversion Shares
then deliverable upon the redemption of the Series C Preferred Stock or the
conversion of the Series B Preferred Stock (to the fullest extent then
determinable), as the case may be.
1.36A "Stockholder Approval" has the meaning given it in Section 8.4 of
this Agreement.
1.37 "Stockholder Meeting" has the meaning set forth in Section 8.4 of
this Agreement.
1.37A "Stockholder Meeting Matters" has the meaning given it in Section
8.4 of this Agreement.
1.38 "Stock Plans" has the meaning given it in Section 5.2 of this
Agreement.
1.39 "Stock Purchase" means the purchase of Series A Preferred Stock and
Series C Preferred Stock by Purchaser from Seller under this Agreement.
1.40 "Subsidiary" means, with respect to Seller, any corporation,
limited or general partnership, joint venture, association, joint stock
company, trust, unincorporated organization, or other entity analogous to any
of the foregoing of which a majority of the equity ownership (whether voting
stock or comparable interest) is, at the time, owned, directly or indirectly
by Seller.
1.41 "Transaction Documents" means this Agreement, the Certificates of
Designation, and the Registration Rights Agreement.
1.42 "Voting Debt" has the meaning given it in Section 5.2 of this
Agreement.
CUSIP NO. 903236107 SCHEDULE 13D Page 22 of 107
ARTICLE II
CLOSING
2.1 Time and Place of the Closing. Seller shall as promptly as
practicable notify Purchaser, and Purchaser shall as promptly as practicable
notify Seller when the conditions, contained in Articles III and IV hereof, to
such parties' respective obligations to effect the Stock Purchase have been
satisfied. The closing of the Stock Purchase (the "Closing") shall take place
at the offices of Cooley Godward LLP in San Francisco, California, or such
other location as the parties may mutually agree, on a date to be agreed upon
by the parties that is no later than November 30, 1999 (the "Closing Date"),
and shall be effective as of 12:01 a.m. on the Closing Date, unless another
date, effective time, or place is agreed to in writing by Purchaser and
Seller.
2.2 Transactions at the Closing. At the Closing, subject to the terms
and conditions of this Agreement, Seller shall issue and sell to Purchaser and
Purchaser shall purchase the Bridge Securities. At the Closing, Seller shall
deliver to Purchaser a certificate or certificates representing the number of
the Bridge Securities to be purchased, each registered in the name of
Purchaser or its nominee against payment of the Purchase Price with respect
thereto by wire transfer of immediately available funds to an account or
accounts previously designated by Seller.
2.3 Use of Proceeds. The proceeds from the purchase and sale of the
Bridge Securities hereunder will be used simultaneously with the Closing of
the Offer (as defined in the Merger Agreement by and among D&M, Seller and one
or more Affiliates of either or both, dated May 5, 1999 (the "Merger
Agreement")), and shall not be used for any other purpose.
ARTICLE III
CONDITIONS PRECEDENT TO OBLIGATIONS OF PURCHASER
The obligations of Purchaser to be discharged under this Agreement on or
prior to the Closing are subject to satisfaction of the following conditions
at or prior to the Closing (unless expressly waived in writing by Purchaser at
or prior to the Closing):
3.1 Material Adverse Effect.
(a) There shall not have occurred and there shall not otherwise
exist any Material Adverse Effect on Seller.
(b) There shall not have occurred (i) any suspension or limit of
trading in securities generally on the NYSE (including automatic halt in
trading pursuant to market-decline triggers other than those in which solely
program trading is temporarily halted), (ii) the imposition generally of
minimum or maximum prices on such exchange or on The Nasdaq Stock Market or
additional material governmental restrictions, in either case not in force on
the date of this Agreement, by such exchange or by order of the SEC or the
NASD or any court or other governmental authority, (iii) the declaration of
CUSIP NO. 903236107 SCHEDULE 13D Page 23 of 107
any general banking moratorium by either Federal or New York State
authorities, or (iv) any material adverse change in the financial or
securities markets in the United States or in political, financial or economic
conditions in the United States or any outbreak or escalation of hostilities
or declaration by the United States of a national emergency or war or other
calamity or crisis, the effect of any of which is such as to make it, in
reasonable judgment of Purchaser, impracticable or inadvisable to acquire the
Bridge Securities on the terms and in the manner contemplated by this
Agreement.
3.2 Minimum D&M EBITDA. D&M EBITDA for the fiscal year ended March 26,
1999, before second quarter restructuring charges, as shown in the audit of
D&M for the fiscal year ended March 26, 1999, which such audit shall be
completed prior to Closing, shall be no less than $65 million.
3.3 Certificates of Designation. The Certificates of Designation shall
have been filed for record with the Office of the Secretary of State for the
State of Delaware and shall have become effective.
3.4 Closing Deliveries. Seller shall have delivered to Purchaser on or
before the Closing the following:
(a) Opinion of Cooley Godward LLP, dated as of the Closing Date,
in form reasonably satisfactory to Purchaser;
(b) Registration Rights Agreement executed by Seller;
(c) Certificate of the Secretary or Assistant Secretary of Seller
dated as of the Closing Date certifying: (i) that attached thereto is a true
and complete copy of the By-Laws of Seller as in effect on the date of such
certification; (ii) that attached thereto is a true and complete copy of all
resolutions adopted by the Board authorizing the execution, delivery and
performance of the Agreement, the issuance, sale and delivery of the Issuable
Securities, and that all such resolutions are in full force in effect and are
all the resolutions adopted in connection with the transactions contemplated
by this Agreement; (iii) that attached thereto is a true and complete copy of
the Certificate of Incorporation as in effect on the date of such
certification; and (iv) to the incumbency and specimen signature of certain
officers of Seller;
(d) Certificate or certificates representing the number of the
Bridge Securities to be purchased, as described in the first recital and
Section 2.2; and
(e) Executed and conformed copies of such other certificates,
letters and documents as Purchaser may reasonably request and as are customary
for transactions such as those contemplated by this Agreement.
3.5 HSR. The waiting period under the Hart-Scott-Rodino Antitrust
Improvements Act of 1976, as amended (the "HSR Act") shall have expired or
been terminated, if applicable.
CUSIP NO. 903236107 SCHEDULE 13D Page 24 of 107
3.6 Section 203. The issuance of (a) the Bridge Securities to Seller
hereunder, (b) additional shares of Series A Preferred Stock and Series B
Preferred Stock as dividends, (c) the Series B Preferred Stock for which the
Bridge Securities are exchangeable, (d) any securities of Seller into which
such Series B Preferred Stock is convertible or exchangeable, and (e) the
Series C Redemption Shares shall have been exempted from the provisions of
Section 203 of the DGCL.
3.7 Merger Agreement. The Merger Agreement shall not have been modified
between the date hereof and the Closing Date in any material respect (except
with the prior written consent of Purchaser).
3.8 Credit Facility. The Credit Facility between Seller and Wells Fargo
Bank, National Association, as agent, as contemplated by the commitment letter
dated as of May 3, 1999 (the "Credit Facility"), shall not deviate from the
terms of such commitment letter in any material respect (except with the prior
written consent of Purchaser).
3.9 Subordinated Notes Offering. Seller's issuance and sale on the date
on which the Offer is consummated, of senior subordinated increasing rate
notes, for permanent financing in replacement thereof, in an aggregate
principal amount of $200 million (the "Bridge Notes"), as contemplated by the
commitment letter between Seller and Morgan Stanley & Co. Incorporated, dated
as of May 3, 1999, shall not deviate from the terms of such commitment letter
in any material respect (except with the prior written consent of Purchaser).
3.10 Simultaneous Closing. (a) The Offer shall have been consummated
and all shares tendered accepted for purchase by Seller or one or more of its
Affiliates, (b) the Credit Facility shall have closed and (c) the Bridge Notes
shall have closed, each of the foregoing substantially simultaneously with the
Closing.
3.11 Accuracy of Seller's Representations and Warranties. The
representations and warranties of Seller contained in Article V hereof which
are not subject to a qualification regarding materiality shall be true and
correct in all material respects as of the date when made and as of the
Closing Date, as though made on such date, the representations and warranties
of Seller contained in Article V hereof, which are subject to a qualification
regarding materiality shall be true and correct in all respects as of the date
when made and as of the Closing Date, as though made on such date, and
Purchaser shall have received a certificate attesting thereto signed by the
Chief Executive Officer of Seller, on behalf of Seller.
3.1 Compliance by Seller. Seller shall have performed, satisfied and
complied with, in all material respects, all covenants, agreements and
conditions required by this Agreement to be performed, satisfied or complied
with on or prior to the Closing Date, and Purchaser shall have received a
certificate attesting thereto signed by the Chief Executive Officer of Seller.
3.13 No Legal Action. No action, suit, investigation or other
proceeding relating to the transactions contemplated hereby shall have been
instituted before or threatened by any Government Entity which presents a
CUSIP NO. 903236107 SCHEDULE 13D Page 25 of 107
substantial risk of the restraint or prohibition of the transactions
contemplated hereby or the obtaining of material damages or other material
relief in connection therewith.
ARTICLE IV
CONDITIONS PRECEDENT TO OBLIGATIONS OF SELLER
The obligations of Seller to be discharged under this Agreement on or
prior to the Closing are subject to satisfaction of the following conditions
at or prior to the Closing (unless expressly waived in writing by Seller at or
prior to the Closing):
4.1 Closing Deliveries. Purchaser shall have delivered to Seller on or
before the Closing the following:
(a) Opinion of Wilmer, Cutler & Pickering, dated as of the Closing
Date, in form reasonably satisfactory to Seller; and
(b) Immediately available funds in the amount of the Purchase
Price.
4.2 HSR. The waiting period under the HSR Act shall have expired or
been terminated, if applicable.
4.3 Simultaneous Closing. (a) The Offer shall have been consummated
and all shares tendered accepted for purchase by Seller or one or more of its
Affiliates, (b) the Credit Facility shall have closed and (c) the Bridge Notes
shall have closed, each of the foregoing substantially simultaneously with the
Closing.
4.4 Accuracy of Purchaser's Representations and Warranties. The
representations and warranties of Purchaser contained in Article VI hereof
which are not subject to a qualification regarding materiality shall be true
and correct in all material respects as of the date when made and as of the
Closing Date, as though made on such date, the representations and warranties
of Purchaser contained in Article VI hereof, which are subject to a
qualification regarding materiality shall be true and correct in all respects
as of the date when made and as of the Closing Date, as though made on such
date, and Seller shall have received a certificate attesting thereto signed by
an officer of Purchaser, on behalf of Purchaser.
4.5 Compliance by Purchaser. Purchaser shall have performed, satisfied
and complied with, in all material respects, all covenants, agreements and
conditions required by this Agreement to be performed, satisfied or complied
with on or prior to the Closing Date, and Seller shall have received a
certificate attesting thereto signed by an officer of Purchaser.
4.6 No Legal Action. No action, suit, investigation or other
proceeding relating to the transactions contemplated hereby shall have been
instituted before or threatened by any Government Entity which presents a
substantial risk of the restraint or prohibition of the transactions
CUSIP NO. 903236107 SCHEDULE 13D Page 26 of 107
contemplated hereby or the obtaining of material damages or other material
relief in connection therewith.
ARTICLE V
REPRESENTATIONS AND WARRANTIES OF SELLER
Except as set forth in the Filed SEC Documents, Seller hereby represents
and warrants to Purchaser as follows:
5.1 Organization, Good Standing, Power, Authority, Etc. Each of Seller
and the Subsidiaries (a) is a corporation duly organized, validly existing and
in good standing under the laws of its jurisdiction of organization, (b) has
all requisite corporate power and authority and possesses all governmental
franchises, licenses, permits, authorizations and approvals necessary to
enable it to own, lease or otherwise hold and operate its properties and to
carry on its business as now being conducted and (c) is duly qualified to do
business and in good standing in each jurisdiction in which the nature of its
business or the ownership or leasing of its properties makes such
qualification necessary, except, in the case of clause (b) or (c) above, where
the failure to have such power or authority, to possess such franchises,
licenses, permits, authorizations or approvals or to be so qualified or in
good standing, individually or in the aggregate, could not reasonably be
expected to have a Material Adverse Effect on Seller.
5.2 Capitalization of Seller.
(a) The authorized capital stock of Seller ("Capital Stock"), the
number of shares of Seller outstanding, the number of shares of Common Stock
reserved for issuance upon the exercise of outstanding Seller stock options
pursuant to stock option plans, the employee stock purchase plan and the
director stock plan, each as described in the Filed SEC Documents
(collectively, the "Stock Plans"), and the number of additional shares of
Common Stock reserved for issuance pursuant to the Stock Plans, are all
substantially as set forth in Seller's proxy statement for its annual meeting
held March 23, 1999. Other than as set forth above, at the close of business
on the date of Seller's proxy statement for its annual meeting held March 23,
1999 ("Proxy Statement Date"), there were outstanding no shares of Capital
Stock or options, warrants or other rights to acquire Capital Stock from
Seller. Since the Proxy Statement Date, there have been no issuances by
Seller of shares of Capital Stock or of options, warrants or other rights to
acquire Capital Stock from Seller, other than issuances and grants of shares
of Common Stock and rights to acquire shares of Common Stock that were
reserved for issuance as of the Proxy Statement Date and that were issued
pursuant to the terms of the Stock Plans.
(b) No bonds, debentures, notes or other indebtedness having the
right to vote (or convertible into or exchangeable for securities having the
right to vote) on any matters on which stockholders of Seller may vote are
issued or outstanding ("Voting Debt").
CUSIP NO. 903236107 SCHEDULE 13D Page 27 of 107
(c) All outstanding shares of Common Stock are, and any shares of
Common Stock which may be issued upon the exercise of stock options when
issued will be, duly authorized, validly issued, fully paid and nonassessable
and not subject to preemptive rights. All shares of Common Stock which may be
issued upon the exercise of stock options will at the time issued by Seller be
free and clear of all liens, claims, charges, pledges, mortgages, security
interests or other encumbrances ("Liens"). Other than as set forth above, and
except for this Agreement (and the securities being issued hereunder) and the
Stock Plans, there are not any options, warrants, rights, convertible or
exchangeable securities, "phantom" stock rights, stock appreciation rights,
stock-based performance units, commitments, contracts, arrangements or
undertakings of any kind to which Seller or any of the Subsidiaries is a party
or by which any of them is bound (i) obligating Seller or any of the
Subsidiaries to issue, deliver or sell, or cause to be issued, delivered or
sold, additional shares of capital stock or other equity interests in, or any
security convertible or exercisable for or exchangeable into any capital stock
of or other equity interest in, Seller or of any of the Subsidiaries or any
Voting Debt, (ii) obligating Seller or any of the Subsidiaries to issue,
grant, extend or enter into any such option, warrant, call, right, security,
commitment, contract, arrangement or undertaking or (iii) that give any person
the right to receive any economic benefit or right similar to or derived from
the economic benefits and rights of holders of Common Stock.
(d) There are no outstanding contractual obligations of Seller or
any of the Subsidiaries to repurchase, redeem or otherwise acquire any shares
of capital stock of Seller or any of the Subsidiaries and, to the Knowledge of
Seller, there are no irrevocable proxies with respect to shares of Common
Stock or shares of capital stock of any Subsidiary of Seller.
5.3 SEC Documents; Financial Statements.
(a) Seller has filed and provided or made available to Purchaser a
true and complete copy of each report, schedule, registration statement and
definitive proxy statement required to be filed by Seller with the SEC since
January 1, 1995 (the "Filed SEC Documents"). As of their respective dates,
each Filed SEC Document complied in all material respects with the
requirements of the Act or the Exchange Act, as the case may be, applicable to
such Filed SEC Document. None of the Filed SEC Documents when filed contained
any untrue statement of a material fact or omitted to state a material fact
required to be stated therein or necessary in order to make the statements
therein, in light of the circumstances under which they were made, not
misleading. Except to the extent that information contained in any Filed SEC
Document has been revised or superseded by a later Filed SEC Document filed
and publicly available prior to the date of this Agreement, none of the Filed
SEC Documents contains any untrue statement of a material fact or omits to
state any material fact required to be stated therein or necessary in order to
make the statements therein, in light of the circumstances under which they
were made, not misleading.
(b) All contracts or agreements, including agreements relating to
indebtedness of Seller or any of the Subsidiaries, required to be filed with
the SEC under the Exchange Act have been filed with the SEC.
CUSIP NO. 903236107 SCHEDULE 13D Page 28 of 107
(c) The financial statements of Seller included in the Filed SEC
Documents comply as to form in all material respects with applicable
accounting requirements and with the published rules and regulations of the
SEC with respect thereto, have been prepared in accordance with generally
accepted accounting principles applied on a consistent basis ("GAAP") during
the periods involved (except, in the case of the unaudited statements, as
permitted by Form 10-Q of the SEC) and fairly present the consolidated
financial position of Seller and its consolidated subsidiaries as at the dates
thereof and the consolidated results of their operations and cash flows for
the periods then ended (subject, in the case of unaudited statements, to
normal and recurring year-end adjustments which are not material). Except as
set forth in the Filed SEC Documents, neither Seller nor any Subsidiary of
Seller has any liabilities or obligations of any nature (whether accrued,
absolute, contingent or otherwise) required by GAAP to be set forth on a
consolidated balance sheet of Seller and the Subsidiaries or in the notes
thereto. None of the Subsidiaries is, or has at any time since January 1,
1995 been, subject to the reporting requirements of Sections 13(a) or 15(d) of
the Exchange Act.
5.4 Authority and Qualification of Seller. Seller has all requisite
corporate power and authority to enter into this Agreement and the Merger
Agreement, and, subject to obtaining the Stockholder Approval with respect to
the matters set forth in Section 8.4, to consummate the transactions
contemplated hereby and thereby. The execution and delivery of this Agreement
and the Merger Agreement, and the consummation of the transactions
contemplated hereby and thereby, have been duly authorized by all necessary
corporate action on the part of Seller subject, in the case of the Exchange,
to obtaining the stockholders' approval and adoption of certain matters
described in Section 8.4 hereof. The Board, at a meeting duly called and
held, duly and unanimously adopted resolutions (a) approving this Agreement,
the Merger Agreement and the transactions contemplated hereby and thereby, (b)
determining that the terms of this Agreement, the Merger Agreement and the
transactions contemplated hereby and thereby are fair to and in the best
interests of Seller and its stockholders, (c) recommending that Seller's
stockholders grant the Stockholder Approval and (d) declaring that this
Agreement and the Merger Agreement are each advisable. Each of this Agreement
and the Merger Agreement has been duly executed and delivered by Seller and,
assuming such agreement constitutes a legal, valid and binding obligation of
each of the other parties thereto, constitutes a valid and binding obligation
of Seller, enforceable against Seller in accordance with its terms, subject to
applicable bankruptcy, insolvency or similar laws affecting creditors' rights
generally and general principles of equity.
5.5 No Contravention, Conflict, Breach, Etc. The execution and
delivery of this Agreement and the Merger Agreement do not, and the
consummation of the transactions contemplated hereby and thereby will not,
conflict with, or result in any breach or violation of, or default (with or
without notice or lapse of time or both) under, or result in the termination
of, or accelerate the performance required by, or give rise to a right of
termination, cancellation or acceleration of any obligation under, or to
increased, additional, accelerated or guaranteed rights or entitlements of any
CUSIP NO. 903236107 SCHEDULE 13D Page 29 of 107
person under, or result in the creation of any Lien on the properties or
assets of Seller or any of the Subsidiaries pursuant to, (a) any provision of
the Certificate of Incorporation or the Seller's By-laws or the comparable
charter or organizational documents of any Subsidiary, or (b) any judgment,
order, decree, statute, law, ordinance, rule or regulation applicable to
Seller or any Subsidiary or their respective properties or assets.
5.6 Consents. No consent, approval, order or authorization of, or
registration, declaration or filing with, any Government Entity is required by
or with respect to Seller or any Subsidiary in connection with the execution
and delivery of this Agreement or the Merger Agreement by Seller, or the
consummation by Seller of the transactions contemplated hereby or thereby,
except for such consents, approvals, orders, authorizations, registrations,
declarations or filings the failure of which to be obtained or made would not,
individually or in the aggregate, have a Material Adverse Effect on Seller,
and except for: (i) the filing with the SEC of (A) a Schedule 14D-9 of Seller
to be filed under the Exchange Act (the "Schedule 14D-9"), (B) a proxy
statement relating to the consideration of D&M's stockholders approval at a
meeting of the stockholders of D&M duly called and convened to consider the
adoption of the Merger Agreement, and (C) such other reports under the
Exchange Act, as may be required in connection with this Agreement or the
Merger Agreement and the transactions contemplated hereby, (ii) the filing of
the Certificate of Merger with the Secretary of State of the State of Delaware
and appropriate documents with the relevant authorities of other states in
which D&M is qualified to do business, (iii) filings required pursuant to the
HSR Act, and the rules and regulations promulgated thereunder, (iv) filings
necessary to satisfy the applicable requirements of state securities or "blue
sky" laws and (v) those filings required under the rules and regulations of
the NYSE.
5.7 Vote Required. The Stockholder Approval is the only vote of the
holders of any class or series of Capital Stock necessary to adopt this
Agreement and approve the transactions contemplated hereby. No stockholder
approval of any kind is required for the issuance of the Series A Preferred
Stock and the Series C Preferred Stock.
5.8 Certain Approvals. The Board has taken any and all necessary and
appropriate action to render inapplicable to Stock Purchase, the Exchange and
the other transactions contemplated hereby the provisions of Section 203 of
the DGCL. No other state takeover statute or similar statute or regulation
applies to the Offer, the Merger Agreement or the other transactions
contemplated hereby.
5.9 Brokers. No broker, investment banker, financial advisor or other
person, other than Morgan Stanley & Co. Incorporated, the fees and expenses of
which will be paid by Seller, is entitled to any broker's, finder's, financial
advisor's or other similar fee or commission in connection with the
transactions contemplated hereby based upon arrangements made by or on behalf
of Seller.
5.10 Certain Agreements. There are no employment contracts to which
Seller or any of the Subsidiaries is a party which provides for any benefit
CUSIP NO. 903236107 SCHEDULE 13D Page 30 of 107
upon or resulting from a "change in control" of Seller or any of the
Subsidiaries or any similar event.
5.11 No Material Adverse Change. Since October 31, 1998, there has not
been any event, change, effect, condition or development that, individually or
in the aggregate, has had or could reasonably be expected to have a Material
Adverse Effect on Seller (other than any such Material Adverse Effect on
Seller the existence of which is specifically disclosed in any report filed
and publicly available on Form 10-Q or Form 8-K under the Exchange Act with
the SEC by Seller after October 31, 1998 and prior to the date hereof).
5.12 Exemption from Registration. Assuming the representations and
warranties of Purchaser set forth in Article VI hereof are true and correct
in all material respects, the offer and sale of the Series A Preferred Stock
and the Series C Preferred Stock made pursuant to this Agreement will be
exempt from the registration requirements of the Act. Neither Seller nor any
Person acting on its behalf has, in connection with the offering of the Series
A Preferred Stock or the Series C Preferred Stock, engaged in (a) any form of
general solicitation or general advertising (as those terms are used within
the meaning of Rule 502(c) under the Act), (b) any action involving a public
offering within the meaning of Section 4(2) of the Act, or (c) any action
which would require the registration of the offering and sale of the Series A
Preferred Stock or the Series C Preferred Stock pursuant to this Agreement
under the Act or which would violate applicable state securities or "blue sky"
laws. Seller has not made and will not make, directly or indirectly, any
offer or sale of the Series A Preferred Stock, the Series C Preferred Stock,
or of securities of the same or a similar class as the Series A Preferred
Stock or the Series C Preferred Stock if as a result the offer and sale of the
Series A Preferred Stock and Series C Preferred Stock contemplated hereby
could fail to be entitled to exemption from the registration requirements of
the Act. As used herein, the terms "offer" and "sale" have the meanings
specified in Section 2(3) of the Act.
5.13 Opinion of Independent Investment Banking Firm. Seller has
obtained advice from Morgan Stanley & Co. Incorporated that the financial
terms of the transactions contemplated by this Agreement are reasonable.
5.14 Other Matters. The Parties agree that each of the representations
and warranties made by Seller to the lenders pursuant to the Credit Facility
will be incorporated herein by reference as if such representations and
warranties had been made directly to Purchaser. By Closing on this Agreement,
Seller agrees that Purchaser may rely on such representations as if set forth
fully herein.
ARTICLE VI
REPRESENTATIONS AND WARRANTIES OF PURCHASER
Purchaser hereby represents and warrants to Seller that:
6.1 Organization, Good Standing, Power, Authority, Etc. Purchaser is a
limited partnership duly organized, validly existing and in good standing
under the laws of its jurisdiction of organization.
CUSIP NO. 903236107 SCHEDULE 13D Page 31 of 107
6.2 Authority and Qualification of Purchaser. Purchaser has all
requisite partnership power and authority to enter into this Agreement and to
consummate the transactions contemplated hereby. The execution and delivery
of this Agreement and the consummation of the transactions contemplated hereby
have been duly authorized by all necessary action on the part of Purchaser.
No vote of the holders of partnership interests is necessary to approve or
adopt this Agreement or the transactions contemplated hereby. This Agreement
has been duly executed and delivered by Purchaser and, assuming such agreement
constitutes a legal, valid and binding obligation of each of the other parties
thereto, constitutes a valid and binding obligation of Purchaser, enforceable
against Purchaser in accordance with its terms, subject to applicable
bankruptcy, insolvency or similar laws affecting creditors' rights generally
and general principles of equity.
6.3 No Contravention, Conflict, Breach, Etc. The execution and
delivery of this Agreement do not, and the consummation of the transactions
contemplated hereby will not, conflict with, or result in any breach or
violation of, or default (with or without notice or lapse of time or both)
under, or result in the termination of, or accelerate the performance required
by, or give rise to a right of termination, cancellation or acceleration of
any obligation under, or to increased, additional, accelerated or guaranteed
rights or entitlements of any person under, or result in the creation of any
Lien on the properties or assets of Purchaser or any of its subsidiaries
pursuant to, (a) any provision of the Purchaser's organizational documents, or
(b) any judgment, order, decree, statute, law, ordinance, rule or regulation
applicable to Purchaser or any subsidiary of Purchaser or their respective
properties or assets.
6.4 Consents. No consent, approval, order or authorization of, or
registration, declaration or filing with, any Federal, state, local, or
foreign government or any court, administrative agency, tribunal or commission
or other Government Entity is required by or with respect to Purchaser in
connection with the execution and delivery of this Agreement by Purchaser or
the consummation by Purchaser of the transactions contemplated hereby, except
for such consents, approvals, orders, authorizations, registrations,
declarations or filings the failure of which to be obtained or made would not,
individually or in the aggregate, have a Material Adverse Effect on Purchaser
or filings required pursuant to the HSR Act.
6.5 Brokers. No broker, investment banker, financial advisor or other
person is entitled to any broker's, finder's, financial advisor's or other
similar fee or commission in connection with the transactions contemplated
hereby based upon arrangements made by or on behalf of Purchaser.
6.6 Investment Intent. Purchaser is an "Accredited Investor" within
the meaning of Rule 501(a) of Regulation D under the Act, and it is or will be
acquiring the Issuable Securities for its own account and not with a view to,
or for sale in connection with, any distribution thereof in violation of the
Act. It understands that the Issuable Securities have not been registered
under the Act by reason of a specific exemption from the registration
CUSIP NO. 903236107 SCHEDULE 13D Page 32 of 107
provisions thereof which depends upon, among other things, the bona fide
nature of their investment intent as expressed herein.
ARTICLE VII
CORPORATE GOVERNANCE
7.1 Board of Directors.
(a) At all times on and after the Closing Date, for so long as
Purchaser and its Affiliates own or control at least 10% of the outstanding
shares of Common Stock, and until Richard C. Blum no longer wishes to serve as
a director, Seller shall take all such actions as may be necessary or
appropriate to cause Mr. Blum to be elected or re-elected as a member of the
Board and to be maintained in such position at all times.
(b) In the event that a vacancy is created on the Board at any
time by the death, disability, retirement, or resignation of Mr. Blum,
Purchaser and Seller will take such actions as will result in the election or
appointment of a new director designated by Purchaser, provided that such
designee is acceptable to Seller.
7.2 Observer Rights for Purchaser Designee. Seller shall, for so long
as Purchaser and its Affiliates own or control at least 10% of the outstanding
shares of Common Stock, permit an individual designated by Purchaser and
acceptable to Seller to attend and observe meetings of the Board, and such
designee shall have the right to receive all written information provided by
Seller to the Board (but only if specifically requested by such designee).
Such designee shall have no right to vote on any matter presented to the
Board, but otherwise shall have all rights of a Director, including: (i) the
right to examine books and records of Seller; (ii) the right to review and
participate in all discussions of the Board including, without limitation,
capital or equity programs; (iii) the right to receive, upon request, any
information relating to Seller and the Subsidiaries, and to any Affiliates
thereof; and (iv) the right to meet on a regular basis with the management
personnel of Seller and the Subsidiaries, or any Affiliates thereof; provided
that any such designee shall agree to be bound by all policies relating to
confidentiality and material non-public information which are applicable to
the Directors and senior executive officers of Seller.
ARTICLE VIII
COVENANTS OF THE PARTIES
8.1 Restrictions. Purchaser covenants and agrees with Seller that
Purchaser will not dispose of any of Purchaser's shares of the Issuable
Securities except pursuant to (a) an effective registration statement under
the Act or (b) an applicable exemption from registration under the Act. In
connection with any sale by Purchaser pursuant to clause (b) of the preceding
sentence, Purchaser shall furnish to Seller, if requested by Seller, an
opinion of counsel reasonably satisfactory to Seller to the effect that such
exemption from registration is available in connection with such sale.
CUSIP NO. 903236107 SCHEDULE 13D Page 33 of 107
8.2 Pre-Closing Activities. From and after the date of this Agreement
until the Closing, each of Seller and Purchaser shall act with good faith
towards, and shall use all commercially reasonable efforts to consummate, the
transactions contemplated by this Agreement, and neither Seller nor Purchaser
will take any action that would prohibit or impair its ability to consummate
the transactions contemplated by the Merger Agreement and this Agreement.
8.3 Filing with SEC. So long as any of the Issuable Securities are
outstanding, Seller shall file with the SEC the annual reports and quarterly
reports and the information, documents and other reports that are required to
be filed with the SEC pursuant to Sections 13 and 15 of the Exchange Act, so
long as Seller has or is required to have a class of securities registered
under the Exchange Act and is then subject to the reporting requirements of
the Exchange Act, at the time Seller is required to file the same with the SEC
and, promptly after Seller is required to file such reports, information or
documents with the SEC, to mail copies of such reports, information and
documents to the holders of the Series A Preferred Stock, Series B Preferred
Stock, the Conversion Shares, Series C Preferred Stock and the Series C
Redemption Shares at their addresses set forth in the register maintained by
the transfer agent therefor.
8.4 Stockholder Meeting. Seller shall cause a special meeting of its
common stockholders (the "Stockholder Meeting") to be held as soon as
practicable but in no event later than six months after the Closing, for the
purpose of approving (i) the issuance of the Series B Preferred Stock
(pursuant to the Exchange contemplated by Section 8.13 hereof (the "Exchange
Approval")) as required by NYSE Rule 312 and (ii) an amendment to the
Certificate of Incorporation of Seller providing for an increase in the number
of authorized common shares to such number as may be deemed appropriate by
Seller (the "Charter Amendment Approval" and, together with the Exchange
Approval, the "Stockholder Approval"), and transacting such other business as
may properly come before the meeting or any adjournment thereof, (the
"Stockholder Meeting Matters"). Seller shall use its best efforts to obtain
the Stockholder Approval no later than six months after the Closing.
Purchaser shall vote, and shall cause its Affiliates to vote, all shares of
Seller voting securities which they may hold at the time of the Stockholder
Meeting in favor of the Stockholder Approval.
8.5 Proxy Statement. Seller covenants that the Proxy Statement will
not include any untrue statement of a material fact, or omit to state any
material fact, necessary to make the statements therein, in the light of the
circumstances under which they were made, not misleading; provided, however,
Seller's covenant shall not encompass any information in the Proxy Statement
that was furnished in writing to Seller by or on behalf of Purchaser for use
specifically in connection with the preparation of the Proxy Statement.
8.6 Stock Exchange Listing. Subsequent to consideration by the
shareholders of Seller of the Stockholder Meeting Matters at the Shareholders
Meeting and until such shares shall cease to be outstanding, Seller shall take
all steps necessary to ensure that the Series A Preferred Stock (if still
outstanding), Conversion Shares and Series C Preferred Stock (if still
CUSIP NO. 903236107 SCHEDULE 13D Page 34 of 107
outstanding) and Series C Redemption Shares (if any) are approved for trading,
subject to notice of issuance by the NYSE and any other securities exchange on
which the Common Stock is listed.
8.7 HSR. Upon the terms and subject to the conditions set forth in
this Agreement, each of the parties agrees to take, or cause to be taken, all
actions, and to do, or cause to be done, and to assist and cooperate with the
other parties in doing, all things necessary, proper or advisable to
consummate and make effective all necessary filings required pursuant to the
HSR Act no later than five Business Days from the date of this Agreement, and
shall use their best efforts to obtain the early termination of the waiting
period thereunder, provided that neither Seller nor Purchaser shall be
required to agree to dispose of or hold separate any portion of its business
or assets.
8.8 Equity Proposals.
(a) Prior to the Closing, Seller agrees that neither Seller nor
any Subsidiary nor any of the respective officers and directors of Seller or
any of the Subsidiaries shall, and Seller shall direct and use its best
efforts to cause its employees, agents and representatives (including, without
limitation, any investment banker, attorney or accountant retained by Seller
or any Subsidiary) not to, initiate, solicit or encourage, directly or
indirectly, any inquiries or the making of any proposal or offer (including,
without limitation, any proposal or offer to stockholders of Seller) with
respect to the offer, sale or issuance of preferred stock or other comparable
equity securities as contemplated by this Agreement (any such proposal or
offer being hereinafter referred to as an "Equity Proposal") or engage in any
negotiations concerning, or provide any confidential information or data to,
or have any discussions with, any Person relating to an Equity Proposal, or
otherwise facilitate directly or indirectly any effort or attempt to make or
implement an Equity Proposal; and
(b) Seller will immediately cease and cause to be terminated any
existing activities, discussions or negotiations with any parties conducted
heretofore with respect to any of the foregoing. Seller will take the
necessary steps to inform the individuals or entities referred to in the first
sentence hereof of the obligations undertaken in this subsection 8.8(b).
Seller will notify Purchaser immediately if any such inquiries or proposals
are received by, any such information is requested from, or any such
negotiations or discussions are sought to be initiated or continued with
Purchaser.
8.9 Publicity. Seller and Purchaser will consult with each other
before issuing any press release or otherwise making any public statements
with respect to the transactions contemplated hereby and shall not issue any
such press release or make any such public statement prior to such
consultation, except as may be required by law or by obligations pursuant to
any listing agreement with any securities exchange.
8.10 Securities. Seller hereby covenants to Purchaser, that from and
after the date hereof and so long as Purchaser owns any Issuable Securities:
CUSIP NO. 903236107 SCHEDULE 13D Page 35 of 107
(a) Unissued Shares of Common Stock. (i) Reserve and keep
available out of its authorized but unissued shares of Series B Preferred
Stock and Common Stock (including any shares held by Seller in its corporate
treasury), for the purpose of issuing any and all payment in kind dividends
and effecting the Exchange and the exercise in full of conversion and other
rights related to the Series B Preferred Stock and the Series C Preferred
Stock, such number of its duly authorized shares of Series B Preferred Stock
and Common Stock as shall be sufficient to effect such exercise, and if at any
time the number of authorized but unissued shares of Series B Preferred Stock
or Common Stock shall not be sufficient to effect such exercise, subject to
any required approval by the holders of the Common Stock and as may otherwise
be required pursuant to the DGCL and applicable federal and state securities
laws, Seller shall take all such corporate action as may be necessary (and
desirable in the reasonable discretion of Purchaser) to increase its
authorized but unissued shares of Series B Preferred Stock and Common Stock to
such number of shares as shall be sufficient for such purposes, and (ii)
reserve and keep available out of its authorized but unissued shares of Series
A Preferred Stock, for the purpose of issuing any and all payment in kind
dividends on the Series A Preferred Stock, such number of its duly authorized
shares of Series A Preferred Stock as shall be sufficient to effect any such
dividend contemplated by the Series A Preferred Stock, and if at any time the
number of authorized but unissued Series A Preferred Stock shall not be
sufficient to effect such dividends, subject to any required approval by the
holders of the Common Stock and as may otherwise be required pursuant to the
DGCL and applicable federal and state securities laws, Seller shall take all
corporate action as may be necessary (and desirable in the reasonable
discretion of Purchaser) to increase its authorized but unissued Series A
Preferred Stock to such number of shares as shall be sufficient for such
purposes.
(b) Exchange of Certificates. Seller shall, upon surrender by the
holder of any certificates representing the Series A Preferred Stock, the
Series B Preferred Stock or the Series C Preferred Stock (or securities issued
upon exchange, conversion or redemption of any of the foregoing) for exchange
or reissuance at the office of Seller, cause to be issued in exchange therefor
new certificates in such denomination or denominations as may be requested for
the same aggregate number of such securities (or securities issued upon
exchange, conversion or redemption thereof) represented by the certificates so
surrendered and registered as such holder may request, subject to the
provisions hereof.
(c) Replacement of Certificates. Upon receipt by Seller of
evidence reasonably satisfactory to it of loss, theft, destruction or
mutilation of any certificate evidencing any of the Series A Preferred Stock,
the Series B Preferred Stock, or the Series C Preferred Stock (or securities
issued upon exchange, conversion or redemption of any of the foregoing), and
(in case of loss, theft or destruction) of indemnity reasonably satisfactory
to Seller, and upon the surrender and cancellation of such certificate, if
mutilated, Seller shall make and deliver in lieu of such certificate a new
certificate for the number of such securities (or securities issued upon
exchange, conversion or redemption thereof), as the case may be, evidenced by
CUSIP NO. 903236107 SCHEDULE 13D Page 36 of 107
such lost, stolen, destroyed or mutilated certificate which remains
outstanding. Purchaser's agreement of indemnity shall constitute indemnity
satisfactory to Seller for the purposes of this Section 8.10 without the need
of any further surety or bond.
(d) Government and Other Approvals. Seller shall promptly
prepare, submit and file with all public and governmental authorities, all
applications, notices, registrations, certificates, statements and such other
information, documents and instruments as may be required pursuant to any
federal, state, local or foreign law or rule or regulation of the NYSE, NASD
or any other securities exchange, in connection with the consummation of the
transactions contemplated by this Agreement, including the effect of any
dividends, exchange, conversion or redemption rights, anti-dilution provisions
or Board control contemplated by the terms of the Series A Preferred Stock,
the Series B Preferred Stock, the Series C Preferred Stock, or other
securities of Seller which may be acquired by Purchaser pursuant to this
Agreement and the Certificates of Designation. Seller shall use its best
efforts to obtain any necessary consents or approvals from any Government
Entity in connection with the consummation of the transactions contemplated by
this Agreement, including the effect of any dividends, exchange, conversion or
redemption rights or anti-dilution provisions contemplated by the terms of the
Series A Preferred Stock, the Series B Preferred Stock, the Series C Preferred
Stock or other securities of Seller which may be acquired by Purchaser
pursuant to this Agreement and the Certificates of Designation. Purchaser
shall provide all cooperation and support, and take all such actions as may be
reasonably required to facilitate such filings and obtain such consents.
8.11 Access, Information and Confidentiality
(a) Pre-Closing Access. Upon reasonable notice prior to the
Closing, Seller shall (and shall cause each of the Subsidiaries to) afford
Purchaser and its representatives reasonable access to its properties, books,
contracts and records and personnel and advisors and Seller shall (and shall
cause each of the Subsidiaries to) furnish promptly to Purchaser all
information concerning its business, properties and personnel as Purchaser or
its representatives may reasonably request.
(b) Post-Closing Access. From the date hereof until the
Stockholder Meeting, Seller shall permit Purchaser (and its designated
representatives) to visit and inspect any of the properties of Seller and the
Subsidiaries, including the books and records of Seller and the Subsidiaries
(and to make extracts and copies therefrom), and to consult with respect to
and discuss the affairs, businesses, finances, operations and accounts of
Seller and the Subsidiaries with the officers, directors and employees of such
entities, all at such reasonable times and as often as Purchaser may
reasonably request.
(c) Information. Seller covenants that so long as Purchaser owns
at least 10% of any Issuable Securities it will deliver to Purchaser the
following:
CUSIP NO. 903236107 SCHEDULE 13D Page 37 of 107
(i) As soon as practicable and in any event within 45 days
after the end of each quarterly period (other than the last quarterly period)
in each fiscal year, (A) a consolidated statement of income and consolidated
statements of changes in financial position and cash flows of Seller and the
Subsidiaries for such quarterly period and for the period from the beginning
of the current fiscal year to the end of such quarterly period, and (B) a
consolidated balance sheet of Seller and the Subsidiaries as at the end of
such quarterly period, setting forth in each case, in comparative form,
figures for the corresponding periods in the preceding fiscal year and
corresponding figures for the budget for such quarterly period, all in
reasonable detail and certified by an authorized financial officer of Seller,
subject to changes resulting from year-end adjustments;
(ii) As soon as practicable and in any event within 120 days
after the end of each fiscal year, (A) a consolidated statement of income and
consolidated statements of changes in financial position and cash flows of
Seller and the Subsidiaries for such year, and (B) a consolidated balance
sheet of Seller and the Subsidiaries as of the end of such year, setting forth
in each case, in comparative form, corresponding consolidated figures from the
preceding annual audit and corresponding figures for the budget for such
fiscal year, all in reasonable detail together with an opinion directed to
Seller of independent public accountants of recognized standing selected by
Seller;
(iii) Promptly upon transmission thereof, copies of all such
financial statements, proxy statements, notices and reports as it shall send
to its public stockholders and copies of all registration statements (without
exhibits), other than on Form S-8 or any similar successor form, and all
reports which it files with the SEC (or any governmental body or agency
succeeding to the functions of the SEC);
(iv) With reasonable promptness, such other financial data as
any Purchaser may reasonably request.
(d) Confidentiality. Purchaser recognizes and acknowledges that
it has in the past, currently has, and in the future may possibly have, access
to certain confidential information of Seller. Purchaser agrees that it will
not disclose confidential information with respect to Seller to any Person for
any purpose or reason whatsoever, except to authorized representatives of
Seller and to counsel and other advisers, provided, however, that such
advisers (other than counsel) agree to the confidentiality provisions of this
subsection 8.11(d), unless (i) such information becomes known to the public
generally through no fault of Purchaser, or (ii) disclosure is required by law
or the order of any governmental authority under color of law; provided,
however, that prior to disclosing any information pursuant to clauses (i) or
(ii) above, Purchaser shall, if possible, give prior written notice thereof to
Seller and provide Seller with the opportunity to contest such disclosure.
8.12 Maintenance of Business. Seller covenants that between the date of
this Agreement and Closing, it shall and shall cause each of the Subsidiaries
to:
CUSIP NO. 903236107 SCHEDULE 13D Page 38 of 107
(a) conduct its business (including, but not limited to, making
loans, paying directors, officers and employees, including any salary, bonus,
or other compensation policy, disposing or acquiring assets, and incurring
liabilities) only in the ordinary course, consistent with past practice;
(b) use commercially reasonable efforts to preserve its business
organizations intact, to retain the services of its present officers and
employees and to preserve the good will of the suppliers and customers and
others having business relations with it;
(c) comply in all material respects with all laws that may be
applicable to its business;
(d) not make any distributions or dividends to its stockholders;
and
(e) comply with its stated official accounting policies with
respect to charge-offs and loss provisions.
Subject to the foregoing, any transaction or action that is not in the
ordinary course of business, consistent with Seller's past practice, shall be
subject to the prior written consent of Purchaser.
8.13 Exchange. In the event Seller shall have obtained the Stockholder
Approval, on the first Business Day following the last to occur of (a)
delivery to Purchaser of a Certificate of the Chief Executive Officer or other
executive officer of Seller certifying that the Stockholder Approval has been
obtained, which Certificate shall be delivered within one Business Day of
obtaining the Stockholder Approval and (b) termination of any applicable
waiting period under the HSR Act, then the Bridge Securities and any
additional shares of Series A Preferred Stock paid as dividends thereon shall,
without any further action on the part of Seller or the holders thereof, be
exchanged for shares of Series B Preferred Stock (the "Exchange"). If the
Stockholder Approval has not been obtained prior to six months after the
Closing, then the Exchange shall not take place without the prior written
consent of the holders of at least 67% of the shares of Series A Preferred
Stock and Series C Preferred Stock. In connection with the Exchange, the
holders of the Bridge Securities or any additional shares of Series A
Preferred Stock paid as dividends thereon shall receive the number of shares
of Series B Preferred Stock equal to 46,082.95 plus the number of any
additional shares of Series A Preferred Stock paid as dividends thereon then
owned by them on the date of the Exchange (after giving effect to any accrued
dividends and interest). From and after the date of the Exchange all of the
Bridge Securities and any additional shares of Series A Preferred Stock paid
as dividends thereon shall be deemed to have been exchanged for the Series B
Preferred Stock into which they were exchangeable. Holders of Issuable
Securities shall be entitled to obtain certificates representing the Series B
Preferred Stock to which they are entitled pursuant to the Exchange by
delivering to Seller certificates representing the Series A Preferred Stock
and the Series C Preferred Stock. Seller shall not take any action between
the date hereof and the date set for redemption of the Series A Preferred
Stock that would cause the Conversion Price (as defined in the Series B
CUSIP NO. 903236107 SCHEDULE 13D Page 39 of 107
Certificate of Designation) to be any amount other than $21.70 per share if
shares of Series B Preferred Stock were outstanding on the date hereof without
making appropriate adjustments thereof in the conversion price (which such
adjustment or cumulative adjustments to the Series B Preferred Stock shall
take effect immediately after the Exchange).
8.14 Tax Matters. Purchaser intends that no pay-in-kind dividends on
the Series A Preferred Stock or the Series B Preferred Stock will, when paid
or accrued, be includible in Purchaser's gross income for federal, state or
local tax purposes. Accordingly, for so long as there are any shares of
Series A Preferred Stock or Series B Preferred Stock outstanding then: (a)
unless Seller concludes in good faith that there is no reasonable basis to
make or file any tax return that is consistent with such intention, Seller
shall not make or file any tax return that is inconsistent with such
intention; (b) if by reason of any action taken by Seller over the objection
of Purchaser the pay-in-kind dividends which accrue or are paid with respect
to the Series A Preferred Stock or Series B Preferred Stock become taxable as
income for tax purposes when paid or accrued, Seller shall pay to the holders
of such securities such additional amount (the "Gross Up Amount") as may be
necessary to fund any federal, state or local income tax payable with respect
to such dividend. Such Gross Up Amount shall also include an amount necessary
to fund the payment of any such income tax payable with respect to the Gross
Up Amount. Such Gross Up Amount shall be paid upon notice to Seller at least
ten (10) days before the date on which the relevant income tax payment is due
or made. Prior to receiving any taxable distribution from Seller, Purchaser
shall provide Seller with such documentation as may be reasonably requested by
Seller in order to make such distribution without withholding for tax
purposes. All amounts paid or accrued on any Issuable Security shall be net of
applicable withholding taxes.
8.15 Authorized Shares. If Seller is unable to obtain the Stockholder
Approval, it will use its best efforts to obtain an amendment to the
Certificate of Incorporation providing for an increase in the number of
authorized shares of Common Stock to such number as is sufficient to permit
the repurchase by Seller of the Series C Preferred Stock pursuant to the terms
of the Certificate of Designation for the Series C Preferred Stock.
ARTICLE IX
TERMINATION
9.1 General. Except for the obligations in Article IX, Article XI and
Section 8.11(a) and (d), this Agreement and the transactions contemplated
hereby shall terminate without any action by the parties hereto if the Closing
shall not have occurred on or before November 30, 1999. This Agreement may be
terminated at any time prior to the Closing (i) by a written instrument
executed and delivered by Seller and Purchaser; (ii) by Purchaser upon any
material breach or default by Seller under this Agreement; or (iii) by Seller
upon any material breach or default by Purchaser under this Agreement.
9.2 Breach By Seller. A material breach or default by Seller shall
occur:
CUSIP NO. 903236107 SCHEDULE 13D Page 40 of 107
(a) in the event that any representation or warranty of Seller set
forth in Article V shall be false in any material respect; or
(b) in the event that Seller (or any applicable Subsidiary) shall
not perform in any material respect any covenant required of it in Article III
or Article VIII not otherwise waived by Purchaser; or
(c) breach of or default by Seller or any Subsidiary under any of
the Transaction Documents.
9.3 Breach By Purchaser. A material breach or default by Purchaser
shall occur
(a) in the event that any representation or warranty of Purchaser
set forth in Article VI shall be false in any material respect; or
(b) in the event that Purchaser shall not perform in any material
respect any covenant required of it in Article IV or VIII not otherwise waived
by Seller; or
(c) breach of or default by Purchaser under any of the Transaction
Documents.
9.4 Specific Remedies. In addition to the termination of this
Agreement and the transactions contemplated herein prior to Closing, in the
event of a material breach or default by a party (the "Breaching Party"), the
Breaching Party shall indemnify the non-breaching party for any and all loss,
cost, and expense caused by the breach of representation, warranty, or
covenant.
ARTICLE X
SURVIVAL; INDEMNIFICATION
10.1 Survival of Representations and Warranties and Covenants. All
representations and warranties contained in this Agreement shall survive the
execution and delivery of this Agreement and the delivery of Bridge Securities
for a period of two (2) years from the date of such delivery and any
examination or investigation made by any party to this Agreement or any of
their successors and assigns. All covenants shall survive for the periods
specified therein or, if no period is specified, for a period of two (2)
years.
10.2 Indemnification of Seller. From and after the Closing Purchaser
shall indemnify Seller and its Affiliates, officers, directors, employees,
partners (general or limited), shareholders, and shareholders of their
partners (general or limited), for, and shall defend and hold harmless each of
them from, against, and with respect to all Indemnifiable Losses as a result
of, arising from, in connection with, or incident to (a) any breach or
inaccuracy of any representation or warranty Purchaser makes in this
CUSIP NO. 903236107 SCHEDULE 13D Page 41 of 107
Agreement; or (b) any failure of Purchaser to fulfill, satisfy, and discharge
any of its obligations or covenants under this Agreement.
10.3 Indemnification of Purchaser. From and after the Closing Seller
shall indemnify Purchaser and its Affiliates, officers, directors, employees,
partners (general or limited) and shareholders of its partners (general or
limited) for, and shall defend and hold harmless each of them from, against,
and with respect to all Indemnifiable Losses as a result of, arising from, in
connection with, or incident to (a) any breach or inaccuracy of any written
representation or warranty made by Seller in this Agreement; or (b) any
failure of Seller to fulfill, satisfy, and discharge any of its obligations or
covenants under this Agreement.
ARTICLE XI
MISCELLANEOUS
11.1 Successors and Assigns. All covenants and agreements contained in
this Agreement by or on behalf of the parties hereto shall bind, and inure to
the benefit of, the respective successors and assigns of the parties hereto;
provided, however, that the rights granted to the parties hereto may not be
assigned (except to wholly-owned subsidiaries of such parties) without the
prior written consent of the other party. Purchaser may assign to one or more
of its affiliated partnerships its obligations hereunder in whole or in part,
but shall not be relieved of such obligations.
11.2 Performance; Waiver. The provisions of this Agreement (including
this Section 11.2) may be modified or amended, and waivers and consents to the
performance and observance of the terms hereof may be given by written
instrument executed and delivered by Seller and (1) prior to the Closing, by
Purchaser and (2) after the Closing, by the holder or holders of a majority of
the Series A Preferred Stock and Series C Preferred Stock or, after the
Exchange, of the Series B Preferred Stock. The failure at any time to require
performance of any provision hereof shall in no way affect the full right to
require such performance at any time thereafter (unless performance thereof
has been waived in accordance with the terms hereof for all purposes and at
all times by the parties to whom the benefit of such performance is to be
rendered). The waiver by any party to this Agreement of a breach of any
provision hereof shall not be taken or held to be a waiver of any succeeding
breach of such provision or any other provision or as a waiver of the
provision itself.
11.3 Notices. All notices or other communications given or made
hereunder shall be validly given or made if in writing and delivered by
facsimile transmission or in person at, or mailed by overnight courier to, the
following addresses (and shall be deemed effective at the time of receipt
thereof).
CUSIP NO. 903236107 SCHEDULE 13D Page 42 of 107
If to Seller:
URS Corporation
100 California Street, Suite 500
San Francisco, California 94111
Attn: Kent P. Ainsworth
Facsimile: (415) 398-2621
with a copy to:
Cooley Godward LLP
One Maritime Plaza, 20th Floor
San Francisco, California 94111-3580
Attn: Samuel M. Livermore
Facsimile: (415) 951-3699
If to Purchaser:
RCBA Strategic Partners, L.P.
909 Montgomery Street, Suite 400
San Francisco, California 94133
Attn: Murray A. Indick
Facsimile: (415) 434-3130
with a copy to:
Wilmer, Cutler & Pickering
2445 M Street, N.W.
Washington, D.C. 20037
Attn: Michael R. Klein and Eric R. Markus
Facsimile: (202) 663-6363
or to such other address as the party to whom notice is to be given may have
previously furnished notice in writing to the other in the manner set forth
above.
11.4 Expenses.
(a) Seller shall reimburse Purchaser for all of Purchaser's
reasonable out-of pocket costs and third party expenses (including
professional fees), that Purchaser incurred in association with this Agreement
including, but not limited to, conducting "due diligence" review of Seller, as
and when such expenses are incurred; provided, however, that if Purchaser has
breached this Agreement as provided in Section 9.3, and Seller terminates this
Agreement, each party shall bear its own expenses.
(b) In addition to any other reimbursement to which Purchaser is
entitled pursuant to this Section, Seller shall pay to Purchaser in cash at
Closing the sum of One Million Five Hundred Thousand Dollars ($1,500,000.00)
as a transaction fee.
CUSIP NO. 903236107 SCHEDULE 13D Page 43 of 107
11.5 Governing Law. This Agreement shall be governed by and construed
in accordance with the laws of the State of Delaware as applied to contracts
made and performed within the State of Delaware, without regard to principles
of conflicts of law.
11.6 Severability; Interpretation. If any term, provision, covenant or
restriction of this Agreement is held by a court of competent jurisdiction to
be invalid, void or unenforceable, each of Seller and Purchaser directs that
such court interpret and apply the remainder of this Agreement in the manner
which it determines most closely effectuates their intent in entering into
this Agreement, and in doing so particularly take into account the relative
importance of the term, provision, covenant or restriction being held invalid,
void or unenforceable.
11.7 Headings. The index and section headings herein are for
convenience only and shall not affect the construction hereof.
11.8 Entire Agreement. This Agreement together with the other
Transaction Documents embody the entire agreement between the Parties relating
to the subject matter hereof and any and all prior oral or written agreements,
representations or warranties, contracts, understandings, correspondence,
conversations, and memoranda, whether written or oral, among Seller and
Purchaser, or between or among any agents, representatives, parents,
subsidiaries, Affiliates, predecessors in interest or successors in interest,
with respect to the subject matter hereof.
11.9 Counterparts. This Agreement may be executed in counterparts, each
of which shall be deemed to be an original and all of which together shall be
deemed to be one and the same instrument.
11.10 Absence of Third Party Beneficiary Rights. No provision of this
Agreement is intended, nor will be interpreted, to provide or to create any
third party beneficiary rights or any other rights of any kind in any client,
customer, Affiliate, shareholder, employee, or partner of any party hereto or
any other Person.
11.11 Mutual Drafting. This Agreement is the mutual product of the
parties hereto, and each provision hereof has been subject to the mutual
consultation, negotiation and agreement of each of the parties, and shall not
be construed for or against any party hereto.
11.12 Further Representations. Each party to this Agreement acknowledges
and represents that it has been represented by its own legal counsel in
connection with the transactions contemplated by this Agreement, with the
opportunity to seek advice as to its legal rights from such counsel. Each
party further represents that it is being independently advised as to the tax
consequences of the transactions contemplated by this Agreement and is not
relying on any representation or statements made by the other party as to such
tax consequences.
11.13 Specific Performance; Remedies.
CUSIP NO. 903236107 SCHEDULE 13D Page 44 of 107
(a) Seller acknowledges that Purchaser will be irreparably harmed
and that there will be no adequate remedy at law for any violation by Seller
of the covenants or agreements contained in Sections 8.4 (Stockholder
Meeting), 8.6 (Stock Exchange Listing), 8.8 (Equity Proposals), 8.9
(Publicity), 8.10 (Securities), 8.11(a), (b) and (c) (Pre-Closing Access;
Post-Closing Access; Information), 8.13 (Exchange), and 8.14 (Tax Matters) of
this Agreement. It is accordingly agreed that, in addition to any other
remedies which may be available upon the breach of any such covenants or
agreements, Purchaser shall have the right to obtain injunctive relief to
restrain a breach or threatened breach of, or otherwise to obtain specific
performance of, these covenants and agreements of Seller.
(b) Purchaser acknowledges that Seller will be irreparably harmed
and that there will be no adequate remedy at law for any violation by
Purchaser of the covenants or agreements contained in Section 8.9 (Publicity)
and subsection 8.11(d) (Confidentiality) of this Agreement. It is accordingly
agreed that, in addition to any other remedies which may be available upon the
breach of any such covenants or agreements, Seller shall have the right to
obtain injunctive relief to restrain a breach or threatened breach of, or
otherwise to obtain specific performance of, these covenants and agreements of
Purchaser.
[Remainder of page left intentionally blank.]
CUSIP NO. 903236107 SCHEDULE 13D Page 45 of 107
IN WITNESS WHEREOF, the parties hereto have executed this Agreement.
RCBA STRATEGIC PARTNERS, L.P. URS CORPORATION
By: RCBA GP, L.L.C.,
its general partner
By: /s/ Murray A. Indick By: /s/ Kent P. Ainsworth
--------------------------- --------------------------
Name: Murray A. Indick Name: Kent P. Ainsworth
Title: Member Title: Executive Vice President and
Chief Financial Officer
CUSIP NO. 903236107 SCHEDULE 13D Page 46 of 107
Exhibit C
REGISTRATION RIGHTS AGREEMENT
REGISTRATION RIGHTS AGREEMENT (the "Agreement"), dated as of June 9,
1999, among URS Corporation, a Delaware corporation (the Corporation"), and
RCBA Strategic Partners, L.P., a Delaware limited partnership (the
"Purchaser").
WHEREAS, the Corporation is a party to a Securities Purchase Agreement,
dated as of May 5, 1999 (as amended, the "Securities Purchase Agreement"),
with the Purchaser, pursuant to which the Corporation agreed to sell to the
Purchaser and the Purchaser agreed to purchase from the Corporation for an
aggregate purchase price of $100 million, upon the terms and subject to the
conditions set forth therein, (x) 46,082.95 shares of Series A Preferred Stock
of the Corporation (the "Series A Preferred Stock") and (y) 450,000 shares of
Series C Preferred Stock of the Corporation (the "Series C Preferred Stock");
WHEREAS, pursuant to the Securities Purchase Agreement, the Corporation
and Purchaser agreed that, upon receipt of stockholder approval of (x) certain
amendments to the Corporation's charter and (y) the issuance of convertible
preferred stock to Purchaser, the Series A Preferred Stock and Series C
Preferred Stock would be converted into Series B Convertible Exchangeable
Preferred Stock of the Corporation (the "Series B Preferred Stock");
WHEREAS, in order to induce the Purchaser to enter into the Securities
Purchase Agreement, the Corporation has agreed to provide the registration
rights set forth in this Agreement for the benefit of the Purchaser and its
direct and indirect transferees;
WHEREAS, the execution and delivery of this Agreement is a condition to
the Purchaser's obligations pursuant to the Securities Purchase Agreement.
NOW, THEREFORE, in consideration of the premises and of the respective
representations, warranties, covenants, agreements and conditions contained
herein, each of Purchaser and the Corporation (together "Parties") agree as
follows:
ARTICLE I
DEFINITIONS
For purposes of this Agreement, the following terms have the following
respective meanings:
1.1 "Affiliate" means, with respect to any Person, any other Person
directly or indirectly Controlling, Controlled by or under common Control with
such first Person. "Control" means the power to direct or cause the direction
of management or policies of such Person, directly or indirectly, whether
through the ownership of voting securities, by contract or otherwise. Any
director, member of management or other employee of the Corporation or any of
CUSIP NO. 903236107 SCHEDULE 13D Page 47 of 107
its Subsidiaries who would not otherwise be an Affiliate of the Purchaser
shall not be deemed to be an Affiliate of the Purchaser.
1.2 "Agreement" is defined in the first paragraph of this Agreement.
1.3 "Business Day" means a day other than a Saturday, Sunday or other
day on which commercial banks in New York City are authorized or required to
close.
1.4 "Closing Date" means the date the closing of the securities
purchase under the Securities Purchase Agreement.
1.5 "Common Stock" means the Common Stock, par value of $.01 per share,
of the Corporation.
1.6 "Conversion Shares" means the shares of Common Stock issued to a
holder upon the conversion of the Series B Preferred Stock.
1.7 "Corporation" is defined in the first paragraph of this Agreement.
1.8 "DTC" means the Depository Trust Company.
1.9 "Distributee" means any person that is a member, stockholder or
partner of Purchaser, or any person that is a member, stockholder or partner
of a Distributee to which Registrable Securities are transferred or
distributed by Purchaser or Distributee.
1.10 "Exchange Act" means the Securities Exchange Act of 1934, as
amended, or any successor federal statute, and the rules and regulations
thereunder which shall be in effect at the time. Any reference to a particular
section thereof shall include a reference to the corresponding section, if
any, of any such successor federal statute, and the rules and regulations
thereunder.
1.11 "Holder" means Purchaser and any other holder of Registrable
Securities under this Agreement, including an Affiliate, a Distributee or
other successors, assigns and transferees of Purchaser or a Holder that has
received Registrable Securities pursuant to Section 3.4 and agree to be bound
by the terms of this Agreement as contemplated by Section 3.4.
1.12 "NASD" means the National Association of Securities Dealers.
1.13 "NYSE" means the New York Stock Exchange.
1.14 "Person" means any natural person, firm, partnership, association,
corporation, company, trust, business trust, governmental entity or other
entity.
1.15 "Postponement Period" is defined in Section 2.3(n).
1.16 "Prospectus" means the prospectus included in any Registration
Statement (including, without limitation, a prospectus that discloses
CUSIP NO. 903236107 SCHEDULE 13D Page 48 of 107
information previously omitted from a prospectus filed as part of an effective
registration statement in reliance upon Rule 430A), as amended or supplemented
by any prospectus supplement, with respect to the terms of the offering of any
portion of the Registrable Securities covered by such Registration Statement
and all other amendments and supplements to the prospectus, including post-
effective amendments, and all material incorporated by reference or deemed to
be incorporated by reference in such prospectus.
1.17 "Purchaser" is defined in the introduction to this Agreement.
1.18 "Registrable Securities" means (i) the Series A Preferred Stock,
(ii) the Series C Preferred Stock; (iii) the Conversion Shares and the
Repurchase Shares, and (iv) any securities issued or issuable with respect to
any of the foregoing clauses (i) through (iii), (x) upon any conversion or
exchange thereof, (y) by way of stock dividend or other distribution, stock
split or reverse stock split or (z) in connection with a combination of
shares, recapitalization, merger, consolidation, exchange offer or other
reorganization. As to any particular Registrable Securities, once issued such
securities shall cease to be Registrable Securities when (A) a Registration
Statement with respect to the sale of such securities shall have become
effective under the Securities Act and such securities shall have been
disposed of in accordance with such Registration Statement, (B) such
securities shall have been distributed to the public in reliance upon Rule 144
or may be so distributed pursuant to Rule 144(k), (C) subject to the
provisions of Section 2.1(b)(ii), such securities shall have been otherwise
transferred, new certificates for such securities not bearing a legend
restricting further transfer shall have been delivered by the Corporation and
subsequent disposition of such securities shall not require registration or
qualification of such securities under the Securities Act or any similar state
law then in force, (D) such securities shall have been acquired by the
Corporation or (E) sold in a private transaction in which the transferor's
rights under this Agreement were not assigned. In determining the number of
Registrable Securities outstanding at any time or whether the Holders of the
requisite number of Registrable Securities have taken any action hereunder and
in calculating the number of Registrable Securities for all other purposes
under this Agreement, each share of Series A Preferred Stock shall be deemed
to have been convertible into Common Stock (on the same terms and conditions
as the Series B Preferred Stock) and to have converted (to the fullest extent
then determinable) and such calculation shall include the number of Conversion
Shares that then would be deliverable upon the conversion of such stock (as if
such stock were convertible), and each share of Series C Preferred Stock shall
be deemed to have been repurchased by the Corporation (to the fullest extent
then determinable) and such calculation shall include the number of Repurchase
Shares then deliverable upon the repurchase of such Series C Preferred Stock
(to the fullest extent then determinable).
1.19 "Registration Expenses" means all fees and expenses incident to the
performance of or compliance with the provisions of this Agreement, whether or
not any registration statement is filed or becomes effective, including,
without limitation, all (i) registration and filing fees (including, without
limitation, (A) fees with respect to filings required to be made with the NASD
in connection with an underwritten offering, (B) fees and expenses of
CUSIP NO. 903236107 SCHEDULE 13D Page 49 of 107
compliance with state securities or blue sky laws, and (C) fees and other
expenses associated with admitting for trading on the NYSE or any other
applicable exchange or automated dealer system) the Series A Preferred Stock,
the Series C Preferred Stock, Conversion Shares and Repurchase Shares, (ii)
printing expenses, (iii) fees and disbursements of all independent certified
public accountants referred to in Section 2.3 (including, without limitation,
the reasonable expenses of any special audit and "cold comfort" letters
required by or incident to such performance), (iv) the fees and expenses of
any "qualified independent underwriter" or other independent appraiser
participating in an offering pursuant to Rule 2720 of the NASD Rules of
Conduct, (v) fees and expenses of all attorneys, advisers, appraisers and
other persons retained by the Corporation or any Subsidiary of the
Corporation, (vi) internal expenses of the Corporation and its Subsidiaries,
(vii) the expense of any annual audit, (viii) the expenses relating to
printing, word processing and distributing all registration statements,
underwriting agreements, securities sales agreements, indentures and any other
documents necessary in order to comply with this Agreement, and (ix) the
reasonable out-of-pocket expenses and, as to in-house counsel, allocated costs
of the Holders of the Registrable Securities being registered in such
registration incurred in connection therewith including, without limitation,
the reasonable fees and disbursements of not more than one outside counsel and
one in-house counsel (who may be employed by an Affiliate of a Holder) chosen
by the Holders of a majority of the Registrable Securities to be included in
such Registration Statement. "Registration Expenses" shall not include any
underwriting discounts or commissions or any transfer taxes payable in respect
of the sale of Registrable Securities, which such expenses shall be paid or
borne by the Holders thereof. Nor shall "Registration Expenses" include any
fees or expenses incurred by or on behalf of any Holder who, without cause,
either withdraws a request for registration or withdraws from a registration.
1.20 "Registration Statement" means any registration statement of the
Corporation that covers any of the Registrable Securities pursuant to the
provisions of this Agreement, and all amendments and supplements to any such
registration statement, including post-effective amendments, in each case
including the Prospectus, all exhibits and all material incorporated by
reference or deemed to be incorporated by reference in such registration
statement.
1.21 "Repurchase Shares" means the shares of Common Stock issued to a
holder upon the repurchase of the Series C Preferred Stock.
1.22 "Rule 144" means Rule 144 (or any successor provision) under the
Securities Act.
1.23 "Rule 145" means Rule 145 (or any successor provision) under the
Securities Act.
1.24 "Securities Act" means the Securities Act of 1933, as amended, or
any successor federal statute, and the rules and regulations thereunder which
shall be in effect at the time. Any reference to a particular section thereof
shall include a reference to the corresponding section, if any, of any such
successor federal statute, and the rules and regulations thereunder.
CUSIP NO. 903236107 SCHEDULE 13D Page 50 of 107
1.25 "SEC" means the Securities and Exchange Commission or any other
federal agency at the time administering the Securities Act or the Exchange
Act.
1.26 "Series A Preferred Stock" has the meaning given it in the first
recital.
1.27 "Series B Preferred Stock" has the meaning given it in second
recital.
1.28 "Special Registration" means the registration of shares of equity
securities and/or options or other rights in respect thereof to be offered
solely to directors, members of management, employees, consultants or sales
agents, distributors or similar representatives of the Corporation or its
direct or indirect Subsidiaries, solely on Form S-8 or any successor form.
1.29 "Subsidiary" means, with respect to any Person, any corporation or
Person, a majority of the outstanding voting stock or other equity interests
of which is owned, directly or indirectly, by that Person.
1.30 "underwritten registration" or "underwritten offering" means a
registration in which securities of the Corporation (including Registrable
Securities) are sold to an underwriter for reoffering to the public.
ARTICLE II
REGISTRATION
2.1 Demand Registration.
(a) Requests. Subject to the provisions of Section 2.6, at any
time or from time to time after 12 months from the date of this Agreement,
Holders of not less than 50% of the then outstanding Registrable Securities
shall have the right to make written requests that the Corporation effect up
to two registrations under the Securities Act of all or part of the
Registrable Securities of the Holders making such request, which requests
shall specify the intended method of disposition thereof by such Holders,
including whether the registration requested is for an underwritten offering.
For a registration to be underwritten, a majority of the Holders requesting
registration (as measured by ownership of Registrable Securities) must so
request. The Corporation shall not be required to effect more than two
registrations under this Section 2.1.
(b) Obligation to Effect Registration.
(i) Within 10 business days after receipt by the Corporation
of any request for registration pursuant to Section 2.1, the Corporation shall
promptly give written notice of such requested registration to all Holders,
and as soon as practicable will use its best efforts to effect the
registration under the Securities Act of
CUSIP NO. 903236107 SCHEDULE 13D Page 51 of 107
(1) the Registrable Securities which the Corporation
has been so requested to register pursuant to Section 2.1, and
(2) all other Registrable Securities which the
Corporation has been requested to register by the Holders thereof by written
request given to the Corporation within 10 days after the Corporation has
given such written notice (which request shall specify the intended method of
disposition of such Registrable Securities), all to the extent required to
permit the disposition (in accordance with the intended methods thereof as
aforesaid) of the Registrable Securities so to be registered.
(ii) The Corporation's obligations under Section 2.1(a)(i)
shall be subject to the following limitations:
(1) the Corporation shall not be required to effect a
registration pursuant to this Section 2.1 during the period starting with the
date of filing of, and ending on the date one hundred eighty (180) days
following the effective date of, the registration statement pertaining to a
public offering by the Corporation; provided, however, that unless the Holders
are permitted to register and sell in such offering all such Registrable
Securities as they have requested be included in such offering without cutback
under Section 2.2(b)(ii), then the Corporation may not decline to register
shares pursuant to this clause (1) more than once every two years (such time
period to commence upon the expiration of the end of the one hundred eighty
(180) day period referred to above); and
(2) the Corporation shall not be required to effect a
registration on Form S-1 if it has filed and has maintained an effective
"shelf" Registration Statement on Form S-3 pursuant to Section 2.1(c) and such
Form S-3 is permitted to be used by the Holders demanding registration.
(c) Shelf Registration. If requested by Holders of a majority of
the Registrable Securities as to which registration has been requested
pursuant to this Section 2.1, and if the Corporation is eligible to file such
Registration Statement on Form S-3, the Registration Statement covering such
Registrable Securities shall provide for the sale by the Holders thereof of
the Registrable Securities from time to time on a delayed or a continuous
basis under Rule 415 under the Securities Act. If more than one underwritten
offering is requested under any particular shelf registration, each such
additional underwritten offering shall constitute a separate "demand"
registration for purposes of Section 2.1.
(d) Effective Registration Statement. A registration requested
pursuant to Section 2.1 shall not be deemed to have been effected unless it is
declared effective by the SEC and remains effective for the period specified
in Section 2.3(b). Notwithstanding the preceding sentence, a registration
requested pursuant to Section 2.1 that does not become effective after the
Corporation has filed a Registration Statement with respect thereto by reason
of the refusal to proceed of the Holders of Registrable Securities requesting
the registration, or by reason of a request by a majority of the Selling
Holders participating in such registration that such registration be
CUSIP NO. 903236107 SCHEDULE 13D Page 52 of 107
withdrawn, shall be deemed to have been effected by the Corporation at the
request of such Holders.
(e) Pro Rata Allocation. If the Corporation determines, based on
consultation with the managing underwriters or, in an offering which is not
underwritten, with an investment banker, that the number of securities to be
sold in any such offering should be limited due to market conditions or
otherwise, Holders of Registrable Securities proposing to sell their
securities in such registration shall share pro rata in the number of
securities being offered (as determined by the Holders holding a majority of
the Registrable Securities for which registration is being requested in
consultation with the managing underwriters or investment banker, as the case
may be) and registered for their account, such sharing to be based on the
number of Registrable Securities as to which registration was requested by
such Holders.
(f) Inclusion of Other Securities in Demand Registration.
Notwithstanding any other provision of this Section 2.1, and subject to the
Registration Rights Agreement dated February 21, 1990 (the "1990 Registration
Rights Agreement") by and among the Corporation, Wells Fargo Bank, N.A., a
national banking association, BK Capital Partners I, BK Capital Partners II,
BK Capital Partners III, Executive Life Insurance Company, Novato Partners,
the Common Fund, Richard C. Blum & Associates I, and the Management Holders
(as defined therein):
(i) The Corporation may, subject to the remainder of this
Section 2.1(f), elect to include in any Registration Statement made pursuant
to Section 2.1(a), authorized but unissued shares of Common Stock or shares of
Common Stock held as treasury stock;
(ii) The Corporation shall not register securities (other
than Registrable Securities) for sale for the account of any Person (other
than the Corporation) in any registration requested pursuant to Section
2.1(a); and
(iii) If any Registration Statement made pursuant to Section
2.1(a) involves an underwritten offering and the managing underwriter of such
offering (or, in connection with an offering that is not underwritten, an
investment banker) shall advise the Corporation that, in its view, the number
of securities requested to be included in such Registration exceeds the
largest number that can be sold in an orderly manner in such offering within a
price range acceptable to the selling Holders, the Corporation shall include
in such Registration:
(1) first, all shares of Common Stock requested to be
included in such Registration by the selling Holders as provided in Section
2.1(e); and
(2) second, to the extent that the number of securities
to be registered pursuant to clause (1) is less than the largest number that
can be sold in an orderly manner in such offering within a price range
CUSIP NO. 903236107 SCHEDULE 13D Page 53 of 107
acceptable to the selling Holders, securities that the Corporation proposes to
register.
2.2 Piggyback Registration. If the Corporation at any time proposes to
register any of its common stock under the Securities Act (other than a
Registration relating solely to the sale of securities to participants in a
Company stock plan, on Form S-4 with respect to any merger, consolidation or
acquisition, pursuant to Section 2.1 or pursuant to a Special Registration),
whether or not for sale for its own account, and the registration form to be
used may be used for the registration of Registrable Securities, it shall each
such time give prompt written notice to all Holders of Registrable Securities
of its intention to do so and, upon the written request of any Holder of
Registrable Securities given to the Corporation within 10 days after the
Corporation has given any such notice (which request shall specify the
Registrable Securities intended to be disposed of by such holder and the
intended method of disposition thereof), the Corporation will use its best
efforts to effect the registration under the Securities Act of all Registrable
Securities which the Corporation has been so requested to register by the
Holders thereof, to the extent required to permit the disposition (in
accordance with the intended methods thereof as aforesaid) of the Registrable
Securities so to be registered, provided that:
(a) if, at any time after giving written notice of its intention
to register any securities and prior to the effective date of the Registration
Statement filed in connection with such registration, the Corporation shall
determine for any reason not to register such securities, the Corporation may,
at its election, give written notice of such determination to each Holder that
was previously notified of such registration and, thereupon, shall not
register any Registrable Securities in connection with such registration (but
shall nevertheless pay the Registration Expenses in connection therewith),
without prejudice, however, to the rights of any Holders to request that a
registration be effected under Section 2.1; and
(b) if the Corporation shall be advised in writing by the managing
underwriters (or, in connection with an offering which is not underwritten, by
an investment banker) that in their or its opinion the number of securities
requested to be included in such registration (whether by the Corporation,
pursuant to this Section 2.2 or pursuant to any other rights granted by the
Corporation to a holder or holders of its securities to request or demand such
registration or inclusion of any such securities in any such registration)
exceeds the number of such securities which can be sold in such offering in an
orderly manner within a price range that is acceptable to the Corporation, the
Corporation shall include in such Registration:
(i) first, all shares of Common Stock that the Company
proposes to register for its own account; and
(ii) subject to the 1990 Registration Rights Agreement:
(1) second, to the extent that the number of shares
registered pursuant to clause (i) is less than the largest number that can be
sold in an orderly manner in such offering within a price range acceptable to
CUSIP NO. 903236107 SCHEDULE 13D Page 54 of 107
the Corporation, the Registrable Securities requested to be included by the
Holders; and
(2) third, to the extent that the number of shares
registered pursuant to clauses (i) and (ii) is less than the largest number
that can be sold in an orderly manner in such offering within a price range
acceptable to the Corporation, the securities requested to be included by any
other holders, and the Corporation shall so provide in any registration
agreement hereinafter entered into with respect to any of its securities.
The securities to be included in any such registration pursuant to clause (ii)
or (iii) shall be allocated on a pro rata basis among all holders requesting
that securities be included in such registration pursuant to such clause on
the basis of the number of securities requested to be included by such
holders. No registration effected under this Section 2.2 shall relieve the
Corporation from its obligation to effect registrations upon request under
Section 2.1. The Corporation shall not be obligated to cause any "piggyback"
registration to be underwritten.
2.3 Registration Procedures. If and whenever the Corporation is
required to use its best efforts to effect the registration of any Registrable
Securities under the Securities Act as provided in Sections 2.1 and 2.2, the
Corporation shall:
(a) prepare and file with the SEC, as soon as practicable, a
Registration Statement with respect to such securities, make all required
filings with the NYSE and use best efforts to cause such Registration
Statement to become effective at the earliest possible date;
(b) prepare and file with the SEC such amendments and supplements
to such Registration Statement and the Prospectus used in connection therewith
and such other documents as may be necessary to keep such Registration
Statement effective until the earlier of (i) 30 days after the effective date
of such Registration Statement (360 days in the case of a Shelf Registration
pursuant to Section 2.1(c)) or (ii) the consummation of the disposition by the
Holders of all the Registrable Securities covered by such Registration
Statement and otherwise comply with the provisions of the Securities Act with
respect to the disposition of all securities covered by such Registration
Statement;
(c) furnish to counsel (if any) selected by the Holders of a
majority of the Registrable Securities covered by such Registration Statement
and to counsel for the underwriters in any underwritten offering copies of all
documents proposed to be filed with the SEC in connection with such
registration a reasonable time prior to the proposed filing thereof and give
reasonable consideration in good faith to any comments of such Holders,
counsel and underwriters. The Corporation shall not file any Registration
Statement or Prospectus or any amendments or supplements thereto pursuant to a
registration under Section 2.1(a) if the Holders of a majority of the
Registrable Securities covered by such Registration Statement, their counsel,
or the underwriters, if any, shall reasonably object in writing;
CUSIP NO. 903236107 SCHEDULE 13D Page 55 of 107
(d) furnish to each seller of Registrable Securities, without
charge, such reasonable number of conformed copies of such Registration
Statement and of each such amendment and supplement thereto (in each case,
including all exhibits (including exhibits incorporated by reference),
financial statements, schedules and all documents incorporated therein, deemed
to be incorporated therein by reference or filed therewith, except that the
Corporation shall not be obligated to furnish any seller of securities with
more than two copies of such exhibits and documents), such number of copies of
the Prospectus included in such Registration Statement (including each
preliminary prospectus and any summary prospectus) in conformity with the
requirements of the Securities Act, and such other documents, as such seller
may reasonably request in order to facilitate the disposition of the
securities owned by such seller;
(e) use its best efforts to register or qualify and cooperate with
the Holders of Registrable Securities, the underwriters and their respective
counsels in connection with the registration or qualification (or exemption
from such registration or qualification) of the securities covered by such
Registration Statement under such other securities or blue sky laws of such
jurisdictions as each seller shall request; provided, however, that where
Registrable Securities are offered other than through an underwritten
offering, the Corporation agrees to cause its counsel to perform blue sky
investigations and file registrations and qualifications required to be filed
pursuant to this Section 2.3(e); keep each such registration or qualification
(or exemption therefrom) effective during the period such Registration
Statement is required to be effective hereunder and do any and all other acts
and things which may be necessary or advisable to enable such seller to
consummate the disposition in such jurisdictions of the securities owned by
such seller, except that the Corporation shall not for any such purpose be
required to qualify generally to do business as a foreign corporation in any
jurisdiction wherein it is not so qualified, subject itself to taxation in any
jurisdiction wherein it is not so subject, or take any action which would
subject it to general service of process in any jurisdiction wherein it is not
so subject;
(f) (i) notify each Holder of Registrable Securities subject to
such Registration Statement if such Registration Statement, at the time it or
any amendment thereto became effective, (x) contained an untrue statement of a
material fact or omitted to state a material fact required to be stated
therein or necessary to make the statements therein not misleading upon
discovery by the Corporation of such material misstatement or omission or (y)
upon discovery by the Corporation of the happening of any event as a result of
which the Corporation believes there would be such a material misstatement or
omission, and, as promptly as practicable, prepare and file with the SEC a
post-effective amendment to such registration statement and use best efforts
to cause such post-effective amendment to become effective such that such
registration statement, as so amended, shall not contain an untrue statement
of a material fact or omit to state a material fact required to be stated
therein or necessary to make the statements therein not misleading, and (ii)
notify each Holder of Registrable Securities subject to such Registration
Statement, at any time when a Prospectus relating thereto is required to be
delivered under the Securities Act, if the Prospectus included in such
CUSIP NO. 903236107 SCHEDULE 13D Page 56 of 107
Registration Statement, as then in effect, includes an untrue statement of a
material fact or omits to state a material fact required to be stated therein
or necessary to make the statements therein, in light of the circumstances
under which they were made, not misleading in each case upon discovery by the
Company of such material misstatement or omission or upon discovery by the
Corporation of the happening of any event as a result of which the Company
believes there would be a material misstatement or omission, and, as promptly
as is practicable, prepare and furnish to such Holder a reasonable number of
copies of a supplement to or an amendment of such Prospectus as may be
necessary so that, as thereafter delivered to the purchasers of such
securities, such Prospectus shall not include an untrue statement of a
material fact or omit to state a material fact required to be stated therein
or necessary to make the statements therein, in light of the circumstances
under which they were made, not misleading;
(g) otherwise use its best efforts to comply with all applicable
rules and regulations of the SEC, and make available to its security holders,
as soon as reasonably practicable, an earnings statement of the Corporation
complying with the provisions of Section 11(a) of the Securities Act and Rule
158 under the Securities Act (or any similar rule promulgated under the
Securities Act) no later than 45 days after the end of any 12-month period (or
90 days after the end of any 12-month period if such period is a fiscal year)
(i) commencing at the end of any fiscal quarter in which Registrable
Securities are sold to an underwriter or to underwriters in a firm commitment
or best efforts underwritten offering and (ii) if not sold to an underwriter
or to underwriters in such an offering, commencing on the first day of the
first fiscal quarter of the Corporation after the effective date of the
relevant Registration Statement, which statements shall cover said 12-month
periods;
(h) promptly notify each Holder of any Registrable Securities
covered by such Registration Statement, their counsel and the underwriters (i)
when such Registration Statement, or any post-effective amendment to such
Registration Statement, shall have become effective, or any amendment of or
supplement to the Prospectus used in connection therewith shall have been
filed, (ii) of any request by the SEC to amend such Registration Statement or
to amend or supplement such Prospectus or for additional information, (iii) of
the issuance by the SEC of any stop order suspending the effectiveness of such
Registration Statement or of any order preventing or suspending the use of any
preliminary prospectus or the initiation or threatening of any proceedings for
any of such purposes, (iv) of the suspension of the qualification of such
securities for offering or sale in any jurisdiction, or of the institution of
any proceedings for any of such purposes and (v) if at any time when a
Prospectus is to be required by the Securities Act to be delivered in
connection with the sale of the Registrable Securities, the representations
and warranties of the Company contained in the underwriting agreement
contemplated in Section 2.4(b) below, to the knowledge of the Corporation,
cease to be true and correct in any material respect;
(i) use its best efforts to prevent the issuance of any order
suspending the effectiveness of the Registration Statement or of any order
preventing or suspending the use of a Prospectus or suspending the
CUSIP NO. 903236107 SCHEDULE 13D Page 57 of 107
qualification (or exemption from qualification) of any of the Registrable
Securities covered thereby for sale in any jurisdiction, and, if any such
order is issued, to obtain the withdrawal of any such order at the earliest
possible moment;
(j) if requested by the managing underwriter, if any, or the
Holders of a majority of the Registrable Securities being sold in connection
with an underwriting offering, (i) promptly incorporate in a prospectus
supplement or post-effective amendment such information as the managing
underwriter, if any, or such Holders reasonably request to be included therein
to comply with applicable law and (ii) make all required filings of such
prospectus supplement or such post-effective amendment as soon as practicable
after the Corporation has received notification of the matters to be
incorporated in such prospectus supplement or post-effective amendment;
(k) cooperate with the Holders and the managing underwriter, if
any, to facilitate the timely preparation and delivery of new certificates
representing Registrable Securities to be sold against delivery by the Holders
of any old certificates representing such Registrable Securities, which new
certificates shall not bear any restrictive legends whatsoever and shall be in
a form eligible for deposit with DTC, and enable such Registrable Securities
to be in such denominations and registered in such names as the underwriters,
if any, or Holders may reasonably request at least two business days prior to
any sale of Registrable Securities in a firm commitment underwritten public
offering;
(l) prior to the effective date of the Registration Statement, (i)
provide the registrar for the Common Stock or such other Registrable
Securities with printed certificates for such securities in a form eligible
for deposit with DTC and (ii) provide a CUSIP number for such securities;
(m) cause the Conversion Shares and Repurchase Shares, and use its
best efforts to cause the Series A Preferred Stock and Series C Preferred
Stock, to be admitted for trading on the NYSE (or such other exchange or
automated trading system as shall be the primary trading system or exchange
for the Common Stock) in the event that the Registrable Securities covered by
such Registration Statement include any Series A Preferred Stock, Series C
Preferred Stock, Conversion Shares and Repurchase Shares not already so
listed; and
(n) have the right -- if the Board of Directors of the Company, in
its good faith judgment, determines that any Registration of shares of Common
Stock should not be made or continued because it would materially interfere
with any material financing, acquisition, corporation reorganization, merger,
or other transaction involving the Company or any of its subsidiaries, or
would require premature disclosure of material non-public information (a
"Valid Business Reason") -- (i) to postpone filing a Registration Statement
until such Valid Business Reason no longer exists, but in no event for more
than 180 days, and (ii) to cause any Registration Statement that has already
been filed to be withdrawn and its effectiveness terminated or to postpone
amending or supplementing such Registration Statement until such Valid
Business Reason no longer exists, but in no event for more than 90 days (the
CUSIP NO. 903236107 SCHEDULE 13D Page 58 of 107
"Postponement Period"); provided, however, that in no event shall the Company
be permitted to postpone or withdraw a Registration Statement within 180 days
after the expiration of the Postponement Period; and
(o) have the right to require each Holder of any Registrable
Securities as to which any registration is being effected to furnish to the
Corporation such information regarding such Holder and the distribution of
such securities as the Corporation may from time to time reasonably request in
writing and as shall be required by law in connection therewith. Each such
Holder agrees to furnish promptly to the Corporation all information required
to be disclosed in order to make the information previously furnished to the
Corporation by such Holder not materially misleading. The Corporation agrees
not to file or make any amendment to any Registration Statement with respect
to any Registrable Securities, or any amendment of or supplement to the
Prospectus used in connection therewith, which refers to any seller of any
securities covered thereby by name, or otherwise identifies such seller as the
holder of any securities of the Corporation, without the consent of such
seller, such consent not to be unreasonably withheld, except that no such
consent shall be required for any disclosure that is required by law. By the
acquisition of Registrable Securities, each Holder shall be deemed to have
agreed that upon receipt of any notice from the Corporation pursuant to
Section 2.3(f) or (n), such Holder will promptly discontinue such Holder's
disposition of Registrable Securities pursuant to the Registration Statement
covering such Registrable Securities until such Holder shall have received, in
the case of clause (i) of Section 2.3(f), notice from the Corporation that
such Registration Statement has been amended, as contemplated by Section
2.3(f); in the case of clause (ii) of Section 2.3(f), copies of the
supplemented or amended Prospectus contemplated by Section 2.3(f); or, in the
case of Section 2.3(n), the time period specified has elapsed or such Holder
has received notice from the Corporation that the Postponement Period has been
terminated. If so directed by the Corporation, each Holder will deliver to
the Corporation (at the Corporation's expense) all copies, other than
permanent file copies, in such Holder's possession of the Prospectus covering
such Registrable Securities at the time of receipt of such notice. In the
event that the Corporation shall give any such notice, the period mentioned in
Section 2.3(b) shall be extended by the number of days during the period from
and including the date of the giving of such notice to and including the date
when each seller of any Registrable Securities covered by such Registration
Statement shall have received the copies of the supplemented or amended
Prospectus contemplated by Section 2.3(f).
2.4 Underwritten Offerings. The provisions of this Section 2.4 do not
establish additional registration rights but instead set forth procedures
applicable, in addition to those set forth in Sections 2.1 through 2.3, to any
registration that is an underwritten offering.
(a) Underwritten Offerings Exclusive. Whenever a registration
requested pursuant to Section 2.1 is for an underwritten offering, only
securities that are to be distributed by the underwriters may be included in
the registration.
CUSIP NO. 903236107 SCHEDULE 13D Page 59 of 107
(b) Underwriting Agreement. If requested by the underwriters for
any underwritten offering by Holders pursuant to a registration requested
under Section 2.1, the Corporation shall enter into an underwriting agreement
with such underwriters for such offering, such agreement to be reasonably
satisfactory in substance and form to the Holders of a majority of the
Registrable Securities to be covered by such registration and to the
underwriters and to contain such representations and warranties by the
Corporation and such other terms and provisions as are customarily contained
in agreements of this type, including, but not limited to, indemnities to the
effect and to the extent provided in Section 2.7, provisions for the delivery
of officers' certificates, opinions of counsel and accountants' "cold comfort"
letters, and hold-back arrangements. The Holders of Registrable Securities to
be distributed by such underwriters shall be parties to such underwriting
agreement.
(c) Selection of Underwriters. Whenever a registration requested
pursuant to Section 2.1 is for an underwritten offering, the Holders of a
majority of the Registrable Securities to be registered pursuant to such
offering shall have the right to select one or more underwriters to administer
the offering, subject to the consent of the Corporation, which shall not be
unreasonably withheld. If the Corporation at any time proposes to register any
of its securities under the Securities Act for sale for its own account and
such securities are to be distributed by or through one or more underwriters,
the Corporation shall have the right to select one or more underwriters to
administer the offering, subject to the consent of the Holders of a majority
of Registrable Securities to be registered pursuant to such offering, which
shall not be unreasonably withheld. In all cases in this Section 2.4(c), at
least one of the underwriters chosen by the Holders or the Corporation shall
be an underwriter of nationally recognized standing.
(d) Hold Back Agreements. If and whenever the Corporation proposes
to register any of its equity securities under the Securities Act, whether or
not for its own account (other than pursuant to a Special Registration), or is
required to use its best efforts to effect the registration of any Registrable
Securities under the Securities Act pursuant to Section 2.1 or 2.2, each
Holder, if required by the managing underwriter in an underwritten offering,
agrees by acquisition of such Registrable Securities not to effect (other than
pursuant to such registration) any public sale or distribution, including, but
not limited to, any sale pursuant to Rule 144, of any Registrable Securities,
any other equity securities of the Corporation or any securities convertible
into or exchangeable or exercisable for any equity securities of the
Corporation during the 10 days prior to, and for 180 days after, the effective
date of such registration, to the extent timely notified in writing by the
Corporation or the managing underwriter, and the Corporation agrees to cause
each holder of any equity security, or of any security convertible into or
exchangeable or exercisable for any equity security, of the Corporation
purchased from the Corporation at any time other than in a public offering to
enter into a similar agreement with the Corporation. The foregoing provisions
shall not apply to any Holder if such Holder is prevented by applicable
statute or regulation from entering into any such agreement; provided,
however, that any such Holder shall undertake, in its request to participate
in any such underwritten offering, not to effect any public sale or
CUSIP NO. 903236107 SCHEDULE 13D Page 60 of 107
distribution of any applicable class of Registrable Securities commencing on
the date of sale of such applicable class of Registrable Securities unless it
has provided 45 days prior written notice of such sale or distribution to the
underwriter or underwriters. The Corporation further agrees not to effect
(other than pursuant to such registration or pursuant to a Special
Registration) any public sale or distribution, or to file any Registration
Statement (other than such registration or a Special Registration) covering
any, of its equity securities, or any securities convertible into or
exchangeable or exercisable for such securities, during the 10 days prior to,
and for 90 days after, the effective date of such registration if required by
the managing underwriter.
(e) in connection with an underwritten public offering only,
furnish to each underwriter
(i) an opinion of counsel for the Corporation experienced in
securities law matters, dated the effective date of the Registration
Statement, and
(ii) a "cold comfort" letter signed by the independent public
accountants who have issued an audit report on the Corporation's financial
statements included in the Registration Statement, subject to each seller
having executed and delivered to the independent public accountants such
certificates and documents as such accountants shall reasonably request,
covering substantially the same matters with respect to the Registration
Statement (and the Prospectus included therein) and, in the case of such
accountants' letter, with respect to events subsequent to the date of such
financial statements, as are customarily covered in opinions of issuer's
counsel and in accountants' letters delivered to the underwriters in
underwritten public offerings of securities.
2.5 Preparation; Reasonable Investigation. In connection with the
preparation and filing of each Registration Statement registering Registrable
Securities under the Securities Act, the Corporation shall give the Holders of
such Registrable Securities so to be registered and their underwriters, if
any, and their respective counsel and accountants, the opportunity to
participate in the preparation of such Registration Statement, each Prospectus
included therein or filed with the SEC, and each amendment thereof or
supplement thereto, and shall give each of them such access to all pertinent
financial, corporate and other documents and properties of the Corporation and
its Subsidiaries, and such opportunities to discuss the business of the
Corporation with its officers, directors, employees and the independent public
accountants who have issued audit reports on its financial statements as shall
be necessary, in the reasonable opinion of such Holders' and such
underwriters' respective counsel, to conduct a reasonable investigation within
the meaning of the Securities Act.
2.6 Other Registrations. If and whenever the Corporation is required
to use its best efforts to effect the registration of any Registrable
Securities under the Securities Act pursuant to Section 2.1 or 2.2, and if
such registration shall not have been withdrawn or abandoned, the Corporation
shall not be obligated to and shall not file any Registration Statement with
CUSIP NO. 903236107 SCHEDULE 13D Page 61 of 107
respect to any of its securities (including Registrable Securities) under the
Securities Act (other than a Special Registration), whether of its own accord
or at the request or demand of any holder or holders of such securities, until
a period of 180 days shall have elapsed from the effective date of such
previous registration, provided that the Corporation shall not be excused from
filing a registration statement by virtue of this Section 2.6 more than once
in a 360 day period.
2.7 Indemnification.
(a) Indemnification by the Corporation. In the event of any
registration of any Registrable Securities under the Securities Act pursuant
to Section 2.1 or 2.2, the Corporation shall indemnify and hold harmless the
seller of such securities, its directors, officers, and employees, each other
person who participates as an underwriter, broker or dealer in the offering or
sale of such securities and each other person, if any, who controls such
seller or any such participating person within the meaning of either Section
15 of the Securities Act or Section 20 of the Exchange Act, against any and
all losses, claims, damages or liabilities, joint or several, to which such
seller or any such director, officer, employee, participating person or
controlling person may become subject under the Securities Act or otherwise,
insofar as such losses, claims, damages or liabilities (or actions or
proceedings in respect thereof) arise out of or are based upon (i) any untrue
statement or alleged untrue statement of a material fact contained in any
Registration Statement under which such securities were registered under the
Securities Act, any Prospectus or preliminary prospectus included therein, or
any amendment or supplement thereto, or (ii) any omission or alleged omission
to state a material fact required to be stated in any such Registration
Statement, Prospectus, preliminary prospectus, amendment or supplement or
necessary to make the statements therein not misleading; and the Corporation
shall reimburse such seller and each such director, officer, employee,
participating person and controlling person for any legal or any other
expenses reasonably incurred by them in connection with investigating or
defending any such loss, claim, liability, action or proceeding as such
expenses are incurred; provided that the Corporation shall not be liable in
any such case to the extent that any such loss, claim, damage, liability or
expense arises out of or is based upon an untrue statement or omission made in
any such Registration Statement, Prospectus, preliminary prospectus, amendment
or supplement in reliance upon and in conformity with written information
furnished to the Corporation by such seller or participating person expressly
for use in the preparation thereof; provided further that the Corporation
shall not be liable and indemnification shall not apply to amounts paid in any
settlement effected without the consent of the Corporation.
(b) Indemnification by the Sellers. In the event of any
registration of any Registrable Securities under the Securities Act pursuant
to Section 2.1 or 2.2, each of the prospective sellers of such securities,
will indemnify and hold harmless the Corporation, each director of the
Corporation, each officer of the Corporation who shall sign such Registration
Statement, and each other person, if any, who controls the Corporation or any
such participating person within the meaning of Section 15 of the Securities
Act or Section 20 of the Exchange Act, against any and all losses, claims,
CUSIP NO. 903236107 SCHEDULE 13D Page 62 of 107
damages or liabilities, joint or several, to which the Corporation or any such
director, officer, employee, participating person or controlling person may
become subject under the Securities Act or otherwise, insofar as such losses,
claims, damages or liabilities (or actions or proceedings in respect thereof)
arise out of or are based upon any untrue statement or alleged untrue
statement of a material fact contained in any Registration Statement under
which such securities were registered under the Securities Act, any Prospectus
or preliminary prospectus included therein, or any amendment or supplement
thereto, or any omission or alleged omission to state a material fact with
respect to such seller required to be stated in any such Registration
Statement, Prospectus, preliminary prospectus, amendment or supplement or
necessary to make the statements therein not misleading if such statement or
omission was made in reliance upon and in conformity with written information
furnished to the Corporation by such seller expressly for use in the
preparation of any such Registration Statement, Prospectus, preliminary
prospectus, amendment or supplement; provided that the liability of each such
seller shall be in proportion to and limited to the gross amount received by
such seller from the sale of Registrable Securities pursuant to such
Registration Statement; provided further that any Seller shall not be liable
and indemnification shall not apply to amounts paid in any settlement effected
without the consent of that Seller.
(c) Notices of Claims, etc. Promptly after receipt by an
indemnified party of notice of the commencement of any action or proceeding
involving a claim referred to in the preceding paragraphs of this Section 2.7,
such indemnified party shall, if a claim in respect thereof is to be made
against an indemnifying party hereunder, give prompt written notice to the
latter of the commencement of such action, provided that the failure of any
indemnified party to give notice as provided therein shall not relieve the
indemnifying party of its obligations under the preceding paragraphs of this
Section 2.7 unless the failure to provide prompt written notice shall cause
actual prejudice to the indemnifying party. In case any such action is brought
against an indemnified party and it notifies the indemnifying party of the
commencement thereof, the indemnifying party shall have the right to retain
counsel reasonably satisfactory to such indemnified party to defend against
such proceeding and shall pay the reasonable fees and disbursements of such
counsel related to such proceeding. In any such proceeding, any indemnified
party shall have the right to retain its own counsel, but the fees and
expenses of such counsel shall be at the expense of such indemnified party
unless (i) the indemnifying party and the indemnified party shall have
mutually agreed to the retention of such counsel and the payment of such fees
by the indemnifying party or (ii) the named parties to any such proceeding
(including any impleaded parties) include both the indemnifying party and the
indemnified party and representation of both parties by the same counsel would
be inappropriate due to actual or potential differing interests between them
or (iii) the indemnifying party has not retained counsel to defend such
proceeding, in which case (under any of such clauses (i), (ii) or (iii)) it is
understood that (x) the indemnifying party shall not, in connection with any
proceeding or related proceedings in the same jurisdiction, be liable for the
reasonable fees and expenses of more than one separate firm for all such
indemnified parties and (y) such firm shall be designated in writing by the
Holders of a majority of the Registrable Securities included in such
CUSIP NO. 903236107 SCHEDULE 13D Page 63 of 107
Registration Statement in the case of parties indemnified pursuant to Section
2.7(a) and by the Corporation in the case of parties indemnified pursuant to
Section 2.7(b). All fees and expenses that an indemnified party is entitled to
receive from an indemnifying party under this Section 2.7 shall be reimbursed
as they are incurred, provided that each such indemnified party shall promptly
repay such fees and expenses if it is finally judicially determined that such
indemnified party is not entitled to indemnification hereunder. No
indemnifying party, in the defense of any such claim or litigation, shall,
except with the consent of such indemnified party, which consent shall not be
unreasonably withheld, consent to entry of any judgment or enter into any
settlement of any pending or threatened action in respect of which any
indemnified party is or could have been a party and indemnity could have been
sought hereunder by such indemnified party unless such judgment or settlement
includes as an unconditional term thereof the giving by the claimant or
plaintiff to such indemnified party of a release from all liability in respect
to such claim or litigation.
(d) Other Indemnification. Indemnification similar to that
specified in the preceding paragraphs of this Section 2.7 (with appropriate
modifications) shall be given by the Corporation and each seller of
Registrable Securities with respect to any required registration or other
qualification of such Registrable Securities under any federal or state law or
regulation of governmental authority other than the Securities Act.
(e) Other Remedies. If for any reason the foregoing indemnity is
unavailable, or is insufficient to hold harmless an indemnified party, other
than by reason of the exceptions provided therein, then the indemnifying party
shall contribute to the amount paid or payable by the indemnified party as a
result of such losses, claims, damages, liabilities or expenses in such
proportion as is appropriate to reflect the relative fault of the indemnifying
party on the one hand and of the indemnified party on the other in connection
with the statements or omissions which resulted in such losses, claims,
damages or liabilities, as well as any other relevant equitable
considerations. The relative fault shall be determined by reference to, among
other things, whether the untrue or alleged untrue statement of a material
fact or the omission or alleged omission to state a material fact relates to
information supplied by the Corporation or the Holders of Registrable
Securities covered by the Registration Statement in question and the parties'
relative intent, knowledge, access to information and opportunity to correct
or prevent such statement or omission. The Corporation and the Holders agree
that it would not be just and equitable if contribution pursuant to this
Section 2.7 were determined by pro rata allocation or by any other method of
allocation which does not take account of the equitable considerations
referred to in the immediately preceding paragraph. The amount paid or payable
by an indemnified party as a result of the losses, claims, damages and
liabilities referred to in the immediately preceding paragraph of this Section
2.7 shall be deemed to include, subject to the limitations set forth above,
any legal or other expenses reasonably incurred by such indemnified party in
connection with investigating or defending any such action or claim. No person
guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of
the Securities Act) shall be entitled to contribution from any person who was
not guilty of such fraudulent misrepresentation. No party shall be liable for
CUSIP NO. 903236107 SCHEDULE 13D Page 64 of 107
contribution under this Section 2.7(e) except to the extent and under such
circumstances as such party would have been liable to indemnify under this
Section 2.7 if such indemnification were enforceable under applicable law.
(f) Officers and Directors. As used in this Section 2.7, the terms
"officers" and "directors" shall include the partners of Holders which are
partnerships and the members of Holders which are limited liability companies.
2.8 Expenses. The Corporation shall pay all Registration Expenses in
connection with each registration of Registrable Securities pursuant to this
Section 2, as provided in this Agreement.
ARTICLE III
MISCELLANEOUS
3.1 Legended Securities; etc. The Corporation shall issue new
certificates for Registrable Securities without a legend restricting further
transfer if (I) such securities have been sold to the public pursuant to an
effective Registration Statement under the Securities Act (other than Form S-8
if the Holder of such Registrable Securities is an Affiliate) or Rule 144, or
(ii) (x) such issuance is otherwise permitted under the Securities Act, (y)
the Holder of such shares has delivered to the Corporation an opinion of
counsel, which opinion and counsel shall be reasonably satisfactory to the
Corporation, to such effect and (z) the Holder of such shares expressly
requests the issuance of such certificates in writing.
3.2 Amendments and Waivers. This Agreement may be amended, modified or
supplemented, and the Corporation may take any action herein prohibited, or
omit to perform any act herein required to be performed by it, only if the
Corporation shall have obtained the written consent to such amendment, action
or omission to act, of the Holder or Holders of at least a majority of the
Registrable Securities. Notwithstanding the foregoing, a waiver or consent to
depart from the provisions hereof with respect to a matter that relates
exclusively to the rights of Holders whose securities are being sold pursuant
to a Registration Statement and that does not directly or indirectly affect,
impair, limit or compromise the rights of other Holders may be given by
Holders of at least a majority of the Registrable Securities being sold by
such Holders pursuant to such Registration Statement; provided, however, that
the provisions of this sentence may not be amended, modified or supplemented
except in accordance with the provisions of the immediately preceding
sentence. No amendment, modification or discharge of this Agreement, and no
waiver hereunder, shall be valid or binding unless set forth in writing. Any
such waiver shall constitute a waiver only with respect to the specific matter
described in such writing and shall in no way impair the rights of the party
or parties granting such waiver in any other respect or at any other time.
3.3 Nominees for Beneficial Owners. In the event that any Registrable
Securities are held by a nominee for the beneficial owner thereof, the
beneficial owner thereof may, at its election and unless notice is otherwise
given to the Corporation by the record owner, be treated as the holder of such
Registrable Securities for purposes of any request or other action by any
CUSIP NO. 903236107 SCHEDULE 13D Page 65 of 107
Holder or Holders pursuant to this Agreement or any determination of any
number or percentage of shares of Registrable Securities held by any Holder or
Holders contemplated by this Agreement. If the beneficial owner of any
Registrable Securities so elects, the Corporation may require assurances
reasonably satisfactory to it of such owner's beneficial ownership of such
Registrable Securities.
3.4 Successors, Assigns and Transferees. This Agreement shall be binding
upon and shall inure to the benefit of the parties hereto and their respective
successors assign and transferees. Purchaser or a Holder may assign its rights
hereunder in whole or in part to an Affiliate or to a Distributee or to other
successors, assigns and transferees of Purchaser or such Holder; provided that
such Affiliate, Distributee or successor, assignee or transferee expressly
agrees to be bound by this Agreement by written supplement. This Agreement
shall survive any transfer of Registrable Securities to and shall inure to the
benefit of an Affiliate, a Distributee or such other successors, assigns and
transferees of Purchaser or such Holder.
3.5 Notices. All notices or other communications given or made under
this Agreement shall be validly given or made if in writing and delivered by
facsimile transmission or in person at, or mailed by overnight courier to, the
following addresses (and shall be deemed effective at the time of receipt
thereof):
If to Seller:
URS Corporation
100 California Street, Suite 500
San Francisco, California 94111
Attn: Kent P. Ainsworth
Facsimile: (415) 398-2621
with a copy to:
Cooley Godward LLP
One Maritime Plaza, 20th Floor
San Francisco, California 94111-3580
Attn: Samuel M. Livermore
Facsimile: (415) 951-3699
If to Purchaser:
RCBA Strategic Partners, L.P.
909 Montgomery Street, Suite 400
San Francisco, California 94133
Attn: Murray A. Indick
Facsimile: (415) 434-3130
CUSIP NO. 903236107 SCHEDULE 13D Page 66 of 107
with a copy to:
Wilmer, Cutler & Pickering
2445 M Street, N.W.
Washington, D.C. 20037
Attn: Michael R. Klein and Eric R. Markus
Facsimile: (202) 663-6363
or to such other address as the party to whom notice is to be given may have
previously furnished notices to the other in the manner set forth above.
3.6 No Inconsistent Agreements. The Corporation shall not hereafter
enter into any agreement, or amend any existing agreement, with respect to its
securities if such agreement would be inconsistent with the rights granted to
the Holders by this Agreement.
3.7 Remedies; Attorneys' Fees. Each Holder of Registrable Securities,
in addition to being entitled to exercise all rights provided herein or
granted by law, including recovery of damages, shall be entitled to specific
performance of its rights under this Agreement. The Corporation agrees that
monetary damages would not be adequate compensation for any loss incurred by
reason of a breach by it of any provision of this Agreement and hereby agrees
to waive the defense in any action for specific performance that a remedy at
law would be adequate. As between the parties to this Agreement, in any action
or proceeding brought to enforce any provision of this Agreement, or where any
provision hereof is validly asserted as a defense, the successful party shall
be entitled to recover reasonable attorney's fees in addition to its costs and
expenses and any other available remedy.
3.8 Severability. If any clause, provision or section of this Agreement
shall be invalid, illegal or unenforceable, the invalidity, illegality or
unenforceability of such clause, provision or section shall not affect the
enforceability or validity of any of the remaining clauses, provisions or
sections hereof to the extent permitted by applicable law. The invalidity of
any one or more phrases, sentences, clauses, Sections or subsections of this
Agreement shall not affect the remaining portions of this Agreement.
3.9 Headings. The headings contained in this Agreement are for purposes
of convenience only and shall not affect the meaning or interpretation of this
Agreement.
3.10 Counterparts. This Agreement may be executed in several
counterparts, each of which shall be deemed an original and all of which
together constitute one and the same instrument.
3.11 No Third Party Beneficiaries. Except as provided in Sections 2.7
and 3.4, nothing in this Agreement shall confer any rights upon any person or
entity other than the parties hereto, each such party's respective successors
and permitted assigns.
3.12 Governing Law; Jurisdiction. This Agreement shall be governed by
and construed in accordance with the laws of the State of Delaware as applied
CUSIP NO. 903236107 SCHEDULE 13D Page 67 of 107
to contracts made and performed within the State of Delaware, without regard
to principles of conflicts of law.
IN WITNESS WHEREOF, each of the undersigned has executed this Agreement
or caused this Agreement to be executed on its behalf as of the date first
written above.
RCBA STRATEGIC PARTNERS, L.P. URS CORPORATION
By: RCBA GP, L.L.C.,
its general partner
By: /s/ Murray A. Indick By: /s/ Kent Ainsworth
-------------------------- -------------------------------
Name: Murray A. Indick Name: Kent P. Ainsworth
Title: Member Title: Executive Vice President and
Chief Executive Officer
CUSIP NO. 903236107 SCHEDULE 13D Page 68 of 107
Exhibit D
CERTIFICATE OF DESIGNATION
of
SERIES A
PREFERRED STOCK
of
URS CORPORATION
Pursuant to Section 151 of the General Corporation Law
of the State of Delaware
URS Corporation, a Delaware corporation (the "Corporation"), certifies
that pursuant to the authority contained in its Certificate of Incorporation,
as amended, and in accordance with the provisions of Section 151 of the
General Corporation Law of the State of Delaware, its Board of Directors (the
"Board of Directors") has adopted the following resolution creating a series
of its Preferred Stock, par value $1.00 per share, designated as Series A
Preferred Stock:
RESOLVED, that a series of authorized Preferred Stock, par value $1.00
per share, of the Corporation be hereby created, and that the designation and
amount thereof and the voting powers, preferences and relative, participating,
optional and other special rights of the shares of such series, and the
qualifications, limitations or restrictions thereof are as follows:
Section 1. Designation and Amount.
The shares of such series shall be designated as the "Series A Preferred
Stock" (the "Series A Preferred Stock") and the number of shares constituting
such series shall be 300,000 shares of Series A Preferred Stock. Section 12
below contains the definitions of certain defined terms used herein.
Section 2. Dividends and Distributions.
(a) The holders of shares of Series A Preferred Stock, in
preference to the holders of shares of the Common Stock and of any other
Capital Stock of the Corporation ranking junior to the Series A Preferred
Stock as to payment of dividends, shall be entitled to receive on the last day
of each calendar quarter, cumulative dividends on the Series A Preferred Stock
accruing on a daily basis (computed on the basis of a 360-day year of twelve
30-day months) at the rate per annum equal to the Dividend Rate (as defined
herein) per share of Series A Preferred Stock calculated as a percentage of
CUSIP NO. 903236107 SCHEDULE 13D Page 69 of 107
$2,170.00, compounded quarterly, from and including the date of issuance until
the redemption of the Series A Preferred Stock. Such dividends shall be paid
in kind as herein provided, and will be paid whether or not they have been
declared and whether or not there are profits, surplus or other funds of the
Corporation legally available for the payment of dividends. Dividends on the
Series A Preferred Stock shall be paid in additional shares of Series A
Preferred Stock valued at $2,170.00 per share. For purposes hereof, the
"Dividend Rate" shall mean eight percent (8%) per annum from the date of
initial issuance of the Series A Preferred Stock until six (6) months after
the date of issuance, and (ii) and fifteen percent (15%) thereafter (except as
otherwise provided in the last sentence of Section 4(b)(ii)); provided,
however, that if Stockholder Approval (as such term is defined in the
Securities Purchase Agreement) has not been obtained within six (6) months
after the date of issuance, then the Dividend Rate shall be retroactively
recalculated as if it were fifteen percent (15%) from the time of issuance and
additional dividend shares shall be paid in respect of such retroactive
increase.
(b) In case the Corporation or any Subsidiary of the Corporation
shall at any time or from time to time declare, order, pay or make a dividend
or other distribution (including, without limitation, any distribution of
stock or other securities or property or rights or warrants to subscribe for
securities of the Corporation or any of its Subsidiaries by way of dividend or
spin off) on the Common Stock, other than any dividend or distribution of
shares of Common Stock covered by paragraph (b)(i) of Section 7 hereof (a
"Covered Distribution"), the holders of shares of Series A Preferred Stock
shall be entitled to receive from the Corporation, with respect to each share
of Series A Preferred Stock held, in addition to the dividends payable under
paragraph (a) of this Section 2, the same dividend or distribution received by
a holder of the number of shares of Common Stock equal to the Common
Liquidation Equivalent per share of Series A Preferred Stock on the record
date for such dividend or distribution. Any such dividend or distribution
shall be declared, ordered, paid or made on the Series A Preferred Stock at
the same time such dividend or distribution is declared, ordered, paid or made
on the Common Stock and shall be in addition to any dividends payable under
paragraph (a) of this Section 2.
Section 3. Voting Rights.
CUSIP NO. 903236107 SCHEDULE 13D Page 70 of 107
So long as any shares of Series A Preferred Stock shall be outstanding
and unless the consent or approval of a greater number of shares shall then be
required by law, without first obtaining the consent or approval of the
Requisite Holders, voting as a single class, given in person or by proxy at a
meeting at which the holders of such shares shall be entitled to vote
separately as a class, or by written consent, the Corporation shall not (and
shall not permit or authorize any subsidiary to): (i) authorize, create or
issue any class or series, or any shares of any class or series, of stock
having any preference or priority as to voting, dividends or upon liquidation,
dissolution or winding up over the Series A Preferred Stock ("Senior Stock");
(ii) authorize, create or issue any class or series, or any shares of any
class or series, of stock ranking on a parity as to voting, dividends or upon
liquidation, dissolution or winding up with the Series A Preferred Stock
("Parity Stock"); (iii) reclassify any shares of stock of the Corporation into
shares of Senior Stock or Parity Stock; (iv) authorize any security
exchangeable for, convertible into, or evidencing the right to purchase any
shares of Senior Stock or Parity Stock, other than the exchange of Series B
Exchangeable Convertible Preferred Stock of the Corporation (the "Series B
Preferred Stock") for shares of Series A Preferred Stock and Series C
Preferred Stock of the Corporation (the "Series C Preferred Stock"); (v) alter
or change the rights, preferences or privileges of the Series A Preferred
Stock; (vi) increase or decrease the authorized number of shares of Series A
Preferred Stock or issue shares of Series A Preferred Stock other than to
holders of Series A Preferred Stock pursuant to its terms; or (vii) amend or
waive any provision of the Corporation's Certification of Incorporation or
bylaws in a manner adverse in any respect to the holders of Series A Preferred
Stock.
Section 4. Mandatory Repurchase by the Corporation.
2 (a) On the twelfth anniversary of the Closing Date of the
Securities Purchase Agreement, the Corporation shall purchase for cash from
each holder of shares of Series A Preferred Stock the number of shares of the
Series A Preferred Stock held by such holder on such twelfth anniversary.
Repurchases made pursuant to this Section 4(a) shall be effected on such
anniversary date (or such other day as the holder and the Corporation may
agree) and shall be for the Liquidation Preference. The place of payment
shall be at an office or agency fixed therefor by the Corporation or, if not
fixed, at the principal executive office of the Corporation.
(b) (i) On the date fixed for repurchase, each holder of shares
of Series A Preferred Stock shall surrender the certificate representing such
shares to the Corporation at the place designated in such notice and shall
thereupon be entitled to receive payment in cash therefor provided in this
Section 4. Dividends with respect to the shares of Series A Preferred Stock
so purchased shall cease to accrue after the date so purchased, such shares
shall no longer be deemed outstanding after such date and the holders thereof
shall cease to be stockholders of the Corporation and all rights whatsoever
with respect to the shares so purchased shall terminate.
CUSIP NO. 903236107 SCHEDULE 13D Page 71 of 107
(ii) If the funds legally available for such purchase are
not sufficient to purchase all the shares of Series A Preferred Stock tendered
to the Corporation for purchase, the Corporation shall purchase the greatest
number of whole shares for which such funds are so available on a pro rata
basis among all tendering holders based on the ratio of the number of shares
tendered by each of them to the aggregate amount of all shares so tendered,
and the certificates representing the unpurchased shares shall be deemed not
to be surrendered for repurchase, such unpurchased shares shall remain
outstanding and the rights of the holders of shares of Series A Preferred
Stock thereafter shall continue to be those of a holder of shares of the
Series A Preferred Stock; provided, however, the Corporation shall thereafter
be required to repurchase all such remaining shares at the first date it has
sufficient funds legally available for such purpose at the price it would have
paid at the date such shares were actually tendered and the Corporation shall
give notice as aforesaid to each holder whose shares were not repurchased for
such reason and such holder shall thereafter have the right to elect to have
such shares repurchased, such election to be made within 30 days of receipt of
such notice. For purposes of this Section, the Corporation shall be deemed
not to have sufficient funds legally available for any such purchase if the
Board of Directors reasonably determines that immediately after such
repurchase the Corporation would be insolvent. Upon the failure to purchase
all of the Series A Preferred Stock as required by this Section 4, the
Dividend Rate on any such stock that has not been purchased shall
automatically, pursuant to Section 2(a), increase to eighteen percent (18%).
(c) Whenever the Corporation shall not have redeemed the shares
of Series A Preferred Stock within five (5) Business Days of the date such
redemption is required by Section 4(a), thereafter and until all redemption
payments shall have been made, if and so long as any shares of Series A
Preferred Stock remain outstanding, the Corporation shall not, nor shall it
permit any of its Subsidiaries to: (i) declare or pay dividends, or make any
other distributions, on any shares of Common Stock or other capital stock of
the Corporation ranking junior (either as to dividends or upon liquidation,
dissolution or winding up) to the Series A Stock ("Junior Stock"), other than
dividends or distribution payable in Junior Stock; (ii) declare or pay
dividends, or make any other distributions, on any shares of Parity Stock,
other than dividends or distributions payable in Junior Stock, except
dividends paid ratably on the Series A Preferred Stock and all Parity Stock on
which dividends are payable or in arrears, in proportion to the total amounts
to which the holders of all such shares are then entitled; (iii) redeem or
purchase or otherwise acquire for consideration (other than Junior Stock) any
shares of Junior Stock or Parity Stock (other than, with respect to Parity
Stock, ratably with the Series A Preferred Stock); or (iv) purchase or
otherwise acquire for consideration any shares of Series A Preferred Stock,
other than purchases ratably among all holders of the Series A Preferred
Stock.
(d) The Corporation shall not permit any Subsidiary of the
Corporation to purchase or otherwise acquire for consideration any shares of
capital stock of the Corporation unless the Corporation could, pursuant to
paragraph (c) of this Section 4, purchase or otherwise acquire such shares at
such time and in such manner.
CUSIP NO. 903236107 SCHEDULE 13D Page 72 of 107
Section 5. Reacquired Shares.
Any shares of Series A Preferred Stock purchased or otherwise acquired by
the Corporation in any manner whatsoever shall be retired and canceled
promptly after the acquisition thereof, and, if necessary to provide for the
lawful purchase of such shares, the capital represented by such shares shall
be reduced in accordance with the General Corporation Law of the State of
Delaware. All such shares shall upon their cancellation become authorized but
unissued shares of Preferred Stock, par value $1.00 per share, of the
Corporation and may be reissued as part of another series of Preferred Stock,
par value $1.00 per share, of the Corporation subject to the conditions or
restrictions on authorizing, or creating or issuing any class or series, or
any shares of any class or series, set forth in Section 3.
Section 6. Liquidation, Dissolution or Winding Up.
If the Corporation shall adopt a plan of liquidation or of dissolution,
or commence a voluntary case under the Federal bankruptcy laws or any other
applicable state or Federal bankruptcy, insolvency or similar law, or consent
to the entry of an order for relief in any involuntary case under any such law
or to the appointment of a receiver, liquidator, assignee, custodian, trustee
or sequestrator (or similar official) of the Corporation or of any substantial
part of its property, or make an assignment for the benefit of its creditors,
or admit in writing its inability to pay its debts generally as they become
due, or if a decree or order for relief in respect of the Corporation shall be
entered by a court having jurisdiction in the premises in an involuntary case
under the Federal bankruptcy laws or any other applicable Federal or state
bankruptcy, insolvency or similar law, or appointing a receiver, liquidator,
assignee, custodian, trustee, sequestrator (or other similar official) of the
Corporation or of any substantial part of its property, or ordering the
winding up or liquidation of its affairs, and any such decree or order shall
be unstayed and in effect for a period of ninety (90) consecutive days and on
account of such event the Corporation shall liquidate, dissolve or wind up, or
upon any other liquidation, dissolution or winding up of the Corporation, no
distribution shall be made (i) to the holders of shares of Junior Stock,
unless prior thereto, the holders of shares of Series A Preferred Stock shall
have received in cash the Liquidation Preference, or (ii) to the holders of
shares of Parity Stock, except distributions made ratably on the Series A
Preferred Stock and all such Parity Stock in proportion to the total amounts
to which the holders of all such shares are entitled upon such liquidation,
dissolution or winding up of the Corporation. A consolidation, merger,
corporate reorganization, recapitalization or other similar transaction as a
result of which the beneficial holders of the Corporation's Common Stock
immediately prior to such transaction do not hold, directly or indirectly, in
excess of 50% of the combined voting securities entitled to vote generally in
the election of the directors of the surviving or resulting corporation
immediately after such transaction, and a sale or other disposition of all or
substantially all of the assets of the Corporation in one transaction or
series of related transactions, each shall be deemed to be a "liquidation"
within the meaning of this Section 6; provided that no such transaction shall
CUSIP NO. 903236107 SCHEDULE 13D Page 73 of 107
be deemed to be a "liquidation" if first approved by the Board of Directors of
the Corporation and the Requisite Holders.
Section 7. Common Liquidation Equivalent.
(a) Subject to the provisions for adjustment hereinafter set
forth, the "Common Liquidation Equivalent" of each share of Series A Preferred
Stock shall be equal to an amount that would be payable to the holder of such
share upon the occurrence of an event described in Section 6 had such holder,
immediately prior to such event, exchanged such shares for shares of Common
Stock at the Applicable Exchange Rate. The Applicable Exchange Rate in effect
at any time shall be the quotient obtained by dividing $2,170.00 by the
Applicable Exchange Value, calculated as provided in Section 7(b).
(b) The Applicable Exchange Value shall be $21.70, except that
such amount shall be adjusted from time to time in accordance with this
Section 7. The Applicable Exchange Value shall be subject to adjustment from
time to time as follows:
(i) In case the Corporation shall at any time or from time
to time after the original issuance of the Series A Preferred Stock declare a
dividend, or make a distribution, on the outstanding shares of Common Stock in
either case, in shares of Common Stock, or effect a subdivision, combination,
consolidation or reclassification of the outstanding shares of Common Stock
into a greater or lesser number of shares of Common Stock, then, and in each
such case, the Applicable Exchange Value in effect immediately prior to such
event or the record date therefor, whichever is earlier, shall be adjusted by
multiplying the Applicable Exchange Value by a fraction, the numerator of
which is the number of shares of Common Stock that were outstanding
immediately prior to such event and the denominator of which is the number of
shares of Common Stock outstanding immediately after such event. An
adjustment made pursuant to this clause (i) shall become effective (x) in the
case of any such dividend or distribution, immediately after the close of
business on the record date for the determination of holders of shares of
Common Stock entitled to receive such dividend or distribution, or (y) in the
case of any such subdivision, reclassification, consolidation or combination,
at the close of business on the day upon which such corporate action becomes
effective.
(ii) In addition to the foregoing adjustments in subsection
(i) above, the Corporation will be permitted to make such reductions in the
Applicable Exchange Value as it considers to be advisable in order that any
event treated for Federal income tax purposes as a dividend of stock or stock
rights will not be taxable to the holders of the shares of Common Stock.
(iii) No adjustment in the Applicable Exchange Value shall be
required unless such adjustment would require an increase or decrease of at
least 0.1% of the Applicable Exchange Value; provided, that any adjustments
which by reason of this subsection (v) are not required to be made shall be
carried forward and taken into account in any subsequent adjustment. All
calculations under this Section 7 shall be made to the nearest cent or to the
nearest one-hundredth of a share, as the case may be.
CUSIP NO. 903236107 SCHEDULE 13D Page 74 of 107
(iv) In each case of an adjustment or readjustment of the
Applicable Exchange Rate, the Corporation at its expense will furnish each
holder of Series A Preferred Stock with a certificate, executed by the
president and chief financial officer (or in the absence of a person
designated as the chief financial officer, by the treasurer) showing such
adjustment or readjustment, and stating in detail the facts upon which such
adjustment or readjustment is based.
Section 8. Rank.
The Series A Preferred Stock shall rank, with respect to dividend rights
and rights upon liquidation, winding up and dissolution, prior to all classes
and series of the Corporation's preferred stock authorized or outstanding on
the date of initial issuance of the Series A Preferred Stock (other than the
Series C Preferred Stock, which shall rank on a par with the Series A
Preferred Stock) and prior to all classes of Common Stock.
Section 9. Other Covenants.
(a) Transfer Taxes. The Corporation shall pay any and all issue
or other taxes that may be payable in respect of any issue or delivery of
shares of Series B Preferred Stock on exchange of the Series A Preferred Stock
and other securities. The Corporation shall not, however, be required to pay
any income tax or tax which may be payable in respect of any transfer involved
in the issue or delivery of Series A Preferred Stock (or other securities or
assets) in a name other than that in which the shares of Series A Preferred
Stock so exchanged were registered, and no such issue or delivery shall be
made unless and until the person requesting such issue has paid to the
Corporation the amount of such tax or has established, to the satisfaction of
the Corporation, that such tax has been paid.
(b) Prior Notice of Certain Events. In case:
(i) the Corporation shall authorize the granting to all
holders of Common Stock of rights or warrants to subscribe for or purchase any
shares of stock of any class or of any other rights or warrants; or
(ii) of any reclassification of Common Stock (other than a
subdivision or combination of the outstanding Common Stock, or a change in par
value, or from par value to no par value, or from no par value to par value),
or of any consolidation or merger to which the Corporation is a party and for
which approval of any stockholders of the Corporation shall be required, or of
the sale or transfer of all or substantially all of the assets of the
Corporation or of any compulsory share exchange whereby the Common Stock is
converted into other securities, cash or other property; or
(iii) of the voluntary or involuntary dissolution,
liquidation or winding up of the Corporation;
then the Corporation shall cause to be filed with the transfer agent for the
Series A Preferred Stock, and shall cause to be mailed to the holders of
CUSIP NO. 903236107 SCHEDULE 13D Page 75 of 107
record of the Series A Preferred Stock, at their last addresses as they shall
appear upon the stock transfer books of the Corporation, at least fifteen days
prior to the applicable record date hereinafter specified, a notice stating,
as the case may be, (x) the record date (if any) for the purpose of such
dividend, distribution, redemption, repurchase or granting of rights or
warrants or, if no record date is to be set, the date as of which the holders
of Common Stock of record to be entitled to such dividend, distribution,
redemption, rights or warrants are to be determined or (y) the date on which
such reclassification, consolidation, merger, sale, transfer, share exchange,
dissolution, liquidation or winding up is expected to become effective, and
the date, if any, as of which it is expected that holders of shares of Common
Stock of record shall be entitled to exchange their shares of Common Stock for
securities or other property deliverable upon such reclassification,
consolidation, merger, sale, transfer, share exchange, dissolution,
liquidation or winding up (but no failure to mail such notice or any defect
therein or in the mailing thereof shall affect the validity of the corporate
action required to be specified in such notice).
Section 10. Remedies.
(a) The Corporation stipulates that the remedies at law of each
holder of Series A Preferred Stock in the event of any failure in the
performance of or compliance with any of the terms hereof are not and will not
be adequate and that, to the fullest extent permitted by law, such terms may
be specifically enforced by a decree for the specific performance of any
agreement contained herein or by an injunction against a violation of any of
the terms hereof or otherwise without requiring any holder to post a bond or
other security except to the extent required by applicable law.
(b) Any holder of Series A Preferred Stock shall be entitled to
recover from the Corporation the reasonable attorneys' fees and expenses
incurred by such holder in connection with the enforcement by such holder of
any obligation of the Corporation hereunder.
(c) No failure or delay on the part of any holder of Series A
Preferred Stock in exercising any right, power or remedy hereunder or under
applicable law or otherwise shall operate as a waiver thereof; nor shall any
single or partial exercise of any such right, power or remedy preclude any
other or further exercise thereof or the exercise of any other right, power or
remedy hereunder or thereunder. The remedies herein provided are cumulative
and not exclusive of any remedies provided by law or otherwise.
Section 11. Severability of Provisions.
Whenever possible, each provision hereof shall be interpreted in a manner
as to be effective and valid under applicable law, but if any provision hereof
is held to be prohibited by or invalid under applicable law, such provision
shall be ineffective only to the extent of such prohibition or invalidity,
without invalidating or otherwise adversely affecting the remaining provisions
hereof. If a court of competent jurisdiction should determine that a
provision hereof would be valid or enforceable if a period of time were
extended or shortened or a particular percentage were increased or decreased,
CUSIP NO. 903236107 SCHEDULE 13D Page 76 of 107
then such court may make such change as shall be necessary to render the
provision in question effective and valid under applicable law.
Section 12. Definitions.
For the purposes of the Certificate of Designation of Series A Preferred
Stock which embodies this resolution:
(a) "Accrued Dividends" to a particular date (the "Applicable
Date") shall mean (i) all dividends accrued but not paid on the Series A
Preferred Stock pursuant to paragraph (a) of Section 2, whether or not
declared, accrued to the Applicable Date, plus (ii) all dividends or
distributions payable pursuant to paragraph (b) of Section 2 for which the
Covered Distribution was declared, ordered, paid or made on or prior to the
Applicable Date.
(b) "Business Day" shall mean any day other than a Saturday,
Sunday, or a day on which commercial banks in the City of New York are
authorized or obligated by law or executive order to close.
(c) "capital stock" shall mean (i) in the case of a corporation,
corporate stock, (ii) in the case of an association or business entity, any
and all shares, interests, participations, rights or other equivalents
(however designated) of corporate stock, (iii) in the case of a partnership or
limited liability company, partnership or membership interests (whether
general or limited) and (iv) any other interest or participation that confers
on a person the right to receive a share of the profits and losses of, or
distributions of assets of, the issuing person.
(d) "Closing Price" per share of Common Stock on any date shall
mean the last sale price, or, in case no such sale takes place on such day,
the average of the closing bid and asked prices, in either case as reported on
the Nasdaq National Market or in the principal consolidated transaction
reporting system with respect to securities listed or admitted to trading on
the New York Stock Exchange or American Stock Exchange, as the case may be,
or, if the Common Stock is listed or admitted to trading on the New York Stock
Exchange or American Stock Exchange, or, if the Common Stock is not listed or
admitted to trading on any national securities exchange, the last quoted sale
price or, if not so quoted, the average of the high bid and low asked prices
in the over-the-counter market, as reported by the National Association of
Securities Dealers, Inc. Automated Quotations System ("NASDAQ") or such other
system then in use, or, if on any such date the Common Stock is not quoted by
any such organization, the average of the Closing bid and asked prices as
furnished by a professional market maker making a market in the Common Stock
selected by the Board of Directors and reasonably acceptable to the Requisite
Holders.
(e) "Common Liquidation Equivalent" shall have the meaning set
forth in Section 7.
(f) "Current Market Price" per share of Common Stock on any date
shall mean the average of the Closing Prices of a share of Common Stock for
CUSIP NO. 903236107 SCHEDULE 13D Page 77 of 107
the twenty (20) consecutive Trading Days ending on the date in question. If
on any such Trading Day the Common Stock is not quoted by any organization
referred to in the definition of Closing Price, the fair value of the Common
Stock on such day, as reasonably determined in good faith by the Board of
Directors of the Corporation, shall be used.
(g) "Exchange Act" shall mean the Securities Exchange Act of
1934, as amended.
(h) "Liquidation Preference" shall mean an amount per share of
Series A Preferred Stock equal to the greater of (i) the Common Liquidation
Equivalent and (ii) the Preferred Liquidation Amount.
(i) "Person" shall mean an individual, partnership, corporation,
limited liability company or partnership, unincorporated organization, trust
or joint venture, or a governmental agency or political subdivision thereof,
or other entity of any kind.
(j) "Preferred Liquidation Amount" per share of Series A
Preferred Stock shall be an amount equal to $2,170.00 plus all Accrued
Dividends thereon to the date of determination.
(k) "Requisite Holders" shall mean the holders of sixty-seven
percent (67%) of the then-outstanding shares of Series A Preferred Stock.
(l) "Securities Purchase Agreement" shall mean that certain
agreement dated as of May 5, 1999 by and among the Corporation and certain
purchasers of the Series A Preferred Stock party thereto.
(m) "Subsidiary" of any Person shall mean any corporation or
other entity of which a majority of the voting power of the voting equity
securities or equity interest is owned, directly or indirectly, by such
Person.
(n) "Trading Day" shall mean a day on which the principal
national securities exchange on which the Common Stock is quoted, listed or
admitted to trading is open for the transaction of business or, if the Common
Stock is not quoted, listed or admitted to trading on any national securities
exchange (including the Nasdaq Stock Market), any day other than a Saturday,
Sunday, or a day on which banking institutions in the State of New York are
authorized or obligated by law or executive order to close.
[Remainder of Page Intentionally Left Blank]
CUSIP NO. 903236107 SCHEDULE 13D Page 78 of 107
IN WITNESS WHEREOF, the Corporation has caused this Certificate of
Designation of Series A Preferred Stock to be duly executed by its President
and attested to by its Secretary and has caused its corporate seal to be
affixed hereto, this 9th day of June, 1999.
URS CORPORATION
By: /s/ Kent Ainsworth
--------------------------
Kent P. Ainsworth
CUSIP NO. 903236107 SCHEDULE 13D Page 79 of 107
EXHIBIT E
CERTIFICATE OF DESIGNATION
of
SERIES C
PREFERRED STOCK
of
URS CORPORATION
Pursuant to Section 151 of the General Corporation Law
of the State of Delaware
URS Corporation, a Delaware corporation (the "Corporation"), certifies
that pursuant to the authority contained in its Certificate of Incorporation,
as amended, and in accordance with the provisions of Section 151 of the
General Corporation Law of the State of Delaware, its Board of Directors (the
"Board of Directors") has adopted the following resolution creating a series
of its Preferred Stock, par value $1.00 per share, designated as Series C
Preferred Stock:
RESOLVED, that a series of authorized Preferred Stock, par value $1.00
per share, of the Corporation be hereby created, and that the designation and
amount thereof and the voting powers, preferences and relative, participating,
optional and other special rights of the shares of such series, and the
qualifications, limitations or restrictions thereof are as follows:
Section 1. Designation and Amount.
The shares of such series shall be designated as the "Series C Preferred
Stock" (the "Series C Preferred Stock") and the number of shares constituting
such series shall be 450,000 shares of Series C Preferred Stock. Section 11
below contains the definitions of certain defined terms used herein.
Section 2. Dividends and Distributions.
(a) The holders of shares of Series C Preferred Stock shall not
be entitled to any dividends or distributions except as provided in Section
2(b).
(b) In case the Corporation or any Subsidiary of the Corporation
shall at any time or from time to time declare, order, pay or make a dividend
CUSIP NO. 903236107 SCHEDULE 13D Page 80 of 107
or other distribution (including, without limitation, any distribution of
stock or other securities or property or rights or warrants to subscribe for
securities of the Corporation or any of its Subsidiaries by way of dividend or
spin off) on the Common Stock, the holders of shares of Series C Preferred
Stock shall be entitled to receive from the Corporation, with respect to each
share of Series C Preferred Stock held, the same dividend or distribution
received by a holder of the number of shares of Common Stock equal to one
share multiplied by the Liquidation Multiplier.
Section 3. Voting Rights.
So long as any shares of Series C Preferred Stock shall be outstanding
and unless the consent or approval of a greater number of shares shall then be
required by law, without first obtaining the consent or approval of the
Requisite Holders, voting as a single class, given in person or by proxy at a
meeting at which the holders of such shares shall be entitled to vote
separately as a class, or by written consent, the Corporation shall not (and
shall not permit or authorize any subsidiary to): (i) authorize, create or
issue any class or series, or any shares of any class or series, of stock
having any preference or priority as to voting, dividends or upon liquidation,
dissolution or winding up over the Series C Preferred Stock ("Senior Stock");
(ii) authorize, create or issue any class or series, or any shares of any
class or series, of stock ranking on a parity as to voting, dividends or upon
liquidation, dissolution or winding up with the Series C Preferred Stock
("Parity Stock") other than the issuance of shares of Series A Preferred Stock
of the Corporation (the "Series A Preferred Stock") as dividends in accordance
with such stock's terms; (iii) reclassify any shares of stock of the
Corporation into shares of Senior Stock or Parity Stock; (iv) authorize any
security exchangeable for, convertible into, or evidencing the right to
purchase any shares of Senior Stock or Parity Stock other than the exchange of
Series B Exchangeable Convertible Preferred Stock of the Corporation (the
"Series B Preferred Stock") for shares of Series A Preferred Stock and Series
C Preferred Stock; (v) alter or change the rights, preferences or privileges
of the Series C Preferred Stock; (vi) increase or decrease the authorized
number of shares of Series C Preferred Stock or issue shares of Series C
Preferred Stock other than to holders of Series C Preferred Stock pursuant to
its terms; or (vii) amend or waive any provision of the Corporation's
Certification of Incorporation or bylaws in a manner adverse in any respect to
the holders of Series C Preferred Stock.
Section 4. Mandatory Repurchase by the Corporation.
(a) On the twelfth anniversary of the Closing Date of the
Securities Purchase Agreement, the Corporation shall repurchase from each
holder of shares of Series C Preferred Stock the number of shares of the
Series C Preferred Stock held by such holder on such twelfth anniversary.
Repurchases made pursuant to this Section 4(a) shall be effected on such
anniversary date (or such other day as the holder and the Corporation may
agree) and shall be for the Liquidation Preference. The Corporation, at its
election, may pay the Liquidation Preference in cash, in Common Stock valued
at the Current Market Price on the date of repurchase, or any combination
thereof. The place of payment shall be at an office or agency fixed therefor
CUSIP NO. 903236107 SCHEDULE 13D Page 81 of 107
by the Corporation or, if not fixed, at the principal executive office of the
Corporation.
(b) On or after the sixth anniversary of the Closing Date of the
Securities Purchase Agreement or, if earlier, the fifth Business Day after the
Corporation has sufficient shares of Common Stock authorized to permit the
repurchase of the oustanding Series C Preferred Stock, any holder of shares of
Series C Preferred Stock shall have the right (a person exercising such right,
an "Electing Holder") to require the Corporation to repurchase all, but not
less than all, of the shares of Series C Preferred Stock owned by such
Electing Holder by giving the Corporation at least one-hundred twenty (120)
days prior written notice of his/her/its intent to have the Corporation
repurchase his/her/its shares of Series C Preferred Stock in exchange for the
Liquidation Preference. The notice shall set forth the date set for
repurchase, which date shall be a Business Day, and the number of shares owned
by the Electing Holder. The Corporation, at its election, may choose to pay
the Liquidation Preference in cash, in Common Stock valued at the Current
Market Price on the date of the written notice to the Corporation, or any
combination of thereof.
(c) (i) On the date fixed for repurchase, each holder of shares
of Series C Preferred Stock shall surrender the certificate representing such
shares to the Corporation at the place designated in such notice and shall
thereupon be entitled to receive payment in cash and/or Common Stock therefor
provided in this Section 4. Such shares shall no longer be deemed outstanding
after such date and the holders thereof shall cease to be holders of Series C
Preferred Stock of the Corporation and all rights whatsoever with respect to
the shares so purchased shall terminate. As promptly as practicable, and in
any event within three Business Days after the surrender of such certificate
or certificates, the Corporation shall deliver or cause to be delivered cash,
Common Stock, or any combination thereof as specified above. To the extent
Common Stock is issued, certificates therefore shall be registered in the name
of such holder representing the number of validly issued, fully paid and
nonassessable full shares of Common Stock to which the holder of shares of
Series C Preferred Stock so repurchased shall be entitled. Such repurchase
shall be deemed to have been made at the close of business on the date of
surrender of the certificate or certificates representing the shares of Series
C Preferred Stock to be repurchased so that the rights of the Electing Holder
as to the shares being repurchased shall cease except for the right to receive
cash and/or shares of Common Stock (and, to the extent the person received the
shares of Common Stock, such person shall be treated for all purposes as
having become the record holder of such shares of Common Stock at such time).
(ii) If the cash legally available and Common Stock
authorized by the board of directors of the Corporation for such purchase are
not sufficient to purchase all the shares of Series C Preferred Stock tendered
to the Corporation for purchase pursuant to paragraph (a) or (b) of this
Section 4, the Corporation shall purchase the greatest number of whole shares
for which such funds and stock are so available on a pro rata basis among all
tendering holders based on the ratio of the number of shares tendered by each
of them to the aggregate amount of all shares so tendered, and the
certificates representing the unpurchased shares shall be deemed not to be
CUSIP NO. 903236107 SCHEDULE 13D Page 82 of 107
surrendered for repurchase, such unpurchased shares shall remain outstanding
and the rights of the holders of shares of Series C Preferred Stock thereafter
shall continue to be those of a holder of shares of the Series C Preferred
Stock; PROVIDED, HOWEVER, the Corporation shall thereafter be required to
repurchase all such remaining shares at the first date it has sufficient funds
legally available and Common Stock authorized for such purpose at the price it
would have paid at the date such shares were actually tendered and the
Corporation shall give notice as aforesaid to each holder whose shares were
not repurchased for such reason and such holder shall thereafter have the
right to elect to have such shares repurchased, such election to be made
within 30 days of receipt of such notice. For purposes of this Section, the
Corporation shall be deemed not to have sufficient funds legally available for
any such purchase if the Board of Directors reasonably determines that
immediately after such repurchase the Corporation would be insolvent or if
such repurchase would conflict with the terms or conditions of, or result in a
default under, any instrument or agreement applicable to or binding upon the
Corporation, pursuant to which the Corporation has incurred indebtedness for
borrowed money in an aggregate principal amount in excess of $50 million.
(d) Whenever the Corporation shall not have redeemed the shares
of Series C Preferred Stock within five (5) Business Days of the date such
redemption is required by Section 4(a) or 4(b), thereafter and until all
redemption payments shall have been made, if and so long as any shares of
Series C Preferred Stock remain outstanding, the Corporation shall not, nor
shall it permit any of its Subsidiaries to: (i) declare or pay dividends, or
make any other distributions, on any shares of Common Stock or other capital
stock of the Corporation ranking junior (either as to dividends or upon
liquidation, dissolution or winding up) to the Series C Stock ("Junior
Stock"), other than dividends or distribution payable in Junior Stock; (ii)
declare or pay dividends, or make any other distributions, on any shares of
Parity Stock (other than Series A Preferred Stock), other than dividends or
distributions payable in Junior Stock, except dividends paid ratably on the
Series C Preferred Stock and all Parity Stock on which dividends are payable
or in arrears, in proportion to the total amounts to which the holders of all
such shares are then entitled; (iii) redeem or purchase or otherwise acquire
for consideration (other than Junior Stock) any shares of Junior Stock or
Parity Stock (other than, with respect to Parity Stock, ratably with the
Series C Preferred Stock); or (iv) purchase or otherwise acquire for
consideration any shares of Series C Preferred Stock, other than purchases
ratably among all holders of the Series C Preferred Stock.
(e) The Corporation shall not permit any Subsidiary of the
Corporation to purchase or otherwise acquire for consideration any shares of
capital stock of the Corporation unless the Corporation could, pursuant to
paragraph (d) of this Section 4, purchase or otherwise acquire such shares at
such time and in such manner.
Section 5. Reacquired Shares.
Any shares of Series C Preferred Stock purchased or otherwise acquired by
the Corporation in any manner whatsoever shall be retired and canceled
promptly after the acquisition thereof, and, if necessary to provide for the
CUSIP NO. 903236107 SCHEDULE 13D Page 83 of 107
lawful purchase of such shares, the capital represented by such shares shall
be reduced in accordance with the General Corporation Law of the State of
Delaware. All such shares shall upon their cancellation become authorized but
unissued shares of Preferred Stock, par value $1.00 per share, of the
Corporation and may be reissued as part of another series of Preferred Stock,
par value $1.00 per share, of the Corporation subject to the conditions or
restrictions on authorizing, or creating or issuing any class or series, or
any shares of any class or series, set forth in Section 3.
Section 6. Liquidation, Dissolution or Winding Up.
If the Corporation shall adopt a plan of liquidation or of dissolution,
or commence a voluntary case under the Federal bankruptcy laws or any other
applicable state or Federal bankruptcy, insolvency or similar law, or consent
to the entry of an order for relief in any involuntary case under any such law
or to the appointment of a receiver, liquidator, assignee, custodian, trustee
or sequestrator (or similar official) of the Corporation or of any substantial
part of its property, or make an assignment for the benefit of its creditors,
or admit in writing its inability to pay its debts generally as they become
due, or if a decree or order for relief in respect of the Corporation shall be
entered by a court having jurisdiction in the premises in an involuntary case
under the Federal bankruptcy laws or any other applicable Federal or state
bankruptcy, insolvency or similar law, or appointing a receiver, liquidator,
assignee, custodian, trustee, sequestrator (or other similar official) of the
Corporation or of any substantial part of its property, or ordering the
winding up or liquidation of its affairs, and any such decree or order shall
be unstayed and in effect for a period of ninety (90) consecutive days and on
account of such event the Corporation shall liquidate, dissolve or wind up, or
upon any other liquidation, dissolution or winding up of the Corporation, no
distribution shall be made (i) to the holders of shares of Junior Stock,
unless prior thereto, the holders of shares of Series C Preferred Stock shall
have received in cash the Liquidation Preference, or (ii) to the holders of
shares of Parity Stock, except distributions made ratably on the Series C
Preferred Stock and all such Parity Stock in proportion to the total amounts
to which the holders of all such shares are entitled upon such liquidation,
dissolution or winding up of the Corporation. A consolidation, merger,
corporate reorganization, recapitalization or other similar transaction as a
result of which the beneficial holders of the Corporation's Common Stock
immediately prior to such transaction do not hold, directly or indirectly, in
excess of 50% of the combined voting securities entitled to vote generally in
the election of the directors of the surviving or resulting corporation
immediately after such transaction, and a sale or other disposition of all or
substantially all of the assets of the Corporation in one transaction or
series of related transactions, each shall be deemed to be a "liquidation"
within the meaning of this Section 6; provided that no such transaction shall
be deemed to be a "liquidation" if first approved by the Board of Directors of
the Corporation and the Requisite Holders.
Section 7. Rank.
The Series C Preferred Stock shall rank, with respect to dividend rights
and rights upon liquidation, winding up and dissolution, prior to all classes
CUSIP NO. 903236107 SCHEDULE 13D Page 84 of 107
and series of the Corporation's preferred stock authorized or outstanding on
the date of initial issuance of the Series C Preferred Stock (other than the
Series A Preferred Stock, which shall rank on a par with the Series C
Preferred Stock) and prior to all classes of Common Stock.
Section 8. Other Covenants.
(a) Transfer Taxes. The Corporation shall pay any and all issue
or other taxes that may be payable in respect of any issue or delivery of
shares of Series B Preferred Stock on exchange of the Series C Preferred Stock
and other securities. The Corporation shall not, however, be required to pay
any income tax or tax which may be payable in respect of any transfer involved
in the issue or delivery of Series C Preferred Stock (or other securities or
assets) in a name other than that in which the shares of Series C Preferred
Stock so exchanged were registered, and no such issue or delivery shall be
made unless and until the person requesting such issue has paid to the
Corporation the amount of such tax or has established, to the satisfaction of
the Corporation, that such tax has been paid.
(b) Prior Notice of Certain Events. In case:
(i) the Corporation shall authorize the granting to all
holders of Common Stock of rights or warrants to subscribe for or purchase any
shares of stock of any class or of any other rights or warrants; or
(ii) of any reclassification of Common Stock (other than a
subdivision or combination of the outstanding Common Stock, or a change in par
value, or from par value to no par value, or from no par value to par value),
or of any consolidation or merger to which the Corporation is a party and for
which approval of any stockholders of the Corporation shall be required, or of
the sale or transfer of all or substantially all of the assets of the
Corporation or of any compulsory share exchange whereby the Common Stock is
converted into other securities, cash or other property; or
(iii) of the voluntary or involuntary dissolution,
liquidation or winding up of the Corporation;
then the Corporation shall cause to be filed with the transfer agent for the
Series C Preferred Stock, and shall cause to be mailed to the holders of
record of the Series C Preferred Stock, at their last addresses as they shall
appear upon the stock transfer books of the Corporation, at least fifteen days
prior to the applicable record date hereinafter specified, a notice stating,
as the case may be, (x) the record date (if any) for the purpose of such
dividend, distribution, redemption, repurchase or granting of rights or
warrants or, if no record date is to be set, the date as of which the holders
of Common Stock of record to be entitled to such dividend, distribution,
redemption, rights or warrants are to be determined or (y) the date on which
such reclassification, consolidation, merger, sale, transfer, share exchange,
dissolution, liquidation or winding up is expected to become effective, and
the date, if any, as of which it is expected that holders of shares of Common
Stock of record shall be entitled to exchange their shares of Common Stock for
securities or other property deliverable upon such reclassification,
CUSIP NO. 903236107 SCHEDULE 13D Page 85 of 107
consolidation, merger, sale, transfer, share exchange, dissolution,
liquidation or winding up (but no failure to mail such notice or any defect
therein or in the mailing thereof shall affect the validity of the corporate
action required to be specified in such notice).
Section 9. Remedies.
(a) The Corporation stipulates that the remedies at law of each
holder of Series C Preferred Stock in the event of any failure in the
performance of or compliance with any of the terms hereof are not and will not
be adequate and that, to the fullest extent permitted by law, such terms may
be specifically enforced by a decree for the specific performance of any
agreement contained herein or by an injunction against a violation of any of
the terms hereof or otherwise without requiring any holder to post a bond or
other security except to the extent required by applicable law.
(b) Any holder of Series C Preferred Stock shall be entitled to
recover from the Corporation the reasonable attorneys' fees and expenses
incurred by such holder in connection with the enforcement by such holder of
any obligation of the Corporation hereunder.
(c) No failure or delay on the part of any holder of Series C
Preferred Stock in exercising any right, power or remedy hereunder or under
applicable law or otherwise shall operate as a waiver thereof; nor shall any
single or partial exercise of any such right, power or remedy preclude any
other or further exercise thereof or the exercise of any other right, power or
remedy hereunder or thereunder. The remedies herein provided are cumulative
and not exclusive of any remedies provided by law or otherwise.
Section 10. Severability of Provisions.
Whenever possible, each provision hereof shall be interpreted in a manner
as to be effective and valid under applicable law, but if any provision hereof
is held to be prohibited by or invalid under applicable law, such provision
shall be ineffective only to the extent of such prohibition or invalidity,
without invalidating or otherwise adversely affecting the remaining provisions
hereof. If a court of competent jurisdiction should determine that a
provision hereof would be valid or enforceable if a period of time were
extended or shortened or a particular percentage were increased or decreased,
then such court may make such change as shall be necessary to render the
provision in question effective and valid under applicable law.
Section 11. Definitions.
For the purposes of the Certificate of Designation of Series C Preferred
Stock which embodies this resolution:
(a) "Business Day" shall mean any day other than a Saturday,
Sunday, or a day on which commercial banks in the City of New York are
authorized or obligated by law or executive order to close.
CUSIP NO. 903236107 SCHEDULE 13D Page 86 of 107
(b) "capital stock" shall mean (i) in the case of a corporation,
corporate stock, (ii) in the case of an association or business entity, any
and all shares, interests, participations, rights or other equivalents
(however designated) of corporate stock, (iii) in the case of a partnership or
limited liability company, partnership or membership interests (whether
general or limited) and (iv) any other interest or participation that confers
on a person the right to receive a share of the profits and losses of, or
distributions of assets of, the issuing person.
(c) "Closing Price" per share of Common Stock on any date shall
mean the last sale price, or, in case no such sale takes place on such day,
the average of the closing bid and asked prices, in either case as reported on
the Nasdaq National Market or in the principal consolidated transaction
reporting system with respect to securities listed or admitted to trading on
the New York Stock Exchange or American Stock Exchange, as the case may be,
or, if the Common Stock is listed or admitted to trading on the New York Stock
Exchange or American Stock Exchange, or, if the Common Stock is not listed or
admitted to trading on any national securities exchange, the last quoted sale
price or, if not so quoted, the average of the high bid and low asked prices
in the over-the-counter market, as reported by the National Association of
Securities Dealers, Inc. Automated Quotations System ("NASDAQ") or such other
system then in use, or, if on any such date the Common Stock is not quoted by
any such organization, the average of the Closing bid and asked prices as
furnished by a professional market maker making a market in the Common Stock
selected by the Board of Directors and reasonably acceptable to the Requisite
Holders.
(d) "Current Market Price" per share of Common Stock on any date
shall mean the average of the Closing Prices of a share of Common Stock for
the twenty (20) consecutive Trading Days ending on the date in question. If
on any such Trading Day the Common Stock is not quoted by any organization
referred to in the definition of Closing Price, the fair value of the Common
Stock on such day, as reasonably determined in good faith by the Board of
Directors of the Corporation, shall be used.
(e) "Exchange Act" shall mean the Securities Exchange Act of
1934, as amended.
(f) "Liquidation Base Amount" shall mean $21.70; PROVIDED,
HOWEVER, that in case the Corporation shall at any time or from time to time
after the original issuance of the Series C Preferred Stock declare a
dividend, or make a distribution, on the outstanding shares of Common Stock in
either case, in shares of Common Stock, or effect a subdivision, combination,
consolidation or reclassification of the outstanding shares of Common Stock
into a greater or lesser number of shares of Common Stock, then, and in each
such case, the Liquidation Base Amount in effect immediately prior to such
event or the record date therefor, whichever is earlier, shall be adjusted by
multiplying the Liquidation Base Amount by a fraction, the numerator of which
is the number of shares of Common Stock that were outstanding immediately
prior to such event and the denominator of which is the number of shares of
Common Stock outstanding immediately after such event. An adjustment made
pursuant to this definition shall become effective (x) in the case of any such
CUSIP NO. 903236107 SCHEDULE 13D Page 87 of 107
dividend or distribution, immediately after the close of business on the
record date for the determination of holders of shares of Common Stock
entitled to receive such dividend or distribution, or (y) in the case of any
such subdivision, reclassification, consolidation or combination, at the close
of business on the day upon which such corporate action becomes effective.
(g) "Liquidation Multiplier" shall mean eight (8); PROVIDED,
HOWEVER, that in case the Corporation shall at any time or from time to time
after the original issuance of the Series C Preferred Stock declare a
dividend, or make a distribution, on the outstanding shares of Common Stock in
either case, in shares of Common Stock, or effect a subdivision, combination,
consolidation or reclassification of the outstanding shares of Common Stock
into a greater or lesser number of shares of Common Stock, then, and in each
such case, the Liquidation Multiplier in effect immediately prior to such
event or the record date therefor, whichever is earlier, shall be adjusted by
dividing the Liquidation Multiplier by a fraction, the numerator of which is
the number of shares of Common Stock that were outstanding immediately prior
to such event and the denominator of which is the number of shares of Common
Stock outstanding immediately after such event. An adjustment made pursuant
to this definition shall become effective (x) in the case of any such dividend
or distribution, immediately after the close of business on the record date
for the determination of holders of shares of Common Stock entitled to receive
such dividend or distribution, or (y) in the case of any such subdivision,
reclassification, consolidation or combination, at the close of business on
the day upon which such corporate action becomes effective. In addition to the
foregoing, (I) if the Corporation fails to authorize sufficient common shares
to permit the repurchase of the Series C Preferred Stock on or prior to the
sixth anniversary or if the Corporation fails to repurchase the Series C
Preferred Stock as requested by an Electing Holder pursuant to Section 4(b)
on or prior to the sixth anniversary of the Closing Date (whether or not such
repurchase is permitted under the terms of the Corporation's debt facilities),
then immediately following the sixth anniversary the Liquidation Multiplier
shall be 1.25 times the Liquidation Multiplier in effect immediately prior to
such date for purposes of the repurchase pursuant to Section 4(a) and 4(b) for
repurchases after that time; and (II) if the Corporation fails to repurchase
the shares requested by an Electing Holder pursuant to Section 4(b) on or
prior to the eighth anniversary (whether or not such repurchase is permitted
under the terms of the Corporation's debt facilities), then immediately
following the eighth anniversary the Liquidation Multiplier shall be 1.6 times
the Liquidation Multiplier in effect immediately prior to the eighth
anniversary for repurchases after that time. The adjustment specified in
clause (II) shall be cumulative to, and not in place of, the adjustment
specified in clause (I).
(h) "Liquidation Preference" shall mean an amount per share of
Series C Preferred Stock equal to the sum of (i) $50.00 plus (ii) the greater
of (y) zero or (z) the product of the Liquidation Multiplier times the excess,
if any, of the Current Market Price on the date set for repurchase pursuant to
Section 4(a) or the date of the written notice pursuant to Section 4(b), as
the case may be, over the Liquidation Base Amount.
CUSIP NO. 903236107 SCHEDULE 13D Page 88 of 107
(i) "Person" shall mean an individual, partnership, corporation,
limited liability company or partnership, unincorporated organization, trust
or joint venture, or a governmental agency or political subdivision thereof,
or other entity of any kind.
(j) "Requisite Holders" shall mean the holders of sixty-seven
percent (67%) of the then-outstanding shares of Series C Preferred Stock.
(k) "Securities Purchase Agreement" shall mean that certain
agreement dated as of May 5, 1999 by and among the Corporation and certain
purchasers of the Series C Preferred Stock party thereto.
(l) "Subsidiary" of any Person shall mean any corporation or
other entity of which a majority of the voting power of the voting equity
securities or equity interest is owned, directly or indirectly, by such
Person.
(m) "Trading Day" shall mean a day on which the principal
national securities exchange on which the Common Stock is quoted, listed or
admitted to trading is open for the transaction of business or, if the Common
Stock is not quoted, listed or admitted to trading on any national securities
exchange (including the Nasdaq Stock Market), any day other than a Saturday,
Sunday, or a day on which banking institutions in the State of New York are
authorized or obligated by law or executive order to close.
[Remainder of Page Intentionally Left Blank]
CUSIP NO. 903236107 SCHEDULE 13D Page 89 of 107
IN WITNESS WHEREOF, the Corporation has caused this Certificate of
Designation of Series C Preferred Stock to be duly executed by its President
and attested to by its Secretary and has caused its corporate seal to be
affixed hereto, this 9th day of June, 1999.
URS CORPORATION
By: /s/ Kent Ainsworth
--------------------------
Kent P. Ainsworth
CUSIP NO. 903236107 SCHEDULE 13D Page 90 of 107
Exhibit F
CERTIFICATE OF DESIGNATION
of
SERIES B EXCHANGEABLE
CONVERTIBLE PREFERRED STOCK
of
URS CORPORATION
Pursuant to Section 151 of the General Corporation Law
of the State of Delaware
URS Corporation, a Delaware corporation (the "Corporation"), certifies
that pursuant to the authority contained in its Certificate of Incorporation,
as amended, and in accordance with the provisions of Section 151 of the
General Corporation Law of the State of Delaware, its Board of Directors (the
"Board of Directors") has adopted the following resolution creating a series
of its Preferred Stock, par value $1.00 per share, designated as Series B
Exchangeable Convertible Preferred Stock:
RESOLVED, that a series of authorized Preferred Stock, par value $1.00
per share, of the Corporation be hereby created, and that the designation and
amount thereof and the voting powers, preferences and relative, participating,
optional and other special rights of the shares of such series, and the
qualifications, limitations or restrictions thereof are as follows:
Section 1. Designation and Amount.
The shares of such series shall be designated as the "Series B
Exchangeable Convertible Preferred Stock" (the "Series B Preferred Stock") and
the number of shares constituting such series shall be 150,000 shares of
Series B Preferred Stock. Section 14 below contains the definitions of
certain defined terms used herein.
Section 2. Dividends and Distributions.
(a) The holders of shares of Series B Preferred Stock, in
preference to the holders of shares of the Common Stock and of any other
capital stock of the Corporation ranking junior to the Series B Preferred
Stock as to payment of dividends, shall be entitled to receive on the last day
of each calendar quarter, cumulative dividends on the Series B Preferred Stock
accruing on a daily basis (computed on the basis of a 360-day year of twelve
CUSIP NO. 903236107 SCHEDULE 13D Page 91 of 107
30-day months) at the rate per annum equal to the Dividend Rate (as defined
herein) per share of Series B Preferred Stock calculated as a percentage of
$2,170.00, compounded quarterly, from and including the date of issuance of
the Series B Preferred Stock until the conversion or exchange of the Series B
Preferred Stock. Such dividends shall be paid in kind as herein provided, and
will be paid whether or not they have been declared and whether or not there
are profits, surplus or other funds of the Corporation legally available for
the payment of dividends. Dividends on the Series B Preferred Stock shall be
paid in additional shares of Series B Preferred Stock valued at $2,170.00 per
share. For purposes hereof, the "Dividend Rate" shall mean eight percent (8%)
per annum from the date of initial issuance of the Series B Preferred Stock
(except as otherwise provided in the last sentence of Section 4(b)(ii)).
(b) In case the Corporation or any Subsidiary of the Corporation
shall at any time or from time to time declare, order, pay or make a dividend
or other distribution (including, without limitation, any distribution of
stock or other securities or property or rights or warrants to subscribe for
securities of the Corporation or any of its Subsidiaries by way of dividend or
spin off) on the Common Stock, other than any dividend or distribution of
shares of Common Stock covered by paragraph (b)(i) of Section 8 hereof (a
"Covered Distribution"), the holders of shares of Series B Preferred Stock
shall be entitled to receive from the Corporation, with respect to each share
of Series B Preferred Stock held, in addition to the dividends payable under
paragraph (a) of this Section 2, the same dividend or distribution received by
a holder of the number of shares of Common Stock into which such share of
Series B Preferred Stock is convertible on the record date for such dividend
or distribution. Any such dividend or distribution shall be declared,
ordered, paid or made on the Series B Preferred Stock at the same time such
dividend or distribution is declared, ordered, paid or made on the Common
Stock and shall be in addition to any dividends payable under paragraph (a) of
this Section 2.
Section 3. Voting Rights.
In addition to any voting rights provided elsewhere herein, and any
voting rights provided by law, the holders of shares of Series B Preferred
Stock shall have the following voting rights:
(a) So long as the Series B Preferred Stock is outstanding, each
share of Series B Preferred Stock shall entitle the holder thereof to vote on
all matters voted on by holders of the capital stock of the Corporation into
which such share of Series B Preferred Stock is convertible, voting together
as a single class with the other shares entitled to vote, at all meetings of
the stockholders of the Corporation. With respect to any such vote, each
share of Series B Preferred Stock shall entitle the holder thereof to cast the
number of votes equal to the number of votes which could be cast in such vote
by a holder of the shares of capital stock of the Corporation into which such
share of Series B Preferred Stock is convertible on the record date for such
vote or, if no such record date is established, on the date any written
consent of stockholders is solicited.
CUSIP NO. 903236107 SCHEDULE 13D Page 92 of 107
(b) So long as any shares of Series B Preferred Stock shall be
outstanding and unless the consent or approval of a greater number of shares
shall then be required by law, without first obtaining the consent or approval
of the Requisite Holders, voting as a single class, given in person or by
proxy at a meeting at which the holders of such shares shall be entitled to
vote separately as a class, or by written consent, the Corporation shall not
(and shall not permit or authorize any subsidiary to): (i) authorize, create
or issue any class or series, or any shares of any class or series, of stock
having any preference or priority as to voting, dividends or upon liquidation,
dissolution or winding up over the Series B Preferred Stock ("Senior Stock");
(ii) authorize, create or issue any class or series, or any shares of any
class or series, of stock ranking on a parity as to voting, dividends or upon
liquidation, dissolution or winding up with the Series B Preferred Stock
("Parity Stock"); (iii) reclassify any shares of stock of the Corporation into
shares of Senior Stock or Parity Stock; (iv) authorize any security
exchangeable for, convertible into, or evidencing the right to purchase any
shares of Senior Stock or Parity Stock; (v) alter or change the rights,
preferences or privileges of the Series B Preferred Stock; (vi) increase or
decrease the authorized number of shares of Series B Preferred Stock or issue
shares of Series B Preferred Stock other than to holders of Series B Preferred
Stock pursuant to its terms; (vii) amend or waive any provision of the
Corporation's Certification of Incorporation or bylaws in a manner adverse in
any respect to the holders of Series B Preferred Stock; (viii) authorize or
pay any cash dividend on Common Stock or any other class or series of stock
over which the Series B Preferred Stock has any preference or priority as to
voting, dividends or upon liquidation, dissolution or winding-up ("Junior
Stock"); or (ix) redeem, repurchase, retire or otherwise acquire Common Stock
or any other Junior Stock (other than by conversion into or exchange for
shares of Junior Stock and other than any redemptions, repurchases or
acquisitions made pursuant to and as required by the terms of any employee
incentive or benefit plan of the Corporation as in effect from time to time).
Section 4. Mandatory Repurchase by the Corporation.
(a) On the twelfth anniversary of the Closing Date of the
Securities Purchase Agreement, the Corporation shall purchase for cash from
each holder of shares of Series B Preferred Stock the number of shares of the
Series B Preferred Stock held by such holder on such twelfth anniversary.
Repurchases made pursuant to this Section 4(a) shall be effected on such
anniversary date (or such other day as the holder and the Corporation may
agree) and shall be for the Conversion Value. The place of payment shall be
at an office or agency fixed therefor by the Corporation or, if not fixed, at
the principal executive office of the Corporation.
(b) (i) On the date fixed for repurchase, each holder of shares
of Series B Preferred Stock shall surrender the certificate representing such
shares to the Corporation at the place designated in such notice and shall
thereupon be entitled to receive payment in cash therefor provided in this
Section 4. Dividends with respect to the shares of Series B Preferred Stock
so purchased shall cease to accrue after the date so purchased, such shares
shall no longer be deemed outstanding after such date and the holders thereof
CUSIP NO. 903236107 SCHEDULE 13D Page 93 of 107
shall cease to be stockholders of the Corporation and all rights whatsoever
with respect to the shares so purchased shall terminate.
(ii) If the funds legally available for such purchase are
not sufficient to purchase all the shares of Series B Preferred Stock tendered
to the Corporation for purchase, the Corporation shall purchase the greatest
number of whole shares for which such funds are so available on a pro rata
basis among all tendering holders based on the ratio of the number of shares
tendered by each of them to the aggregate amount of all shares so tendered,
and the certificates representing the unpurchased shares shall be deemed not
to be surrendered for repurchase, such unpurchased shares shall remain
outstanding and the rights of the holders of shares of Series B Preferred
Stock thereafter shall continue to be those of a holder of shares of the
Series B Preferred Stock; provided, however, the Corporation shall thereafter
be required to repurchase all such remaining shares at the first date it has
sufficient funds legally available for such purpose at the price it would have
paid at the date such shares were actually tendered and the Corporation shall
give notice as aforesaid to each holder whose shares were not repurchased for
such reason and such holder shall thereafter have the right to elect to have
such shares repurchased, such election to be made within 30 days of receipt of
such notice. For purposes of this Section, the Corporation shall be deemed
not to have sufficient funds legally available for any such purchase if the
Board of Directors reasonably determines that immediately after such
repurchase the Corporation would be insolvent. Upon the failure to purchase
all of the Series B Preferred Stock as required by this Section 4, the
Dividend Rate on any such stock that has not been purchased shall
automatically, pursuant to Section 2(a), increase to twelve percent (12%). If
any part of the Series B Preferred Stock has not been purchased pursuant to
this Section 4 three (3) months after the twelfth anniversary of the Closing
Date of the Securities Purchase Agreement, the Dividend Rate shall thereafter
increase to fifteen percent (15%).
Section 5. Conversion at Option of the Corporation.
(a) Securities Purchase Agreement (the "Third Anniversary"), so
long as shares of Common Stock shall have traded on the Primary Exchange for
at least thirty (30) of the forty-five (45) trading days immediately preceding
the Determination Date (defined below), at a Closing Price in excess of the
Hurdle Percentage of the Conversion Price then in effect for the Series B
Preferred Stock for each such trading day, all, but not less than all, of the
shares of Series B Preferred Stock may, at the option of the Corporation, be
converted into shares of Common Stock. The Corporation shall send notice of
mandatory conversion to each of the holders of the Series B Preferred Stock at
such holder's address as it appears on the transfer books of the Corporation.
(b) Subject to the provisions for adjustment set forth in Section
8, each share of Series B Preferred Stock shall be _____ if the Corporation so
elects as provided in Section 5(a) _____converted into a number of fully paid
and nonassessable shares of Common Stock equal to the product obtained by
multiplying the Applicable Conversion Rate by the number of shares of Series B
Preferred Stock being converted. The Applicable Conversion Rate shall be the
CUSIP NO. 903236107 SCHEDULE 13D Page 94 of 107
quotient obtained by dividing the Conversion Value on the date of conversion
by the applicable Conversion Price .
Section 6. Reacquired Shares.
Any shares of Series B Preferred Stock converted, purchased or otherwise
acquired by the Corporation in any manner whatsoever shall be retired and
canceled promptly after the acquisition thereof, and, if necessary to provide
for the lawful purchase of such shares, the capital represented by such shares
shall be reduced in accordance with the General Corporation Law of the State
of Delaware. All such shares shall upon their cancellation become authorized
but unissued shares of Preferred Stock, par value $1.00 per share, of the
Corporation and may be reissued as part of another series of Preferred Stock,
par value $1.00 per share, of the Corporation subject to the conditions or
restrictions on authorizing, or creating or issuing any class or series, or
any shares of any class or series, set forth in paragraph (b) of Section 3.
Section 7. Liquidation, Dissolution or Winding Up.
If the Corporation shall adopt a plan of liquidation or of dissolution,
or commence a voluntary case under the Federal bankruptcy laws or any other
applicable state or Federal bankruptcy, insolvency or similar law, or consent
to the entry of an order for relief in any involuntary case under any such law
or to the appointment of a receiver, liquidator, assignee, custodian, trustee
or sequestrator (or similar official) of the Corporation or of any substantial
part of its property, or make an assignment for the benefit of its creditors,
or admit in writing its inability to pay its debts generally as they become
due, or if a decree or order for relief in respect of the Corporation shall be
entered by a court having jurisdiction in the premises in an involuntary case
under the Federal bankruptcy laws or any other applicable Federal or state
bankruptcy, insolvency or similar law, or appointing a receiver, liquidator,
assignee, custodian, trustee, sequestrator (or other similar official) of the
Corporation or of any substantial part of its property, or ordering the
winding up or liquidation of its affairs, and any such decree or order shall
be unstayed and in effect for a period of ninety (90) consecutive days and on
account of such event the Corporation shall liquidate, dissolve or wind up, or
upon any other liquidation, dissolution or winding up of the Corporation, no
distribution shall be made (i) to the holders of shares of Junior Stock,
unless prior thereto, the holders of shares of Series B Preferred Stock shall
have received in cash the Liquidation Preference, or (ii) to the holders of
shares of Parity Stock, except distributions made ratably on the Series B
Preferred Stock and all such Parity Stock in proportion to the total amounts
to which the holders of all such shares are entitled upon such liquidation,
dissolution or winding up of the Corporation.
Section 8. Conversion.
Each share of Series B Preferred Stock may, at the option of the holder
thereof, be converted into shares of Common Stock at any time, whether or not
the Corporation has given notice of exchange under Section 9, on the terms and
conditions set forth in this Section 8. In addition:
CUSIP NO. 903236107 SCHEDULE 13D Page 95 of 107
(a) Subject to the provisions for adjustment hereinafter set
forth, each share of Series B Preferred Stock shall be convertible in the
manner hereinafter set forth into a number of fully paid and nonassessable
shares of Common Stock equal to the product obtained by multiplying the
Applicable Conversion Rate by the number of shares of Series B Preferred Stock
being converted. The Applicable Conversion Rate shall be the quotient obtained
by dividing the Conversion Value on the date of conversion by the applicable
Conversion Price.
(b) The Conversion Price shall be subject to adjustment from time
to time as follows:
(i) In case the Corporation shall at any time or from time
to time after the original issuance of the Series B Preferred Stock declare a
dividend, or make a distribution, on the outstanding shares of Common Stock in
either case, in shares of Common Stock, or effect a subdivision, combination,
consolidation or reclassification of the outstanding shares of Common Stock
into a greater or lesser number of shares of Common Stock, then, and in each
such case, the Conversion Price in effect immediately prior to such event or
the record date therefor, whichever is earlier, shall be adjusted by
multiplying the Conversion Price by a fraction, the numerator of which is the
number of shares of Common Stock that were outstanding immediately prior to
such event and the denominator of which is the number of shares of Common
Stock outstanding immediately after such event. An adjustment made pursuant
to this clause (i) shall become effective (x) in the case of any such dividend
or distribution, immediately after the close of business on the record date
for the determination of holders of shares of Common Stock entitled to receive
such dividend or distribution, or (y) in the case of any such subdivision,
reclassification, consolidation or combination, at the close of business on
the day upon which such corporate action becomes effective.
(ii) In addition to the foregoing adjustments in subsections
(i), the Corporation will be permitted to make such reductions in the
Conversion Price as it considers to be advisable in order that any event
treated for Federal income tax purposes as a dividend of stock or stock rights
will not be taxable to the holders of the shares of Common Stock.
(iii) In any case in which this Section 8 shall require that
an adjustment (including by reason of the last sentence of subsection (i)
above) be made immediately following a record date, the Corporation may elect
to defer the effectiveness of such adjustment (but in no event until a date
later than the effective time of the event giving rise to such adjustment), in
which case the Corporation shall, with respect to any share of Series B
Preferred Stock converted after such record date and on and before such
adjustment shall have become effective (x) defer paying any cash payment
pursuant to Section 8(f) hereof or issuing to the holder of such shares of
Series B Preferred Stock the number of shares of Common Stock and other
capital stock of the Corporation (or other assets or securities) issuable upon
such conversion in excess of the number of shares of Common Stock and other
capital stock of the Corporation issuable thereupon only on the basis of the
Conversion Price prior to adjustment, and (y) not later than five Business
Days after such adjustment shall have become effective, pay to such holder the
CUSIP NO. 903236107 SCHEDULE 13D Page 96 of 107
appropriate cash payment pursuant to Section 8(f) hereof and issue to such
holder the additional shares of Common Stock and other capital stock of the
Corporation issuable on such conversion.
(iv) No adjustment in the Conversion Price shall be required
unless such adjustment would require an increase or decrease of at least 0.1%
of the Conversion Price; provided, that any adjustments which by reason of
this subsection (iv) are not required to be made shall be carried forward and
taken into account in any subsequent adjustment. All calculations under this
Section 8 shall be made to the nearest cent or to the nearest one-hundredth of
a share, as the case may be.
(c) (i) In case of any capital reorganization or
reclassification of outstanding shares of Common Stock (other than a
reclassification covered by paragraph (b) (i) of this Section 8), or in case
of any consolidation or merger of the Corporation with or into another
corporation, or in case of any sale or conveyance to another corporation of
the property of the Corporation as an entirety or substantially as an entirety
(each of the foregoing being referred to as a "Transaction"), (x) if such
Transaction occurs prior to the Third Anniversary and constitutes or leads to
a Change in Control, each holder of Series B Preferred Stock shall then be
entitled to the acceleration and immediate vesting of all dividends such
holder would have accrued on and prior to the Third Anniversary, and (y) each
share of Series B Preferred Stock then outstanding shall thereafter be
convertible into, in lieu of the Common Stock issuable upon such conversion
prior to the consummation of such Transaction, the kind and amount of shares
of stock and other securities and property (including cash) receivable upon
the consummation of such transaction by a holder of that number of shares of
Common Stock into which one share of Series B Preferred Stock was convertible
immediately prior to such Transaction (including, on a pro rata basis, the
cash, securities or property received by holders of Common Stock in any tender
or exchange offer that is a step in such Transaction). In any such case, if
necessary, appropriate adjustment (as determined by the Board of Directors)
shall be made in the application of the provisions set forth in this Section 8
with respect to rights and interests thereafter of the holders of shares of
Series B Preferred Stock to the end that the provisions set forth herein for
the protection of the conversion rights of the Series B Preferred Stock shall
thereafter be applicable, as nearly as reasonably may be, to any such other
shares of stock and other securities and property deliverable upon conversion
of the shares of Series B Preferred Stock remaining outstanding (with such
adjustments in the conversion price and number of shares issuable upon
conversion and such other adjustments in the provisions hereof as the Board of
Directors shall determine to be appropriate). In case securities or property
other than Common Stock shall be issuable or deliverable upon conversion as
aforesaid, then all references in this Section 8 shall be deemed to apply, so
far as appropriate and as nearly as may be, to such other securities or
property.
(ii) Notwithstanding anything contained herein to the
contrary, the Corporation will not effect any Transaction unless, prior to the
consummation thereof, the Surviving Person (as defined in Section 14) thereof
shall assume, by written instrument mailed to each record holder of shares of
CUSIP NO. 903236107 SCHEDULE 13D Page 97 of 107
Series B Preferred Stock, at such holder's address as it appears on the
transfer books of the Corporation, the obligation to deliver to such holder
such cash and such securities to which, in accordance with the foregoing
provisions, such holder is entitled. Nothing contained in this paragraph (c)
shall limit the rights of holders of the Series B Preferred Stock to convert
the Series B Preferred Stock in connection with the Transaction .
(d) The holder of any shares of Series B Preferred Stock may
exercise its right to convert such shares into shares of Common Stock by
surrendering for such purpose to the Corporation, at its principal office or
at such other office or agency maintained by the Corporation for that purpose,
a certificate or certificates representing the shares of Series B Preferred
Stock to be converted duly endorsed to the Corporation in blank accompanied by
a written notice stating that such holder elects to convert all or a specified
whole number of such shares in accordance with the provisions of this Section
8. The Corporation will pay any and all issue and other taxes (other than
taxes based on income) that may be payable in respect of any issue or delivery
of shares of Common Stock on conversion of Series B Preferred Stock pursuant
hereto. As promptly as practicable, and in any event within three Business
Days after the surrender of such certificate or certificates and the receipt
of such notice relating thereto and, if applicable, payment of all transfer
taxes (or the demonstration to the satisfaction of the Corporation that such
taxes have been paid), the Corporation shall deliver or cause to be delivered
(i) certificates registered in the name of such holder representing the number
of validly issued, fully paid and nonassessable full shares of Common Stock to
which the holder of shares of Series B Preferred Stock so converted shall be
entitled and (ii) if less than the full number of shares of Series B Preferred
Stock evidenced by the surrendered certificate or certificates are being
converted, a new certificate or certificates, of like tenor, for the number of
shares evidenced by such surrendered certificate or certificates less the
number of shares converted. Such conversion shall be deemed to have been made
at the close of business on the date of receipt of such notice and of such
surrender of the certificate or certificates representing the shares of Series
B Preferred Stock to be converted so that the rights of the holder thereof as
to the shares being converted shall cease except for the right to receive
shares of Common Stock and any declared but unpaid dividends in accordance
herewith, and the person entitled to receive the shares of Common Stock shall
be treated for all purposes as having become the record holder of such shares
of Common Stock at such time.
(e) Notwithstanding any other provisions of this Certificate of
Designation, shares of Series B Preferred Stock may be converted at any time
and, if subject to exchange, up to the close of business on the last Business
Day immediately preceding the date fixed for such exchange of such shares.
(f) In connection with the conversion of any shares of Series B
Preferred Stock, no fractions of shares of Common Stock shall be issued, but
in lieu thereof the Corporation shall pay a cash adjustment in respect of such
fractional interest in an amount equal to such fractional interest multiplied
by the Current Market Price per share of Common Stock on the day on which such
shares of Series B Preferred Stock are deemed to have been converted.
CUSIP NO. 903236107 SCHEDULE 13D Page 98 of 107
(g) In case at any time or from time to time the Corporation
shall pay any dividend or make any other distribution to the holders of its
Common Stock, or shall offer for subscription pro rata to the holders of its
Common Stock any additional shares of stock of any class or any other right,
or there shall be any capital reorganization or reclassification of the Common
Stock of the Corporation or consolidation or merger of the Corporation with or
into another corporation, or any sale or conveyance to another corporation of
the property of the Corporation as an entirety or substantially as an
entirety, or there shall be a voluntary or involuntary dissolution,
liquidation or winding up of the Corporation, then, in any one or more of said
cases the Corporation shall give at least twenty (20) days' prior written
notice (the time of mailing of such notice shall be deemed to be the time of
giving thereof) to the registered holders of the Series B Preferred Stock at
the addresses of each as shown on the books of the Corporation of the date on
which (i) the books of the corporation shall close or a record shall be taken
for such stock dividend, distribution or subscription rights or (ii) such
reorganization, reclassification, consolidation, merger, sale or conveyance,
dissolution, liquidation or winding up shall take place, as the case may be,
provided that in the case of any Transaction to which paragraph (c) applies
the Corporation shall give at least thirty (30) days' prior written notice as
aforesaid. Such notice shall also specify the date as of which the holders of
the Common Stock and of the Series B Preferred Stock of record shall
participate in said dividend, distribution or subscription rights or shall be
entitled to exchange their Common Stock or Series B Preferred Stock for
securities or other property deliverable upon such reorganization,
reclassification, consolidation, merger, sale or conveyance, or participate in
such dissolution, liquidation or winding up, as the case may be.
(h) Whenever the number of shares of Common Stock into which each
share of Series B Preferred Stock is convertible (or the number of votes to
which each share of Series B Preferred Stock is entitled) is adjusted as
provided in Section 8 hereof, the Corporation shall promptly mail to the
holders of record of the outstanding shares of Series B Preferred Stock at
their respective addresses as the same shall appear in the Corporation's stock
records a notice stating that the number of shares of Common Stock into which
the shares of Series B Preferred Stock are convertible has been adjusted and
setting forth the new number of shares of Common Stock (or describing the new
stock, securities, cash or other property) into which each share of Series B
Preferred Stock is convertible, as a result of such adjustment, a brief
statement of the facts requiring such adjustment and the computation thereof,
and when such adjustment became effective.
Section 9. Exchange at the Option of the Corporation.
(a) The Corporation may, at its option, exchange the Series B
Preferred Stock, in whole but not in part, at any time, for Exchange
Debentures; provided, however, that (i) on the date of such exchange there are
no accumulated and unpaid dividends on the Series B Preferred Stock (including
the dividend payable on such date) that are not paid contemporaneously with
such exchange or other contractual impediments to such exchange; (ii) such
exchange is permitted under applicable law; and (iii) the Corporation shall
have delivered to the Trustee under the Exchange Indenture, an opinion of
CUSIP NO. 903236107 SCHEDULE 13D Page 99 of 107
counsel with respect to the due authorization and issuance of the Exchange
Debentures.
(b) Upon any exchange of Series B Preferred Stock for Exchange
Debentures pursuant to this Section 9, each Holder of Series B Preferred Stock
will be entitled to receive, subject to the second succeeding sentence, $1.00
principal amount of Exchange Debentures for each $1.00 of Conversion Value of
Series B Preferred Stock so exchanged. The Exchange Debentures will be issued
in registered form without coupons. Exchange Debentures issued in exchange
for Preferred Stock will be issued in principal amounts of $1,000 and integral
multiples thereof to the extent possible, and will also be issued in principal
amounts less than $1,000 so that each Holder of Series Preferred Stock will
receive certificates representing the entire amount of Exchange Debentures to
which such Holder's shares of Preferred Stock entitle such Holder; provided,
however, that the Corporation may pay cash in lieu of issuing a Exchange
Debenture in a principal amount less than $1,000.
(c) The Corporation will send a written notice of exchange (the
"Exchange Notice") by first-class mail to each Holder of record of shares of
Series B Preferred Stock not fewer than thirty (30), nor more than sixty (60),
days before the date fixed for any exchange (the "Exchange Date") at its
registered address and notice, if mailed in the manner herein provided, shall
conclusively be presumed to have been given, whether or not the Holder
receives such notice; provided, however, that no failure to give such notice
nor any deficiency therein shall affect the validity of the procedure for the
exchange of any shares of Series B Preferred Stock to be exchanged except as
to the Holder or Holders to whom the Corporation has failed to give said
notice or except as to the Holder or Holders whose notice was defective. The
Exchange Notice shall state: (1) the Exchange Date; (2) that the Holder is to
surrender to the Corporation, in the manner and at the place or places
designated, his certificate or certificates representing the shares of
Preferred Stock to be exchanged; (3) that dividends on the shares of Series B
Preferred Stock to be exchanged shall cease to accrue on such Exchange Date
whether or not certificates representing shares of Series B Preferred Stock
are surrendered for exchange on such Exchange Date unless the Corporation
shall default in the delivery of the Exchange Debentures to Holders of the
Preferred Stock who have duly surrendered their certificates for exchange in
accordance with Section 9(c) on or before the Exchange Date; and (4) that
interest on the Exchange Debentures shall accrue from the Exchange Date
whether or not certificates for shares of Series B Preferred Stock are
surrendered for exchange on such Exchange Date.
(d) On and after the Exchange Date, dividends will cease to
accrue on the outstanding shares of Series B Preferred Stock, and all rights
of the Holders of Series B Preferred Stock (except the right to receive the
Exchange Debentures or an amount in cash, to the extent applicable, equal to
the accumulated and unpaid dividends to the Exchange Date and, if the
Corporation so elects, cash in lieu of any Exchange Debenture that is in a
principal amount that is not an integral multiple of $1,000) will terminate.
From and after the Exchange Date, the person entitled to receive the Exchange
Debentures issuable upon such exchange will be treated for all purposes as the
registered holder of such Exchange Debentures.
CUSIP NO. 903236107 SCHEDULE 13D Page 100 of 107
(e) On or before the Exchange Date, each Holder of Series B
Preferred Stock shall surrender the certificate or certificates representing
such shares of Preferred Stock, in the manner and at the place designated in
the Exchange Notice. Upon surrender in accordance with the Exchange Notice of
the certificates representing any shares of Series B Preferred Stock so
exchanged, duly endorsed (or otherwise in proper form for transfer, as
determined by the Company), such shares shall be exchanged by the Company for
Exchange Debentures in accordance with Section 9(b). The Corporation shall
pay interest on the Exchange Debentures at the rate and on the dates specified
therein from the Exchange Date.
(f) Notwithstanding the foregoing provisions of this Section 9,
the Corporation shall not be entitled to exchange the Series B Preferred Stock
for Exchange Debentures if such exchange, or any term or provision of the
Exchange Indenture or the Exchange Debentures, or the performance of the
Company's obligations under this Certificate of Designation, the Preferred
Stock, the Exchange Indenture or the Exchange Debentures, shall violate or
conflict with any applicable law or agreement or instrument then binding on
the Company or if, at the time of such exchange, the Company is insolvent or
would be rendered insolvent by such exchange.
(g) Notwithstanding the foregoing, if notice of exchange has been
given pursuant to this Section 9 and any holder of shares of Preferred Stock
shall, prior to the close of business on the Exchange Date, give written
notice to the Corporation pursuant to Section 8 of the conversion of any or
all of the shares held by the holder (accompanied by a certificate or
certificates for such shares, duly endorsed or assigned to the Corporation),
then the exchange shall not become effective as to the shares to be converted
and the conversion shall become effective as provided in Section 8.
(h) Prior to the Exchange Date, the Corporation will comply with
any applicable securities and blue sky laws with respect to the exchange of
the Series B Preferred Stock for the Debentures.
Section 10. Rank.
The Series B Preferred Stock shall rank, with respect to dividend rights
and rights upon liquidation, winding up and dissolution, prior to all classes
and series of the Corporation's preferred stock authorized or outstanding on
the date of initial issuance of the Series B Preferred Stock and prior to all
classes of Common Stock.
Section 11. Other Covenants.
(a) Reservation of Shares; Transfer Taxes; Etc.
(i) The Corporation shall at all times reserve and keep
available, out of its authorized and unissued stock, solely for the purpose of
effecting the conversion of the Series B Preferred Stock, such number of
shares of its Common Stock or Common Stock free of preemptive rights as shall
from time to time be sufficient to effect the conversion of all shares of
CUSIP NO. 903236107 SCHEDULE 13D Page 101 of 107
Series B Preferred Stock from time to time outstanding. The Corporation shall
from time to time, in accordance with the laws of the State of Delaware,
increase the number of authorized shares of Common Stock if at any time the
number of shares of authorized and unissued Common Stock shall not be
sufficient to permit the conversion of all the then outstanding shares of
Series B Preferred Stock.
(ii) If any shares of Common Stock required to be reserved
for purposes of conversion of the Series B Preferred Stock hereunder require
registration with or approval of any governmental authority under any Federal
or State law before such shares may be issued upon conversion, the Corporation
will in good faith and as expeditiously as possible endeavor to cause such
shares to be duly registered or approved, as the case may be. If the Common
Stock is listed on the New York Stock Exchange or any other national
securities exchange or national quotation service, the Corporation will list
and keep listed on such exchange, upon official notice of issuance, all shares
of Common Stock issuable upon conversion of the shares of Series B Preferred
Stock.
(iii) The Corporation shall pay any and all issue or other
taxes that may be payable in respect of any issue or delivery of shares of
Common Stock on conversion or exchange of the Series B Preferred Stock. The
Corporation shall not, however, be required to pay any income tax or tax which
may be payable in respect of any transfer involved in the issue or delivery of
Common Stock (or other securities or assets) in a name other than that in
which the shares of Series B Preferred Stock so converted were registered, and
no such issue or delivery shall be made unless and until the person requesting
such issue has paid to the Corporation the amount of such tax or has
established, to the satisfaction of the Corporation, that such tax has been
paid.
(b) Prior Notice of Certain Events. In case:
(i) the Corporation shall authorize the granting to all
holders of Common Stock of rights or warrants to subscribe for or purchase any
shares of stock of any class or of any other rights or warrants; or
(ii) of any reclassification of Common Stock (other than a
subdivision or combination of the outstanding Common Stock, or a change in par
value, or from par value to no par value, or from no par value to par value),
or of any consolidation or merger to which the Corporation is a party and for
which approval of any stockholders of the Corporation shall be required, or of
the sale or transfer of all or substantially all of the assets of the
Corporation or of any compulsory share exchange whereby the Common Stock is
converted into other securities, cash or other property; or
(iii) of the voluntary or involuntary dissolution,
liquidation or winding up of the Corporation;
(iv) then the Corporation shall cause to be filed with the
transfer agent for the Series B Preferred Stock, and shall cause to be mailed
to the holders of record of the Series B Preferred Stock, at their last
CUSIP NO. 903236107 SCHEDULE 13D Page 102 of 107
addresses as they shall appear upon the stock transfer books of the
Corporation, at least fifteen days prior to the applicable record date
hereinafter specified, a notice stating, as the case may be, (x) the record
date (if any) for the purpose of such dividend, distribution, redemption,
repurchase or granting of rights or warrants or, if no record date is to be
set, the date as of which the holders of Common Stock of record to be entitled
to such dividend, distribution, redemption, rights or warrants are to be
determined or (y) the date on which such reclassification, consolidation,
merger, sale, transfer, share exchange, dissolution, liquidation or winding up
is expected to become effective, and the date, if any, as of which it is
expected that holders of shares of Common Stock of record shall be entitled to
exchange their shares of Common Stock for securities or other property
deliverable upon such reclassification, consolidation, merger, sale, transfer,
share exchange, dissolution, liquidation or winding up (but no failure to mail
such notice or any defect therein or in the mailing thereof shall affect the
validity of the corporate action required to be specified in such notice).
Section 12. Remedies.
(a) The Corporation stipulates that the remedies at law of each
holder of Series B Preferred Stock in the event of any Triggering Event or
threatened Triggering Event or otherwise or other failure in the performance
of or compliance with any of the terms hereof are not and will not be adequate
and that, to the fullest extent permitted by law, such terms may be
specifically enforced by a decree for the specific performance of any
agreement contained herein or by an injunction against a violation of any of
the terms hereof or otherwise without requiring any holder to post a bond or
other security except to the extent required by applicable law.
(b) Any holder of Series B Preferred Stock shall be entitled to
recover from the Corporation the reasonable attorneys' fees and expenses
incurred by such holder in connection with any Triggering Event or enforcement
by such holder of any obligation of the Corporation hereunder.
(c) No failure or delay on the part of any holder of Series B
Preferred Stock in exercising any right, power or remedy hereunder or under
applicable law or otherwise shall operate as a waiver thereof; nor shall any
single or partial exercise of any such right, power or remedy preclude any
other or further exercise thereof or the exercise of any other right, power or
remedy hereunder or thereunder. The remedies herein provided are cumulative
and not exclusive of any remedies provided by law or otherwise.
Section 13. Severability of Provisions.
Whenever possible, each provision hereof shall be interpreted in a manner
as to be effective and valid under applicable law, but if any provision hereof
is held to be prohibited by or invalid under applicable law, such provision
shall be ineffective only to the extent of such prohibition or invalidity,
without invalidating or otherwise adversely affecting the remaining provisions
hereof. If a court of competent jurisdiction should determine that a
provision hereof would be valid or enforceable if a period of time were
extended or shortened or a particular percentage were increased or decreased,
CUSIP NO. 903236107 SCHEDULE 13D Page 103 of 107
then such court may make such change as shall be necessary to render the
provision in question effective and valid under applicable law.
Section 14. Definitions.
For the purposes of the Certificate of Designation of Series B
Exchangeable Convertible Preferred Stock which embodies this resolution:
(a) "Acceleration Amount" per share of Series B Preferred Stock
shall mean, as of the date of conversion or exchange of the Series B Preferred
Stock under Section 5, 8 or 9 hereof, or the date of any payments on the
Series B Preferred Stock under Section 7 hereof, or as of any other date on
which it is necessary to determine the number of shares of Common Stock into
which a share of Series B Preferred Stock is then convertible: (i) following
a Change in Control and prior to the Third Anniversary, an amount calculated
to provide the holder of a share of Series B Preferred Stock, as of such date,
with a gross amount of accretion calculated at the rate of eight percent (8%)
on $2,170.00 per share of Series B Preferred Stock, compounded quarterly, from
the date of conversion or exchange of the Series B Preferred Stock under
Section 5, 8 or 9 hereof, or the date of any payments on the Series B
Preferred Stock under Section 7 hereof, or the date of any other
determination, as the case may be, to and including the Third Anniversary, or
(ii) other than as specified in clause (i), zero.
(b) "Accrued Dividends" to a particular date (the "Applicable
Date") shall mean (i) all dividends accrued but not paid on the Series B
Preferred Stock pursuant to paragraph (a) of Section 2, whether or not
declared, accrued to the Applicable Date, plus (ii) all dividends or
distributions payable pursuant to paragraph (b) of Section 2 for which the
Covered Distribution was declared, ordered, paid or made on or prior to the
Applicable Date.
(c) "Affiliate" shall have the meaning set forth in Rule 12b-2
promulgated by the Securities and Exchange Commission under the Exchange Act.
(d) "Business Day" shall mean any day other than a Saturday,
Sunday, or a day on which commercial banks in the City of New York are
authorized or obligated by law or executive order to close.
(e) "capital stock" shall mean (i) in the case of a corporation,
corporate stock, (ii) in the case of an association or business entity, any
and all shares, interests, participations, rights or other equivalents
(however designated) of corporate stock, (iii) in the case of a partnership or
limited liability company, partnership or membership interests (whether
general or limited) and (iv) any other interest or participation that confers
on a person the right to receive a share of the profits and losses of, or
distributions of assets of, the issuing person.
(f) "Change in Control" shall mean any of the following:
(i) the acquisition by any individual, entity or group
(within the meaning of Section 13(d)(3) or 14(d)(2) of the Exchange Act),
CUSIP NO. 903236107 SCHEDULE 13D Page 104 of 107
other than the Corporation, or any of its Subsidiaries, or any employee
benefit plan or related trust of the Corporation or any of its Subsidiaries or
any Excluded Person or Excluded Group (an "Acquiring Person"), of beneficial
ownership (within the meaning of Rule 13d-3 promulgated under the Exchange
Act) of more than fifty percent (50%) of the combined voting power of the then
outstanding voting securities of the Corporation entitled to vote generally in
the election of directors; or
(ii) the approval by the stockholders of the Corporation,
other than any Excluded Person or Excluded Group, of a reorganization, merger
or consolidation, in each case, with respect to which all or substantially all
of the individuals and entities who were the respective beneficial owners of
the voting securities of the Corporation immediately prior to such
reorganization, merger or consolidation do not, following such reorganization,
merger or consolidation, beneficially own, directly or indirectly, more than
fifty percent (50%) of the combined voting power of the then outstanding
voting securities entitled to vote generally in the election of directors of
the Corporation resulting from such reorganization, merger or consolidation;
or
(iii) the sale or other disposition of all or any
substantial part of the assets of the Corporation, other than to any Excluded
Person or Excluded Group, in one transaction or series of related
transactions;
provided that the occurrence of any event identified in subparagraphs (i)
through (iii) above that would otherwise be treated as a Change in Control
shall not constitute a Change in Control hereunder if (x) the Board of
Directors of the Corporation, by vote duly taken, and (y) the Requisite
Holders of Series B Preferred Stock, by written consent, shall so determine.
(g) "Closing Price" per share of Common Stock on any date shall
mean the last sale price, or, in case no such sale takes place on such day,
the average of the closing bid and asked prices, in either case as reported on
the Nasdaq National Market or in the principal consolidated transaction
reporting system with respect to securities listed or admitted to trading on
the New York Stock Exchange or American Stock Exchange, as the case may be,
or, if the Common Stock is listed or admitted to trading on the New York Stock
Exchange or American Stock Exchange, or, if the Common Stock is not listed or
admitted to trading on any national securities exchange, the last quoted sale
price or, if not so quoted, the average of the high bid and low asked prices
in the over-the-counter market, as reported by the National Association of
Securities Dealers, Inc. Automated Quotations System ("NASDAQ") or such other
system then in use, or, if on any such date the Common Stock is not quoted by
any such organization, the average of the Closing bid and asked prices as
furnished by a professional market maker making a market in the Common Stock
selected by the Board of Directors and reasonably acceptable to the Requisite
Holders.
(h) "Conversion Price" shall mean initially $21.70 per share, as
adjusted from time to time in accordance with Section 8.
CUSIP NO. 903236107 SCHEDULE 13D Page 105 of 107
(i) "Conversion Value" per share of Series B Preferred Stock
shall mean an amount equal to the sum of (x) $2,170.00, (y) all Accrued
Dividends thereon to the date of conversion and (z) the Acceleration Amount.
(j) "Current Market Price" per share of Common Stock on any date
shall mean the average of the Closing Prices of a share of Common Stock for
the twenty (20) consecutive Trading Days ending on the date in question. If
on any such Trading Day the Common Stock is not quoted by any organization
referred to in the definition of Closing Price, the fair value of the Common
Stock on such day, as reasonably determined in good faith by the Board of
Directors of the Corporation, shall be used.
(k) "Exchange Act" shall mean the Securities Exchange Act of
1934, as amended.
(l) "Exchange Debenture" shall mean the Subordinated Exchange
Debentures of the Corporation, issuable in exchange for the Series B Preferred
Stock.
(m) "Excluded Group" shall mean a "group" (as such term is used
in Sections 13(d) and 14(d) of the Exchange Act) that includes one or more
Excluded Persons; provided that the voting securities of the Corporation
"beneficially owned" (as such term is used in Rule 13d-3 promulgated under the
Exchange Act) by such Excluded Persons represents a majority of the voting
securities "beneficially owned" (as such term is used in Rule 13d-3
promulgated under the Exchange Act) by such group.
(n) "Excluded Person" shall mean each of RCBA Strategic Partners,
L.P., Richard C. Blum & Associates, L.P. and any affiliate (as defined in the
Exchange Act) of any of the foregoing.
(o) "Hurdle Percentage" shall mean 135%.
(p) "Liquidation Preference" shall mean an amount per share of
Series B Preferred Stock equal to the greater of (i) the Conversion Value or
(ii) in the event of any liquidation or winding up of the Corporation, the
amount the holders of the Series B Preferred Stock would have received had
they converted into Common Stock immediately prior to such liquidation or
winding up and, if such liquidation or winding up occurs prior to the Third
Anniversary of the Closing Date of the Securities Purchase Agreement, the
amount such holders would have received had they received the additional
dividends that would have been paid from the date of liquidation or winding up
through such Third Anniversary, and such additional shares were also
converted into Common Stock immediately prior to such liquidation or winding
up.
(q) "Person" shall mean an individual, partnership, corporation,
limited liability company or partnership, unincorporated organization, trust
or joint venture, or a governmental agency or political subdivision thereof,
or other entity of any kind.
CUSIP NO. 903236107 SCHEDULE 13D Page 106 of 107
(r) "Requisite Holders" shall mean the holders of sixty-seven
percent (67%) of the then-outstanding shares of Series B Preferred Stock.
(s) "Securities Purchase Agreement" shall mean that certain
agreement dated as of May 5, 1999 by and among the Corporation and certain
purchasers of the Series B Preferred Stock party thereto.
(t) "Subsidiary" of any Person shall mean any corporation or
other entity of which a majority of the voting power of the voting equity
securities or equity interest is owned, directly or indirectly, by such
Person.
(u) "Surviving Person" shall mean the continuing or surviving
Person of a merger, consolidation or other corporate combination, the Person
receiving a transfer of all or a substantial part of the properties and assets
of the Corporation, or the Person consolidating with or merging into the
Corporation in a merger, consolidation or other corporate combination in which
the Corporation is the continuing or surviving Person, but in connection with
which the Series B Preferred Stock or Common Stock of the Corporation is
exchanged, converted or reinstated into the securities of any other Person or
cash or any other property; provided, however, if such Surviving Person is a
direct or indirect Subsidiary of a Person, the parent entity also shall be
deemed to be a Surviving Person.
(v) "Trading Day" shall mean a day on which the principal
national securities exchange on which the Common Stock is quoted, listed or
admitted to trading is open for the transaction of business or, if the Common
Stock is not quoted, listed or admitted to trading on any national securities
exchange (including the Nasdaq Stock Market), any day other than a Saturday,
Sunday, or a day on which banking institutions in the State of New York are
authorized or obligated by law or executive order to close.
(w) "Triggering Event" shall mean any one or more of the
following:
(i) The Corporation shall fail to redeem any part or all of
the Series B Preferred Stock in accordance with Section 4.
(ii) The Corporation shall fail to pay any dividend on any
Series B Preferred Stock on any dividend payment date in accordance with
Section 2 for any reason, including but not limited to, that such payment is
prohibited by applicable law or the Board of Directors elect not to pay such
dividend, or shall otherwise violate any term of Section 2 and such failure
shall not be cured within a period of 30 days after such dividend payment date
or violation (which cure shall be effected in a manner ensuring the holders
the same yield as if such violation had not occurred).
(iii) The Corporation shall enter into any transaction or
take any action required to be approved by any holders of Series B Preferred
Stock without obtaining the requisite approval of the holders of the Series B
Preferred Stock.
CUSIP NO. 903236107 SCHEDULE 13D Page 107 of 107
(iv) The Corporation shall (A) fail for any reason to issue
Common Stock as required under Section 8 upon the request of any holder of
Series B Preferred Stock; or (B) so long as any shares of the Series B
Preferred Stock are outstanding, fail to make any anti-dilution adjustment
thereunder, and, in each case, such failure to issue Common Stock or to make
such adjustment shall continue for 30 days after notice.
(v) The Corporation shall adopt a plan of liquidation or of
dissolution, or commence a voluntary case under the Federal bankruptcy laws or
any other applicable state or Federal bankruptcy, insolvency or similar law,
or consent to the entry of an order for relief in any involuntary case under
any such law or to the appointment of a receiver, liquidator, assignee,
custodian, trustee or sequestrator (or similar official) of the Corporation or
of any substantial part of its property, or make an assignment for the benefit
of its creditors, or admit in writing its inability to pay its debts generally
as they become due, or if a decree or order for relief in respect of the
Corporation shall be entered by a court having jurisdiction in the premises in
an involuntary case under the Federal bankruptcy laws or any other applicable
Federal or state bankruptcy, insolvency or similar law, or appointing a
receiver, liquidator, assignee, custodian, trustee, sequestrator (or other
similar official) of the Corporation or of any substantial part of its
property, or ordering the winding up or liquidation of its affairs.
(x) "Voting Stock" shall mean the outstanding shares of capital
stock of the Corporation entitled to vote generally in the election of
directors.
IN WITNESS WHEREOF, the Corporation has caused this Certificate of
Designation of Series B Exchangeable Convertible Preferred Stock to be duly
executed by its President and attested to by its Secretary and has caused its
corporate seal to be affixed hereto, this 9th day of June, 1999.
URS CORPORATION
By: /s/ Kent Ainsworth
--------------------------
Kent P. Ainsworth
